Selection from HEOR Bibliography

IMS logo
Search criteria
Condition: Diabetes
 
USO DE DATOS DE PRACTICA REAL PARA ANALIZAR LOS TRATAMIENTOS PRESCRITOS EN LA DIABETES TIPO 2 EN ESPA?A
Authors: Maria Targhetta*, Jean Paul Tang*, Hector Gutierrez*, Nuria Perulero*, Daniel Callejo*, Miriam Solozabal*
Affiliations: IQVIA Spain
Publications: 
XXXIX Jornadas de EconomŪa de la Salud. Albacete, 12 al 14 de junio de 2019
Document Types: , Oral presentation
Countries: , Spain
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf
Condition Year Language Analysis type
, Diabetes 2019 Spanish , Clinical setting: Primary care, Population Based Study, Retrospective database analysis
 
 
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Authors: Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations: IQVIA, Eli Lilly
Publications: 
Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Types: , Article
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31028689
Condition Year Language Analysis type
, Diabetes 2019 English , Retrospective database analysis
 
 
European Multi-Country Drug Utilization Study of Dulaglutide
Authors: Ayad K. Ali1, Karen E. Wells2, Mathieu Rosť3, Massoud Toussi3
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA 2IQVIA, Oakland, MI, USA 3IQVIA, Courbevoie, France
Publications: 
ICPE, Philadelphia, USA, 24-28 August 2019
Document Types: , Abstract
Countries: , France, Germany, Spain, Sweden, UK
Condition Year Language Analysis type
, Diabetes, Drug safety 2019 English , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis
 
 
A population-based analysis of anti-diabetic medications in four Canadian provinces: secular trends and prescribing patterns
Authors: Secrest MH, Azoulay L, Dahl M, Clemens KK, Durand M, Hu N, Targownik L, Turin TC, Dormuth CR, and Filion KB
Affiliations: IQVIA, Cambridge, MA
Publications: 
Pharmacoepidemiology & Drug Safety (in press)
Document Types: , Article, In press/to be published
Countries: , Canada
Condition Year Language Analysis type
, Diabetes, Drug Utlization Study 2019 English , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis
 
 
CLUE: Consequences for life of children with in utero exposure to metformin in Finland
Authors: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch, Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Affiliations: Merck KGaA: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch IQVIA (SF-EPID): Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Publications: 
The International Diabetes Federation (IDF) Congress 2019
Document Types: , Oral presentation
Countries: , Finland
Condition Year Language Analysis type
, Diabetes 2019 English , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Public Health, Retrospective cohort analysis, Retrospective database analysis
 
 
EMPAGLIFLOZIN VS SITAGLITPIN, SAXAGLIPTIN AND LIRAGLUTIDE IN SPAIN. A BUDGET IMPACT MODEL BASED ON THE CORE DIABETES MODEL AND CARDIOVASCULAR OUTCOMES TRIALS
Authors: Carrasco Perez M, Ustyugova A, Rubio M, Callejo-Velasco D, Gasche D, Gonzalez-Rojas Guix N
Affiliations: Boehringer Ingelheim and IQVIA
Publications: 
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2019 English , Budget impact, Clinical setting: Primary care
 
 
Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data
Authors: Kathleen Lang, Hiep Nguyen, Huan Huang, Elise Bauer, Philip Levin
Affiliations: Huan Huang, IQVIA
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , USA
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2018.1437027
Condition Year Language Analysis type
, Diabetes 2018 English , Population Based Study, Retrospective database analysis
 
 
The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling.
Authors: Ramos M, Foos V, McEwan P, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: 
ISPOR 20th Annual European Congress, 2017, November 4-8, Glasgow, Scotland
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Health economics 2018 English , Cost effectiveness
 
 
Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease
Authors: Huan Huang, Sharash Shetty, Elise Bauer, Kathleen Lang
Affiliations: Huan Huang, IQVIA
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , USA
Abstract: http://www.tandfonline.com/eprint/PqtzuUz9tjZ3mSt7AaIz/full
Condition Year Language Analysis type
, Diabetes 2018 English , Population Based Study, Retrospective database analysis
 
 
Child growth and development outcomes following in-utero exposure to metformin versus insulin for treatment of gestational diabetes.
Authors: Landi SN, Radke S, Engel SM, Sturmer T, Boggess K, Howe A, Jonsson Funk M
Affiliations: 
Publications: 
Pharmacoepidemiol Drug Saf 2018: 27 (2):351-351.
Document Types: 
Countries: 
Condition Year Language Analysis type
, Diabetes 2018 English
 
 
A Retrospective Real-World Study of Dapagliflozin Versus Other Oral Antidiabetic Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D).
Authors: Huang H, Bell K, Gani R, Tugwell C, Eudicone J, Krukas‚ÄźHampel MR
Affiliations: Huan Huang is at IQVIA
Publications: 
Am J Manag Care
Document Types: , Article
Countries: , USA
Abstract: https://www.ajmc.com/journals/supplement/2018/real-world-evidence-type2-diabetes-sglt2-inhibitors/retrospective-realworld-study-dapagliflozin-vs-oral-antidiabetic
Condition Year Language Analysis type
, Diabetes 2018 English , Population Based Study
 
 
"Risk of chronic kidney disease in young adults with impaired glucose tolerance/ impaired fasting glucose: a retrospective cohort study using electronic primary care records"
Authors: Ferozkhan Jadhakhan, Tom Marshall, Ronan Ryan and Paramjit Gill.
Affiliations: University of Birmingham
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2018 English , Retrospective database analysis
 
 
EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
Authors: Bodaghi Charles, Benque Emma, Troubat Arnaud
Affiliations: IQVIA France - RWI
Publications: 
ISPOR 2018
Document Types: , Poster
Countries: , France, Germany, Spain, UK
Condition Year Language Analysis type
, Diabetes 2018 English , Clinical setting: Home care, Pricing & Reimbursement
 
 
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.
Authors: Palmer AJ1, Si L1, Tew M2, Hua X2, Willis MS3, Asseburg C3, McEwan P4, Leal J5, Gray A5, Foos V6, Lamotte M6, Feenstra T7, 8, O‚ÄôConnor PC 9, Brandle M 10, Smolen HJ11, Gahn JC11, Valentine WJ12, Pollock RF12, Breeze P13, Brennan A13, Pollard D13, Ye W14, Herman WH15, Isaman DJ14, Kuo S16, Laiteerapong N17, Tran-Duy A2, Clarke PM2
Affiliations: 1 University of Tasmania, Hobart, Tasmania, Australia 2 University of Melbourne, Melbourne, Victoria, Australia 3 The Swedish Institute for Health Economics, Lund, Sweden 4 Health Economics and Outcomes Research Ltd., Cardiff, UK 5 University of Oxford, Oxford, UK 6 IQVIA, Zaventem, Belgium 7 National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands 8 Groningen University, Groningen, The Netherlands 9 HealthPartners Institute and HealthPartners Center for Chronic Care Innovation, Minneapolis, MN, USA 10 Kantonsspital St. Gallen, St. Gallen, Switzerland 11 Medical Decision Modeling Inc., Indianapolis, IN, USA 12 Ossian Health Economics and Communications, Basel, Switzerland 13 University of Sheffield, Sheffield, UK 14 University of Michigan, Ann Arbor, MI, USA 15 University of Michigan, Ann Arbor, MI, USA 16 University of Michigan, Ann Arbor, MI, USA 17 University of Chicago, Chicago, IL, USA
Publications: 
Value in Health, 2018, 21(6): 724-731
Document Types: , Article
Countries: , International
Abstract: https://doi.org/10.1016/j.jval.2018.02.002
Condition Year Language Analysis type
, Diabetes, Health economics 2018 English , Cost effectiveness
 
 
Review and Validation of Cardiovascular Risk Prediction Models in East Asian Populations.
Authors: Foos V, McEwan P, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: 
Value in Health, Volume 21, Supplement 1, May 2018, Page S220
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Health economics 2018 English , Cost effectiveness
 
 
Changes in Patient Characteristics, Glucose Lowering Treatment, Glycemic Control and Complications in Type 2 Diabetes in General Practices (Disease Analyzer, Germany: 2008-2016)
Authors: Rathmann W, Scheerer M, Rohwedder K, Busch S, Kostev K
Affiliations: 
Publications: 
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2018 English
 
 
Increased Depression Symptom Score in Newly Diagnosed Type 2 Diabetes Patients
Authors: Rathmann W, Engelhard J, ANderson D, Kostev K, Zou M, Busch S, Kuss O, Hahn M
Affiliations: 
Publications: 
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes, Mental health 2018 English
 
 
Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Testing in Type 2 Diabetes Mellitus: A Retrospective Study with 43,509 Patients
Authors: Kostev K, Lucas A, Jacob L
Affiliations: 
Publications: 
EXP CLIN ENDOCRINOL DIABETES. 2018 MAR 12.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes, Metabolic Disorders , Vascular disease 2018 English , Retrospective cohort analysis
 
 
Assessing the Benefits of Co-pay Card Usage Among Diabetic Patients in Canada
Authors: Jing Guo 1, Christian Silva 1, Chris Stewart 1, Andrew Leung 1, Behlool Khan 2, Johanna Mancini 2
Affiliations: 1 Department of Mechanical and Industrial Engineering, University of Toronto 2 IQVIA
Publications: 
Document Types: , Poster
Countries: , Canada
Abstract: http://imsbrogancapabilities.com/pdf/rwe/frontiers-2018-final-poster-for-presentation.pdf
Condition Year Language Analysis type
, Diabetes 2018 English , Retrospective cohort analysis
 
 
Persistence with Insulin Glargine 300 lU/mL compared to other Basal Insulins: A Canadian Retrospective Cohort Study
Authors: Kobina Quansah 1, Luc Sauriol 2, Atif Kukaswadia 1, Samantha Bremner 3, Bradley Millson 3
Affiliations: 1 IQVIA, Mississauga, ON, Canada, 2 Sanofi, Laval, QC, Canada, 3 IQVIA, Kanata, ON, Canada
Publications: 
ADA 2018, June 22-26, 2018, Orlando, FL
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2018 English , Retrospective cohort analysis
 
 
Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes
Authors: Mocarski M, Yeaw J, Divino V, DeKoven M, Guerrero G, Langer J, Thorsted BL
Affiliations: Novo Nordisk, IQVIA
Publications: 
J Manag Care Spec Pharm
Document Types: , Article
Countries: , USA
Abstract: https://www.jmcp.org/doi/10.18553/jmcp.2017.17218
Condition Year Language Analysis type
, Diabetes 2018 English , Utility analysis
 
 
Real-World Use of Dulaglutide in Europe: A Multi-Country Drug Utilization Study
Authors: Ali AK, Toussi M, Phillips S, Roste M
Affiliations: Ali AK: Eli Lilly and Company; Toussi M: IQVIA; Phillips S: IQVIA; Roste M: IQVIA
Publications: 
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , France, Germany, Spain, Sweden
Condition Year Language Analysis type
, Diabetes, Drug Utlization Study, Drug Utlization Study 2018 English , Database Study, Epidemiological study
 
 
Identification of Incident Pancreatic Cancer in Administrative Health Data: A Validation Study by the Canadian Network for Observational Drug Effect Studies
Authors: Wu JW, Axzoulay L, Huang A, Paterson M, Wu F, Secrest MH, Filion K
Affiliations: Wu JW: Analysis Group; Secrest MH: IQVIA
Publications: 
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , Canada
Condition Year Language Analysis type
, Database Validity and methodology, Diabetes, Oncology 2018 English , Database Study, Retrospective cohort analysis, Retrospective database analysis
 
 
The impact of non-medical switch on type 2 diabetes patients treated with canagliflozin in the commercially insured US population.
Authors: Blonde L, Burudpakdee C, Divino V, Bookhart B, Cai J, Pfeifer M, Coleman CI.
Affiliations: Ochsner Medical Center, Hartford Hospital Evidence-Based Practice Center, Janssen Scientific Affairs, Janssen Medical Affairs, IQVIA
Publications: 
Curr Med Res Opin.
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29671627
Condition Year Language Analysis type
, Diabetes 2018 English , Retrospective database analysis
 
 
TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES
Authors: Norrbacka K, Divino V, Boye K, Lebrec J, Dekoven M
Affiliations: Eli Lilly, IQVIA
Publications: 
ISPOR Europe 2018
Document Types: , Poster
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84796?pdfid=57383
Condition Year Language Analysis type
, Diabetes 2018 English , Retrospective database analysis
 
 
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study.
Authors: Federici, M.O., McQuillan, J., Biricolti, G., Losi, S.
Affiliations: Eli Lilly Italy; IQVIA London
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2018 English , Epidemiological study
 
 
Different patterns of second‚Äźline treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Authors: Persson F, Bodegard J, Lahtela JT, Nystr√∂m T, J√łrgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW
Affiliations: StatFinn & EPID Research, Espoo, Finland
Publications: 
Endocrinol Diabetes Metab.
Document Types: , Article
Countries: , Denmark, Finland, Norway, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354817/
Condition Year Language Analysis type
, Diabetes 2018 English , Population Based Study, Retrospective database analysis
 
 
Comparison of cost-effectiveness acceptability curves (CEAC) in modeled analyses with and without established heterogeneity of patient characteristics.
Authors: Foos V, McEwan P, Lamotte M
Affiliations: 
Publications: 
22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2017 English , Cost effectiveness
 
 
Estimating glomerular filtration rate in primary care electronic medical record databases in Europe
Authors: Jouaville SL1, Bizouard G1, Boutmy E1, Keja J2
Affiliations: 1QuintilesIMS, Boulogne Billancourt, France, 2QuintilesIMS, Rotterdam, Netherlands
Publications: 
22nd ISPOR Annual International Meeting, Boston, 2017
Document Types: , Abstract
Countries: , Germany, UK
Condition Year Language Analysis type
, Diabetes, Methodology, Nephrology 2017 English , Clinical setting: Primary care, Retrospective database analysis
 
 
Assessing the economic burden of type 2 diabetes in China reflecting the current standard of the disease management and for improved management scenarios using a modeling approach.
Authors: Foos V1, Lamotte M1, McEwan P4, Jiang X3, Zhang YL3, Qu S2, De Moor R1, Ramos R1, Xiong T2, Wang K3
Affiliations: 1 IMS Health, Brussels, Belgium 2 IMS Health, Shanghai, China 3 Eli Lilly, Shanghai, China 4 Swansea University, Wales
Publications: 
22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA
Document Types: , Abstract
Countries: , China
Condition Year Language Analysis type
, Diabetes 2017 English , Cost effectiveness
 
 
Approaches to standardizing cardiovascular risk equation endpoints in order to facilitate their inclusion within a type 2 diabetes model.
Authors: McEwan P, Foos V, Lamotte M
Affiliations: 
Publications: 
22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2017 English , Cost effectiveness
 
 
Etude DISCOVER France - étude enrichie visant à décrire la prise en charge des patients diabétiques de type 2
Authors: Harmand S.1, Maillard C.1, Thomas F.2
Affiliations: 1. QuintilesIMS, La D√©fense, France. 2. Astra Zeneca, La D√©fense, France
Publications: 
ADELF-SFSP congress (l'Association des épidémiologistes de langue française - Société française de santé publique) June 2017 in France
Document Types: , Abstract, Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2017 French , Clinical setting: Primary care, Longitudinal study, Observational study, Patient questionnaire, Quality of life, Real World Data
 
 
Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation
Authors: Jensen ML1,2, J√łrgensen ME1, Hansen EH2, Aagaard L3, Carstensen B1.
Affiliations: 1 Steno Diabetes Center Copenhagen, Gentofte, Denmark. QuintilesIMS 2 Faculty of Health and Medical Sciences, Department of Pharmacy, Section for Social and Clinical Pharmacy, Universitetsparken 2, University of Copenhagen,Denmark. 3 Faculty of Health, University of Southern Denmark, Odense, Denmark.
Publications: 
PLoS One. 2017; 12(6): e0179546.
Document Types: , Article
Countries: , Denmark
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493299/
Condition Year Language Analysis type
, Clinical practice, Diabetes 2017 English , clinical setting: Secondary care, Compliance, Epidemiological study, Retrospective cohort analysis
 
 
The impact of biosimilar launch on molecule price and pharmaceutical expense: the case of the insulin glargine in Italy
Authors: Tucci C1, Cioni L1, Mantuano M1, Tettamanti A1
Affiliations: 1 QuintilesIMS, Milan, Italy
Publications: 
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Diabetes, Health policy, Pricing and reimbursement, Regulatory 2017 English , Literature Review, Pricing & Reimbursement, Public Health
 
 
Regional Differences in Insulin Therapy Regimens in 5 European Countries
Authors: Rathmann W, Czech M, Franek E, Kostev K
Affiliations: 
Publications: 
Int J Clin Pharmacol Ther. 2017 May;55(5):403-408.
Document Types: , Article
Countries: , France, Germany, Hungary, Poland, UK
Condition Year Language Analysis type
, Diabetes 2017 English
 
 
Risk of non-fatal stroke in type 2 diabetes mellitus patients: a retrospective comparison between disease management programs and standard care
Authors: Wiefarn S, Heumann C, Rettelbach A, Karel K
Affiliations: 
Publications: 
J Diabetes Sci Technol. 2017 Jul;11(4):808-813.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes, Stroke and other CNS 2017 English
 
 
Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy In Type 2 Diabetes: A Primary Care Database Study
Authors: Kostev K, Pscherer S, Rist R, Busch S, Scheerer MF
Affiliations: 
Publications: 
J Diabetes Sci Technol. 2017 May;11(3):590-596.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2017 English
 
 
Calculated Daily Insulin Dosages Overestimate Prescribed Insulin Doses in Type 2 Diabetes: A Primary Care Database Study.
Authors: Kostev K, Rathmann W
Affiliations: 
Publications: 
J Diabetes Sci Technol. 2017 May;11(3):597-601.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2017 English , Database Study
 
 
Treatment Persistence of Basal Insulins in Poland and Germany
Authors: Rathmann W, Czech M, Franek E, Kostev K
Affiliations: 
Publications: 
Int J Clin Pharmacol Ther. 2017 Feb;55(2):119-125.
Document Types: , Article
Countries: , Germany, Poland
Condition Year Language Analysis type
, Diabetes 2017 English
 
 
Psoriasis risk in patients with type 2 diabetes in German primary care practices
Authors: Jacob L, Kostev K
Affiliations: 
Publications: 
Prim Care Diabetes. 2017 Feb;11(1):52-56
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Dermatology, Diabetes 2017 English
 
 
Treatment outcomes and tolerability following initiation of GLP-1 Receptor Agonists among Type 2 diabetes patients in Primary Care Practices in Germany
Authors: Qiao Q, Johnsson K, Grandy S, Kostev K
Affiliations: 
Publications: 
J Diabetes Sci Technol. 2017 Mar;11(2):272-277.
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2017 English
 
 
Prescription patterns and the cost of antihyperglycemic drugs in patients with type 2 diabetes mellitus in Germany
Authors: Jacob L, von Vultee C, Kostev K
Affiliations: 
Publications: 
J Diabetes Sci Technol. 2017 Jan;11(1):123-127.
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2017 English
 
 
Impact of disease management program on HbA1c values in diabetes type 2 patients in Germany
Authors: Kostev K , Rockel T, Jacob J
Affiliations: 
Publications: 
J Diabetes Sci Technol. 2017 Jan;11(1):117-122.
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2017 English
 
 
Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: Reply to Dr. Driessen and colleagues [letter].
Authors: Kostev K, Dombrwoski S
Affiliations: Epidemiology, QuintilesIMS, Darmst√§dter Landstra√üe 108, 60598, Frankfurt am Main, Germany. kkostev@de.imshealth.com. Epidemiology, QuintilesIMS, Darmst√§dter Landstra√üe 108, 60598, Frankfurt am Main, Germany.
Publications: 
Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4139-4. [Epub ahead of print]
Document Types: , Abstract, Letter
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28707089
Condition Year Language Analysis type
, Diabetes 2017 English
 
 
Persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients with dementia in Germany
Authors: Jacob L, Adam-Schnepf L, Kostev K
Affiliations: Faculty of Medicine, University of Paris 5, Paris, France. Department of Neurology, Epilepsy Center, University of Erlangen, Germany. Epidemiology QuintilesIMS, Frankfurt, Germany. Electronic address: kkostev@de.imshealth.com.
Publications: 
J Diabetes Sci Technol. 2017 Jun 1:1932296817719090
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28648971
Condition Year Language Analysis type
, Diabetes, Neurological disorders 2017 English , Retrospective database analysis
 
 
Prescription patterns and disease control in type 2 diabetes mellitus patients in nursing home and home care settings: a retrospective analysis in Germany
Authors: Kostev K, Rockel T, Jacob L
Affiliations: QuintilesIMS, Frankfurt, Germany. Faculty of Medicine, University of Paris 5, Paris, France.
Publications: 
J Diabetes Sci Technol. 2017
J Diabetes Sci Technol. 2018 Jan;12(1):136-139
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28539088
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective cohort analysis
 
 
Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany ‚Äď a retrospective analysis of real-world data
Authors: Dombrowski S, Kostev K, Jacob L
Affiliations: 
Publications: 
Osteoporos Int. 2017 Apr 29. doi: 10.1007/s00198-017-4051-y. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2017 English , Real World Data, Retrospective cohort analysis
 
 
Seasonality of insulin use in German outpatients with diabetes: a retrospective analysis
Authors: Kostev K, Gl√§ser S, Jacob L
Affiliations: 
Publications: 
J Diabetes Sci Technol. 2017 Apr 1:1932296817703994. doi: 10.1177/1932296817703994. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective cohort analysis
 
 
Association of Dipeptidyl Peptidase 4 Inhibitors with Risk of Metastases in Patients with Type 2 Diabetes and Breast, Prostate or Digestive System Cancer
Authors: Rathmann W, Kostev K
Affiliations: 
Publications: 
J Diabetes Complications. 2017 Jan 26. pii: S1056-8727(16)31034-0. doi: 10.1016/j.jdiacomp.2017.01.012. [Epub ahead of print]
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes, Oncology 2017 English
 
 
IMPLICATIONS OF THE GERMAN HTA-PROCESS ON MARKET-UPTAKE OF ORAL TREATMENTS FOR TYPE-2-DIABETES (T2DM) SINCE 2007
Authors: Dr. Roger-Axel Greiner; Tina Fischer; Benno Antoni; Dr. Ariane Batscheider
Affiliations: 
Publications: 
ISPOR 20th Annual European Congress
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2017 English , Market impact, Retrospective database analysis
 
 
The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling.
Authors: Ramos M1, McEwan P2, Lamotte M1, Foos V1
Affiliations: 1 QuintilesIMS, Zaventem, Belgium, 2 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, Nov 4 - 8, 2017, Glasgow, Scotland, United Kingdom
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes, Methodology 2017 English , Cost effectiveness
 
 
Exploration of run-time requirements in probabilistic sensitivity analysis utilizing a patient level based type 2 diabetes simulation model.
Authors: Foos V1, Lamotte M1, Sathananthan A2, Altrabsheh E2, McEwan P3
Affiliations: 1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, London, United Kingdom, 3 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Health economics 2017 English , Cost effectiveness
 
 
L‚Äôobservance m√©dicamenteuse des patients diab√©tiques de type 2 en √ģle-de-france : √©tat des lieux et priorit√©s d‚Äôactions [Drug adherence in patients with type 2 diabetes in √éle-de-France: state of play and priorities for action].
Authors: Bardoulat I1, Chauvin F1, De Sauni√®re A2, Le Jeunne P1, Perrot D1, Collet C2
Affiliations: 1 QuintilesIMS, La D√©fense, France 2 ARS √éle-de-France, Paris, France
Publications: 
9ème Colloque données de santé en vie réelle / AFCROs (Cité Universitaire, Paris, 13 juin 2017)
Document Types: , Oral presentation
Countries: , France
Condition Year Language Analysis type
, Diabetes, Medication compliance 2017 French , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis
 
 
L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions
Authors: Catherine Collet(1) ‚Äď Anne de Sauni√®re (1) ‚Äď Dominique Perrot (2) ‚Äď Isabelle Bardoulat (2)
Affiliations: (1) ARS Ile de France, Paris, France ‚Äď (2) Quintiles IMS, Paris, France
Publications: 
Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes, Medication compliance 2017 French , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis
 
 
L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions [Drug adherence in patients with type II diabetes in the Île-de-France region: study results and priorities for action].
Authors: Collet C1, De Sauni√®re A1, Perrot D2, Bardoulat I2
Affiliations: 1 ARS Ile de France, Paris, France 2 Quintiles IMS, Paris, France
Publications: 
Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes, Medication compliance 2017 French , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis
 
 
An√°lisis de coste-efectividad de empagliflozina en pacientes con diabetes mellitus tipo 2 y enfermedad cardiovascular establecida en Espa√Īa [Analysis of cost-effectiveness of empagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease established in Spain].
Authors: Barrull C1, Massafrets M2, Planellas L1, Perulero N1
Affiliations: 1 RWI, QuintilesIMS, Barcelona 2 Market Access Department, Boehringer Ingelheim, Barcelona
Publications: 
XXXVII Jornadas de Econom√≠a de la Salud2017, 6 - 8 de septiembre, Barcelona, Espa√Īa
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Health economics, Pricing and reimbursement 2017 Spanish , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Cost effectiveness, Cost utility, Literature Review, Patient questionnaire, Randomised controlled trial
 
 
GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries.
Authors: Divino V., DeKoven M., Khan FA., Boye KS., Sapin H., Norrbacka K.
Affiliations: Lilly. IMS authors: Divino V, DeKoven M
Publications: 
Diabetes Ther.
Document Types: , Article
Countries: , Belgium, France, Germany, Netherlands, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28070733
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Adherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United States.
Authors: Cai J., Divino V., Burudpakdee C.
Affiliations: Janssen. IMS authors: Divino V, Burudpakdee C
Publications: 
Curr Med Res Opin.
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28418262
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Real-World Basal Insulin Intensification Patterns in the United States
Authors: Mocarski M., Yeaw J., Divino V., DeKoven M., Guerrero G., Langer J., Thorsted B.
Affiliations: Novo Nordisk. IMS authors: Yeaw J, Divino V, DeKoven M
Publications: 
AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017
Document Types: , Poster
Countries: , USA
Abstract: http://www.jmcp.org/mwg-internal/de5fs23hu73ds/progress?id=4SaagFc0EJa9TDRbm9m3nOTNIHytJhnoIrRBnUTh5TE,&dl
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Dosing Concordance with Prescribing Information (PI) of Dipeptidyl-Peptidase-IV Inhibitors (DPP4-is) When Renal Function
Authors: Huang H, Shetty S, Weijia W, Bauer E, Pascual JR, White C
Affiliations: QuintilesIMS
Publications: 
Annual Congress of Endocrine Disorders and Therapies 2017
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2017 English , Epidemiological study, Population Based Study, Retrospective database analysis
 
 
A Retrospective Real-World Study of Dapagliflozin vs. Other Oral Antidiabetic Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D)
Authors: Huan Huang, Kelly Bell, Ray Gani, Cathy Tugwell, James Eudicone, Michelle R. Krukas-Hampel
Affiliations: QuintilesIMS
Publications: 
American Diabetes Association 2017
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2017 English , Epidemiological study, Retrospective database analysis
 
 
A Retrospective Real-World Study of Dapagliflozin versus Other Oral Antidiabetic (OAD) Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D) and hypertension
Authors: Huan Huang, Kelly Bell, Ray Gani, Cathy Tugwell, James Eudicone, Michelle R. Krukas-Hampel
Affiliations: QuintilesIMS
Publications: 
ISPOR 2017
Document Types: , Poster
Countries: , USA
Abstract: https://www.ispor.org/research_pdfs/55/pdffiles/PDB14.pdf
Condition Year Language Analysis type
, Diabetes 2017 English , Epidemiological study, Retrospective database analysis
 
 
"Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a largescale multinational family of cohort studies of five outcomes"
Authors: "Vincent Lo Re, Dena M Carbonari, M Elle Saine, Craig W Newcomb, Jason A Roy, Qing Liu, Qufei Wu, Serena Cardillo, Kevin Haynes, Stephen E Kimmel, Peter P Reese, David J Margolis, Andrea J Apter, K Rajender Reddy, Sean Hennessy, Harshvinder Bhullar, Arlene M Gallagher, Daina B Esposito, Brian L Strom."
Affiliations: University of Pennsylvania
Publications: 
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs
Authors: Saine ME, Gizaw M, Carbonari DM, Newcomb CW, Roy JA, Cardillo S, Esposito DB, Bhullar H, Gallagher AM, Strom BL & Lo Re V 3rd
Affiliations: Perelman School of Medicine, University of Pennsylvania
Publications: 
Pharmacoepidemiology and Drug Safety
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Database Validity and methodology, Diabetes 2017 English , Retrospective database analysis
 
 
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a largescale multinational family of cohort studies of five outcomes
Authors: Lo Re V, Carbonari DM, Saine ME, Newcomb CW, Roy JA, Liu Q, Wu Q, Cardillo S, Haynes K, Kimmel SE, Reese PP, Margolis DJ, Apter AJ, Reddy KR, Hennessy S, Bhullar H, Gallagher AM, Esposito DB & Strom BL
Affiliations: University of Pennsylvania
Publications: 
BMJ Open Diabetes Research & Care
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom
Authors: Feher M, Vega-Hernandez G, Mocevic E, Buysse B, Myland M, Power GS, Nystrup Husemoen LL, Kim J & Witte DR
Affiliations: Chelsea and Westminster Hospital
Publications: 
Diabetes Therapy
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes, Drug Utlization Study 2017 English , Retrospective database analysis
 
 
"Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom."
Authors: "Michael Feher . Gabriela Vega-Hernandez . Emina Mocevic .Brian Buysse . Melissa Myland . Geraldine S. Power . Lise L. Nystrup Husemoen . Joseph Kim . Daniel R. Witte."
Affiliations: IQVIA/Novo Nordisk
Publications: 
Diabetes Therapy
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Determinants of the relationship between improved glucose control and modelled health outcomes in type 2 diabetes simulation models.
Authors: Foos V1, Lamotte M1, Altrabsheh E2, Sathananthan A2, McEwan P3
Affiliations: 1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, London, United Kingdom, 3 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, November 4 - 8, Glasgow, Scotland
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Health economics 2017 English , Cost effectiveness
 
 
Real-world basal insulin intensification patterns in the United States
Authors: Thorsted B, Divino V, DeKoven M, Guerrero G,Langer J, Yeaw J,
Affiliations: Novo Nordisk. IMS authors: Yeaw J, Divino V, DeKoven M
Publications: 
53rd EASD Annual Meeting
Document Types: , Poster
Countries: , USA
Abstract: https://www.easd.org/virtualmeeting/home.html#!resources/real-world-basal-insulin-intensification-patterns-in-the-united-states-cc3f25a7-276f-451c-9618-05a417f5fce9
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
SCH√ČMAS TH√ČRAPEUTIQUES ET POSOLOGIQUES CHEZ DES PATIENTS AVEC UN DIAB√ąTE DE TYPE 2 (DT2) INITIANT UN TRAITEMENT PAR AGONISTE DU R√ČCEPTEUR DU GLUCAGON-LIKE PEPTIDE 1 (AR GLP-1) EN EUROPE
Authors: Norrbacka K, Divino V, Dekoven M, Boye KS
Affiliations: Eli Lilly, IQVIA
Publications: 
Societé Francophone du Diabete 2017
Document Types: , Poster
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/evenements/17sfd_final_v12.pdf
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom.
Authors: Feher, M., Vega-Hernandez, G., Mocevic, E., Buysse, B., Myland, M., Power, GS
Affiliations: Chelsea and Westminster Hospital; IQVIA London
Publications: 
Document Types: , Article
Countries: , England
Condition Year Language Analysis type
, Diabetes 2017 English , Epidemiological study
 
 
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study
Authors: Strongman H, Korhonen P, Williams R, Bahmanyar S, Hoti F, Christopher S, Majak M, Kool-Houweling L, Linder M, Dolin P, Heintjes EM
Affiliations: EPID Research, Espoo, Finland
Publications: 
BMJ Open Diab Res Care (2017);5: p. e000364-e000364
Document Types: , Article
Countries: , Finland, Netherlands, Sweden, UK
Abstract: https://drc.bmj.com/content/5/1/e000364
Condition Year Language Analysis type
, Diabetes 2017 English , Epidemiological study, Retrospective database analysis
 
 
Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults
Authors: Strandberg AY, Khanfir H, M√§kimattila S, Saukkonen T, Strandberg TE, Hoti F
Affiliations: University of Helsinki, Clinicum, Helsinki, Finland, Aava Medical Centre, Kerava, Finland
Publications: 
Ann Med. (2017) 49(4):357-364
Document Types: , Article
Countries: , Finland
Abstract: https://www.tandfonline.com/doi/abs/10.1080/07853890.2016.1278302?journalCode=iann20
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
Authors: Vega-Hernandez G1, Wojcik R2, Schlueter M2
Affiliations: 1 Novo Nordisk Ltd, London, UK. 2 QuintilesIMS, London, UK
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2017 English , Retrospective database analysis
 
 
Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden
Authors: Lind M1,2, Matsson PO3, Linder R4, Svenningsson I5, J√łrgensen L6, Ploug UJ7, Gydesen H7, Dorkhan M8, Larsen S8, Johansson G9.
Affiliations: 1Department of Medicine, NU-Hospital Group, Trollh√§ttan/Uddevalla, Sweden. lind.marcus@telia.com. 2Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. lind.marcus@telia.com. 3Domnarvet VC, Borl√§nge, Sweden. 4Pygargus, Stockholm, Sweden. 5Research and Development Unit, Primary Health Care, N√§rh√§lsan, V√§nersborg, Sweden. 6IMS Health, Stockholm, Sweden. 7Novo Nordisk A/S, S√łborg, Denmark. 8Novo Nordisk Scandinavia AB, Malm√∂, Sweden. 9Department of Caring Sciences and Family Medicine, Uppsala University, Uppsala, Sweden.
Publications: 
Diabetes Ther
Document Types: , Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900983/
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective cohort analysis
 
 
Implications of introducing patient heterogeneity in cost effectiveness modeling.
Authors: Foos V1, McEwan P2, Lamotte M3
Affiliations: 1 IMS Health, Zaventem, Belgium 2 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom 3 IMS Health, Vilvoorde, Belgium
Publications: 
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2016 English , Methodology
 
 
Replacing input probability distributions with mean values can bias simulation output: an illustration using the Core Diabetes Model.
Authors: McEwan P1, Foos V2, Lamotte M3
Affiliations: 1 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom 2 IMS Health, Zaventem, Belgium, 3 IMS Health, Vilvoorde, Belgium
Publications: 
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2016 English , Methodology
 
 
Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study.
Authors: Lefebvre P1, Pilon D1, Robitaille MN1, Lafeuille MH1, Chow W2, Pfeifer M2, Duh MS3.
Affiliations: 1a Groupe d'analyse, Lt√©e , Montr√©al , Qu√©bec , Canada ; 2b Janssen Scientific Affairs, LLC , Raritan , NJ , USA ; 3c Analysis Group, Inc. , Boston , MA , USA.
Publications: 
Curr Med Res Opin. 2016 Jun;32(6):1151-9
Document Types: , Article
Countries: , USA
Abstract: http://www.tandfonline.com/doi/full/10.1080/03007995.2016.1183604
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes
Authors: Anyanwagu U, Mamza J, Mehta R, Donnelly R, Idris I
Affiliations: Division of Medical Sciences & Graduate Entry Medicine, School of Medicine; Research Design Services (East Midlands), School of Medicine
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Miscellaneous 2016 English , Retrospective database analysis
 
 
Type 2 diabetes, high blood pressure and acute pancreatitis
Authors: Bexelius TS, Ljung R, Garcia Rodriguez LA
Affiliations: Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, and Department of Medical Epidemiology and Biostatistics, Karolinska Institute
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Miscellaneous 2016 English , Retrospective database analysis
 
 
Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database
Authors: Mamza J, Mehta R, Donnelly R, Idris I
Affiliations: Division of Medical Sciences & Graduate Entry Medicine, School of Medicine; Trent Research Design Services, University of Nottingham
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study
Authors: Mamza J, Mehta R, Donnelly R, Idris I
Affiliations: Division of Medical Sciences & Graduate Entry Medicine , University of Nottingham; Research Design Services (East Midlands), School of Medicine
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Intra-cluster and inter-period correlation coefficients for cross-sectional cluster randomised controlled trials for type-2 diabetes in UK primary care
Authors: Martin J, Girling A, Nirantharakumar K, Ryan R, Marshall T, Hemming K
Affiliations: Institute of Applied Health Research, University of Birmingham
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Risk factors for diabetic retinopathy in people with Type 2 diabetes: A case-control study in a UK primary care setting
Authors: Mart√≠n-Merino E, Fortuny J, Rivero-Ferrer E, Lind M, Garcia-Rodriguez LA
Affiliations: Centro Espa√Īol de Investigaci√≥n Farmacoepidemiol√≥gica; DS&E ‚ÄďGlobalClinicalEpidemiology,NovartisFarmaceuticaS.A.,Barcelona; Institute ofMedicine,UniversityofGothenburg,Gothenburg; Department ofMedicine,NU-HospitalOrganization,Uddevalla
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project
Authors: Roberto G, Leal I, Sattar N, Loomis AK, Avillach P, Egger P, van Wijngaarden R, Ansell D, Reisberg S, Tammesoo ML, Alavere H, Pasqua A, Pedersen L, Cunningham J, Tramontan L, Mayer MA, Herings R, Coloma P, Lapi F, Sturkenboom M, van der Lei J, Schuemie MJ, Rijnbeek P, Gini R
Affiliations: Development, Groton, Connecticut, United States of America; Department of Biomedical Informatics, Harvard Medical School & Children‚Äôs Hospital Informatics Program, Boston Children‚Äôs Hospital, Boston, Massachusetts, United States of America; GlaxoSmithKline, Worldwide Epidemiology GSK, Stockley Park West, Uxbridge, United Kingdom,; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands; The Health Improvement Network, Cegedim Strategic Data Medical Research Ltd, London, United Kingdom; Quretec, Software Technology and Applications Competence Center, University of Tartu, Tartu, Estonia; Estonian Genome Center, University of Tartu, Tartu, Estonia; Tartu University Hospital, Tartu, Estonia; Health Search, Italian College of General Practitioners and Primary Care, Firenze, Italy; Department of Clinical Epidemiology, Aarhus University Hosptial, Aarhus, Denmark; University of Manchester, Manchester, United Kingdom; Arsen√†l.IT Consortium, Veneto's Research Centre for eHealth Innovation, Treviso, Italy,; Hospital del Mar Medical Research Institute (IMIM) and Universitat Pompeu Fabra, Barcelona, Spain; Janssen Research & Development, Epidemiology, Titusville, New Jersey, United States of America,; Observational Health Data Sciences and Informatics, New York, New York, United States of America
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study
Authors: Sharma M, Nazareth I, Petersen I
Affiliations: Department of Primary Care and Population Health, University College London; Department of Clinical Epidemiology, Aarhus University
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany
Authors: Ehlken B, Kostev K
Affiliations: 
Publications: 
ISPOR 19TH ANNUAL EUROPEAN CONGRESS, VIENNA
Document Types: , Conference
Countries: 
Condition Year Language Analysis type
, Diabetes 2016 English
 
 
Cost of Antihyperglycemic Therapy In Type 2 Diabetes Patients Depending on HBA1C And Bmi Values
Authors: Sorg A, Dombrowski S, Kostev K
Affiliations: 
Publications: 
ISPOR 19TH ANNUAL EUROPEAN CONGRESS
Document Types: , Conference
Countries: 
Condition Year Language Analysis type
, Diabetes 2016 English
 
 
Prevalence of medically treated children with ADHD and type 1 diabetes in Germany ‚Äď Analysis of two representative databases
Authors: Kapellen TM, Reimann R, Kiess W, Kostev K
Affiliations: 
Publications: 
J Pediatr Endocrinol Metab. 2016 Nov 1;29(11):1293-1297
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes, Neurological disorders, Pediatrics 2016 English , Epidemiological study
 
 
Changes in HbA1c, Body Weight, and Systolic Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Therapy: A Primary Care Database Study
Authors: Scheerer M, Rist R, Proske O, Meng A, Kostev K
Affiliations: 
Publications: 
Diabetes Metab Syndr Obes. 2016 Oct 31;9:337-345.
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Metabolic Disorders 2016 English , Database Study
 
 
Change in HbA1c after Initiating Second-Line Therapy in Type 2 Diabetes: A Primary Care Database Study.
Authors: Rathmann W, Bongaerts B, Kostev K
Affiliations: 
Publications: 
Diabetes Obes Metab. 2016 Aug;18(8):840-3
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2016 English , Database Study
 
 
Impact of Metformin on Metastases in Patients with Breast Cancer and Type 2 Diabetes
Authors: Jacob L, Kostev K, Rathmann W, Kalder M
Affiliations: 
Publications: 
J Diabetes Complications. 2016 Aug;30(6):1056-9
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes, Oncology 2016 English
 
 
Clinical and Patient-Related Variables Associated with Initiating GLP-1 Receptor Agonist Therapy in Type 2 Diabetes Patients in Primary Care in Germany
Authors: Qiao Q, Grandy S, Hiller J, Kostev K
Affiliations: 
Publications: 
PLoS One. 2016 Mar 28;11(3):e0152281
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2016 English
 
 
Adherence to GLP-1 Receptor Agonist Therapy Administered by Once-Daily or Once-Weekly Injection in Type 2 Diabetes Patients in Germany
Authors: Qiao Q, Grandy S, Ouwens M, Kostev K
Affiliations: 
Publications: 
Diabetes Metab Syndr Obes. 2016 Jun 28;9:201-5
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes, Metabolic Disorders 2016 English
 
 
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records.
Authors: Kolaczynski WM, Hankins M, Ong SH, Richter H, Clemens A, Toussi M.
Affiliations: 
Publications: 
Diabetes Ther. 2016 Sep;7(3):483-96. doi: 10.1007/s13300-016-0177-8.
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Metabolic Disorders 2016 English , Retrospective database analysis
 
 
REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS NEWLY INITIATED WITH ANTIHYPERGLYCEMIC MEDICATIONS IN THE UNITED STATES
Authors: Cai J., Burudpakdee C., Divino V.
Affiliations: Janssen. IMS authors: Burudpakdee C, Divino V
Publications: 
ISPOR 21st Annual International Meeting
Document Types: , Oral presentation
Countries: , USA
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/62486?pdfid=44270
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Treatment and dosing patterns among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Europe.
Authors: Kirsi Norrbacka; Victoria Divino; Mitch DeKoven; Kristina Secnik Boye
Affiliations: Lilly. IMS authors: Divino V, DeKoven M
Publications: 
European Association for the Study of Diabetes 52nd annual meeting
Document Types: , Poster
Countries: , Belgium, France, Germany, Netherlands, Sweden
Abstract: https://www.easd.org/virtualmeeting/home.html#!resources/treatment-and-dosing-patterns-among-patients-with-type-2-diabetes-initiating-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-in-europe-5ef3fe71-7e5d-4bdd-8b32-b4187d2a9aac
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project
Authors: Roberto G, Leal I, Sattar N, Loomis AK, Avillach P, Egger P, van Wijngaarden R, Ansell D, Reisberg S, Tammesoo ML, Alavere H, Pasqua A, Pedersen L, Cunningham J, Tramontan L, Mayer MA, Herings R, Coloma P, Lapi F, Sturkenboom M, van der Lei J, Schuemie MJ, Rijnbeek P & Gini R
Affiliations: Regional Agency for Healthcare Services of Tuscany, Epidemiology unit
Publications: 
PLoS One
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2016 English , Retrospective database analysis
 
 
Adjusting for the Effect of Switching Basal Insulin Treatment on the Risk of First Severe Hypoglycaemia
Authors: Khanfir H, Korhonen P, M√§kimattila S, Hoti F
Affiliations: EPID Research, Espoo, Finland
Publications: 
Pharmacoepidemiology and Drug Safety (2016); 25(S3): 3-679
Document Types: , Abstract
Countries: , Finland
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4070
Condition Year Language Analysis type
, Diabetes 2016 English , Population Based Study, Retrospective database analysis
 
 
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
Authors: Korhonen P, Heintjes E M, Williams R, Hoti F, Christopher S, Majak M, Kool-Houweling L, Strongman H, Linder M, Dolin P, Bahmanyar S
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
BMJ (2016);354:i3903
Document Types: , Article
Countries: , Finland, Netherlands, Sweden, UK
Abstract: https://researchonline.lshtm.ac.uk/4646203/1/Pioglitazone%20use%20and%20risk_GOLD%20VoR.pdf
Condition Year Language Analysis type
, Diabetes 2016 English , Population Based Study, Retrospective cohort analysis
 
 
All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine
Authors: Strandberg AY, Hoti FJ, Strandberg TE, Christopher S, Haukka J, Korhonen P
Affiliations: University of Helsinki, Clinicum, Helsinki, Finland, Aava Medical Centre, Kerava, Finland
Publications: 
PLoS ONE (2016);11(3): e0151910
Document Types: , Article
Countries: , Finland
Abstract: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0151910
Condition Year Language Analysis type
, Diabetes 2016 English , Epidemiological study, Population Based Study, Retrospective database analysis
 
 
Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies.
Authors: McDonell AL1, Kiiskinen U2, Zammit DC3, Kotchie RW1, Thuresson PO3, Nicolay C4, Haslam T1, Bruinsma M5, Janszen-Van Oosterhout AJ6, Otto T4
Affiliations: 1IMS Health, London, UK; 2Eli Lilly and Company, Helsinki, Finland; 3IMS Health, Basel, Switzerland; 4Eli Lilly and Company, Bad Homburg, Germany; 5IMS Health, Rotterdam, the Netherlands; 6Eli Lilly Nederland, Houten, the Netherlands
Publications: 
ClinicoEconomics and Outcomes Research, 2015; 7:95-103
Document Types: , Article
Countries: , Germany, Netherlands, UK
Abstract: http://www.dovepress.com/estimating-the-real-world-daily-usage-and-cost-for-exenatide-twice-dai-peer-reviewed-article-CEOR
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Cost-effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp-30) in type 2 diabetes patients with suboptimal glycaemic control in Singapore
Authors: Goh SY1, Tan SC2, Lim LC3, Chua B4, Hunt B5
Affiliations: 1 Department of Endocrinology, Singapore General Hospital, Singapore 2 Health Economics & Outcomes Research, IMS Health Asia Pacific, Singapore 3 Department of Medicine, Alexandra Hospital, Singapore 4 Department of Vascular Surgery, Singapore General Hospital, Singapore 5 Ossian Health Economics and Communications, Switzerland
Publications: 
Journal of Diabetology, February 2015; 1:2
Document Types: , Online article
Countries: , Singapore
Condition Year Language Analysis type
, Diabetes 2015 English , Cost effectiveness
 
 
If we followed NICE guidelines and treated people with diabetes earlier, patients and the NHS would benefit from a reduction in complications, mortality and direct healthcare costs
Authors: Baxter M1, Hex N2, Samyshkin Y3, Hudson R1, Mahon J2, Alexiou D3, Bartlett C2
Affiliations: 1 Sanofi, Guildford, UK, 2 York Health Economics Consortium, York, UK, 3 IMS Health, London, UK
Publications: 
Diabetes UK Professional Conference 2015 11-13 March 2015, ExCeL London
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2015 English , Cost analysis
 
 
Incidence of Microvascular Outcomes among Type 2 Diabetes Patients Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Cohort Study Using German Electronic Medical Records
Authors: Hankins M1, Ong SH, Richter H, Kolaczynski WM, Clemens A, Vora J, Machnicki G, Toussi M
Affiliations: 1 IMS Health, London, UK 2 Novartis 3 IMS Health, Paris, France
Publications: 
American Diabetes Association’s 75th Scientific Sessions, June 5-9, 2015, Boston, Massachusetts
Document Types: , Oral presentation
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective cohort analysis
 
 
The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study
Authors: Lycett D, Nichols L, Ryan R, Farley A, Roalfe A, Mohammed MA, Szatkowski L, Coleman T, Morris R, Farmer A & Aveyard P
Affiliations: 1Coventry University, Faculty of Health and Life Sciences, Coventry, UK. 2School of Health and Population Sciences, University of Birmingham, Birmingham, UK. 3University of Bradford, Bradford, UK. 4School of Medicine, University of Nottingham, Division of Epidemiology and Public Health, Clinical Sciences Building, Nottingham City Hospital, Nottingham, UK. 5School of Medicine, University of Nottingham, Division of Primary Care, Medical School, Queen's Medical Centre, Nottingham, UK. 6School of Social and Community Medicine, University of Bristol, Canynge Hall, Bristol, UK. 7University of Oxford, Nuffield Department of Primary Care Health Sciences, New Radcliffe House Radcliffe Observatory Quarter, Oxford, UK
Publications: 
Lancet Diabetes Endocrinol 3(6):423-30
Document Types: , Article
Countries: , UK
Abstract: http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00082-0/abstract
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
The effect of past antibiotic exposure on diabetes risk
Authors: Boursi B1,2,3, Mamtani R1, Haynes K1 & Yang YX1
Affiliations: 1Perelman School of Medicine at the University of Pennsylvania,Philadelphia, USA.2 The Integrated Cancer Prevention Center,Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. 3 Tel-Aviv University, Tel-Aviv, Israel
Publications: 
Eur J Endocrinol. 2015 Jun;172(6):639-48. doi: 10.1530/EJE-14-1163. Epub 2015 Mar 24
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25805893
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study
Authors: Toulis KA1, Nirantharakumar K2,3, Ryan R2, Marshall T2 & Hemming K2
Affiliations: 1 Department of Endocrinology, General Military Hospital, Thessaloniki, Greece; 2 Departments of Public Health, Epidemiology, and Biostatistics and Primary Care Clinical Sciences,University of Birmingham, Birmingham , United Kingdom; 3 University Hospitals Birmingham National Health Service Foundation Trust, Birmingham, United Kingdom.
Publications: 
J Clin Endocrinol Metab. 2015 May;100(5):1933-40. doi: 10.1210/jc.2014-3481. Epub 2015 Feb 19.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25695881
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs
Authors: Saine ME, Carbonari DM, Newcomb CW, et al.
Affiliations: Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania
Publications: 
BMC Pharmacology and Toxicology 2015, 16:8 doi:10.1186/s40360-015-0007-z
Document Types: , Article
Countries: , UK, USA
Abstract: http://www.biomedcentral.com/2050-6511/16/8
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases
Authors: Charbonnel B1, Gomes MB2, Khunti K3, Nicolucci A4, Pocock S5, Shestakova MV6, Shimomura I6, Fenici P7, Garc√≠a-√Ālvarez L8, Hammar N9, Hashigami K10, Hiller J8, Medina J11, Surmont FA12, Ji L13
Affiliations: 1University of Nantes, Nantes, France; 2Rio de Janeiro State University, Rio de Janeiro, Brazil; 3University of Leicester, Leicester, UK; 4Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy; 5London School of Hygiene and Tropical Medicine, London, UK; 6Endocrinology Research Center, Moscow, Russian Federation; 7Osaka University, Osaka, Japan; 8AstraZeneca, Cambridge, UK; 9IMS Health, London, UK; 10AstraZeneca, M√∂lndal, Sweden; 11AstraZeneca, Tokyo, Japan; 12AstraZeneca, Madrid, Spain; 13AstraZeneca, Shanghai, China; 14Diabetes Center, Peking University People‚Äôs Hospital, Beijing, China
Publications: 
EASD - 51st Annual Meeting of the European Association for the Study of Diabetes, 14‚Äď18 September 2015, Stockholm, Sweden
Document Types: , Poster
Countries: , Canada, France, Germany, UK
Abstract: http://www.easdvirtualmeeting.org/resources/discovering-treatment-of-type-2-diabetes-in-real-world-settings-using-electronic-medical-record-databases--3
Condition Year Language Analysis type
, Diabetes 2015 English , Real World Data, Retrospective database analysis
 
 
Cost-effectiveness of dulaglutide 1.5mg once weekly for the treatment of patients with type two diabetes mellitus in Sweden
Authors: Raibouaa A1, Borgeke H2, Alexiou D3, Lowin J3, Norrbacka K4
Affiliations: 1Eli Lilly and Company Limited, Windlesham, Surrey, UK, 2Eli Lilly Sweden AB, Solna, Sweden, 3IMS Health, London, UK, 4Eli Lilly and Company, Helsinki, Finland
Publications: 
ISPOR, 18th Annual European Congress,7-11 November 2015
Document Types: , Abstract
Countries: , Italy
Condition Year Language Analysis type
, Diabetes 2015 English , Cost effectiveness
 
 
Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK
Authors: Valentine WJ, Curtis BH, Pollock RF, Van Brunt K, Paczkowski R, Br√§ndle M, Boye KS & Kendall DM
Affiliations: Ossian Health Economics and Communications, Basel, Switzerland
Publications: 
Diabetes Res Clin Pract. 2015 Jul;109(1):95-103.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25989713
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Diabetes, Lower-Extremity Amputation, and Death
Authors: Hoffstad O, Mitra N, Walsh J & Margolis DJ
Affiliations: Department of Biostatistics and Epidemiology, University of Pennsylvania
Publications: 
Diabetes care; vol: 38 no. 10 1852-1857
Document Types: , Article
Countries: , UK
Abstract: http://care.diabetesjournals.org/content/38/10/1852.short?rss=1
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Type 1 Diabetes Is Associated With an Increased Risk of Fracture Across the Life Span: A Population-Based Cohort Study Using The Health Improvement Network (THIN)
Authors: Weber DR, Haynes K, Leonard MB, Willi SM & Denburg MR
Affiliations: Perelman School of Medicine at the University of Pennsylvania
Publications: 
Diabetes Care [ahead of print]
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/26216874
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study
Authors: Lycett D, Nichols L, Ryan R, Farley A, Roalfe A, Mohammed MA, Szatkowski L, Coleman T, Morris R, Farmer A & Aveyard P
Affiliations: School of Health and Population Sciences, University of Birmingham
Publications: 
Lancet Diabetes Endocrinol 3(6):423-30
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Comparative Efficacy of Adding Sitagliptin to Metformin, Sulfonylurea or Dual Therapy: A Propensity Score-Weighted Cohort Study
Authors: Mamza J, Mehta R, Donnelly R & Idris I
Affiliations: Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham
Publications: 
Diabetes Ther. 6(2):213-26
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/26014844
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Incidence of Microvascular Outcomes among Type 2 Diabetes Patients Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Cohort Study Using German Electronic Medical Records
Authors: Matthew Hankins, Siew Hwa Ong, Hartmut Richter, Wlodzimierz M. Kolaczynski, Andreas Clemens, Gerardo Machnicki, Jiten Vora, Massoud Toussi
Affiliations: 
Publications: 
75th Scientific Sessions of the American Diabetes Association, American Diabetes Association’s 75th Scientific Sessions, June 5-9, 2015, Boston, Massachusetts
Document Types: , Conference
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective cohort analysis
 
 
Treatment maintenance duration of dual therapy with metformin and sitagliptin in type 2 diabetes: The ODYSSEE observational study
Authors: Valensi P1, de Pouvourville G2, Benard N3, Chanut-Vogel C3, Kempf C4, Eymard E5, Moisan C3, Dallongeville J6.
Affiliations: 1Department of Endocrinology-Diabetology-Nutrition, Jean-Verdier Hospital, AP-HP, Paris Nord University, CRNH-IdF, CINFO, Bondy, France.2ESSEC, Cergy-Pontoise, France.3MSD France, Courbevoie, France.4CSD, Boulogne, France.5MSD France, Courbevoie, France 6INSERM U744, Institut Pasteur, Lille, France.
Publications: 
Diabetes Metab. 2015 Jun;41(3):231-8
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Diabetes 2015 English , Prospective study
 
 
Durée de maintien d'une bitherapie par Metformine-Sitagliptine chez les diabétiques de type 2 - Etude observationelle ODYSSEE
Authors: C. Moisan 1,, P. Valensi 2, G. De Pouvourville 3, N. Benard 4, C. Chanut-Vogel 4, J. Dallongeville 5
Affiliations: 1 MSD France, Paris, France, 2 Service d‚Äôendocrinologie, diab√©tologie, nutrition, H√īpital Jean-Verdier, CRNH-IdF, CINFO, Bondy, Paris, France, 3 ESSEC, Paris, France, 4 MSD France, Paris, France, 5 INSERM U744, Institut Pasteur, Paris, France.
Publications: 
SFD 2015
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
A CROSS-SECTIONAL STUDY ON INSULIN TREATMENTS AND GLYCEMIC CONTROL IN TYPE 2 DIABETES IN FRANCE, ITALY, GERMANY, UK AND SPAIN
Authors: Phan T1, Boutmy E2, Coulombel N2
Affiliations: 1Novo Nordisk Health Care AG, Z√ľrich, Switzerland, 2IMS Health, Boulogne-Billancourt, France
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.ispor.org/research_pdfs/51/pdffiles/PDB13.pdf
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
CARDIOVASCULAR OUTCOMES OF ANTIDIABETIC THERAPY - RESULTS OF A LITERATURE
Authors: Greiner R, Eheberg D, Paulus G, Batscheider A
Affiliations: IMS Health, Munich, Germany
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2015 English
 
 
Synthetic Glucocorticoids and Early Variations of Blood Pressure: A Population-Based Cohort Study
Authors: Fardet L, Nazareth I1, Petersen I
Affiliations: Department of Primary Care and Population Health, University College London
Publications: 
J Clin Endocrinol Metab. 2015 Jul;100(7):2777-83. doi: 10.1210/jc.2015-1127.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25978108
Condition Year Language Analysis type
, Diabetes, Miscellaneous 2015 English , Retrospective database analysis
 
 
ASSESSMENT OF A FRENCH ENDOCRINOLOGIST ELECTRONIC MEDICAL RECORD DATABASE FOR USE IN OBSERVATIONAL STUDIES
Authors: Hellard C, Jouaville SL, Pilet S, Meihoc A
Affiliations: Cededim Strategic Data, Boulogne-Billancourt, France
Publications: 
ISPOR 20th Annual International Meeting Philadelphia, PA, USA May, 2015
Document Types: , Poster
Countries: , France
Abstract: http://www.ispor.org/research_study_digest/details.asp
Condition Year Language Analysis type
, Database Validity and methodology, Diabetes 2015 English , Retrospective database analysis
 
 
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database.
Authors: Detournay B1, Halimi S2, Robert J1, Deschaseaux C3, Dejager S4.
Affiliations: 1Cemka-Eval, Bourg-la Reine, France. 2Department of Diabetology, Endocrinology and Nutrition, Grenoble University Hospital Center, Grenoble, France ; University Joseph Fourier, Grenoble, France. 3Novartis Pharma SAS, Market Access Department, Rueil-Malmaison, France. 4Novartis Pharma SAS, Medical and Scientific Affairs, Rueil Malmaison, France ; Department of Diabetology, Metabolism and Endocrinology, Piti√©-Salp√©tri√®re Hospital, Paris, France.
Publications: 
Vasc Health Risk Manag. 2015 Jul 17;11:417-25. doi: 10.2147/VHRM.S84507. eCollection 2015.
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Diabetes, Pricing and reimbursement 2015 English , Prospective study, Retrospective database analysis
 
 
Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study
Authors: Grundvold I1, Bodegard J2, Nilsson PM3, Svennblad B4, Johansson G5, √Ėstgren CJ6, Sundstr√∂m J7,8.
Affiliations: 1Department of Cardiology, Oslo University Hospital, Ullevaal, PB 4956, Nydalen, 0424, Oslo, Norway. uxirgr@ous-hf.no. 2AstraZeneca Nordic, S√∂dert√§lje, Sweden. Johan.Bodegard@astrazeneca.com. 3Department of Clinical Sciences, Lund University, Sk√•ne University Hospital, Malm√∂, Sweden. peter.nilsson@med.lu.se. 4Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. bodil.svennblad@ucr.uu.se. 5Department of Public health and Caring Science, Uppsala University, Uppsala, Sweden. gunnar.johansson@pubcare.uu.se. 6Department of Medical and Health Sciences, Link√∂ping University, Link√∂ping, Sweden. carl.johan.ostgren@liu.se. 7Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. johan.sundstrom@medsci.uu.se. 8Department of Medical Sciences, Uppsala University, Uppsala, Sweden. johan.sundstrom@medsci.uu.se.
Publications: 
Cardiovasc Diabetol
Document Types: , Article
Countries: , Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299152/
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2015 English , Real World Evidence
 
 
Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting
Authors: Sabale U1, Bodeg√•rd J2, Sundstr√∂m J3, √Ėstgren CJ4, Nilsson P5, Johansson G3, Svennblad B3, Henriksson M2.
Affiliations: 1AstraZeneca Nordic-Baltic, S√∂dert√§lje, Sweden. Electronic address: ugne.sabale@astrazeneca.com. 2AstraZeneca Nordic-Baltic, S√∂dert√§lje, Sweden. 3Uppsala University, Uppsala, Sweden. 4Link√∂ping University, Link√∂ping, Sweden. 5Lund University, Malm√∂, Sweden
Publications: 
Prim Care Diabetes
Document Types: 
Countries: , Sweden
Abstract: http://www.primary-care-diabetes.com/article/S1751-9918(15)00002-9/abstract
Condition Year Language Analysis type
, Diabetes 2015 English , Cost of illness, Real World Evidence
 
 
Healthcare utilisation and costs following initiation of insulin treatment in type 2 diabetes: a longterm follow-up in clinical practice
Authors: A. Kalkan1, J. Bodegard1, J. Sundstr√∂m2, B. Svennblad2, C. √Ėstgren3, P.M. Nilsson4, G. Johansson2, M. Ekman1
Affiliations: 1 AstraZeneca, S√∂dert√§lje, 2Uppsala University, 3Link√∂ping University, 4Lund University, Malm√∂, Sweden.
Publications: 
European Association for the Study of Diabetes (EASD) Annual Meeting; 2015; Stockholm
Document Types: , Abstract
Countries: , Sweden
Abstract: http://www.easdvirtualmeeting.org/resources/healthcare-utilisation-and-costs-following-initiation-of-insulin-treatment-in-type-2-diabetes-a-long-term-follow-up-in-clinical-practice--2
Condition Year Language Analysis type
, Diabetes 2015 English , Cost of illness, Real World Evidence
 
 
Weight change over time and its link to healthcare costs among newly-diagnosed type 2 diabetes patients in Sweden
Authors: U. Sabale1, J. Bodegard1, J. Sundstr√∂m2, B. Svennblad2, C. √Ėstgren3, P.M. Nilsson4, G. Johansson2, M.Ekman1
Affiliations: 1AstraZeneca, S√∂dert√§lje, 2Uppsala University, Uppsala, 3Link√∂ping University, Link√∂ping, 4Lund University, Malm√∂, Sweden.
Publications: 
European Association for the Study of Diabetes (EASD) Annual Meeting; 2015; Stockholm.
Document Types: , Abstract
Countries: , Sweden
Abstract: http://staging.easdvirtualmeeting.org/resources/weight-change-over-time-and-its-link-to-healthcare-costs-among-newly-diagnosed-type-2-diabetes-patients-in-sweden--2
Condition Year Language Analysis type
, Diabetes 2015 English , Real World Evidence
 
 
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database.
Authors: Detournay B1, Halimi S2, Robert J1, Deschaseaux C3, Dejager S4.
Affiliations: 1Cemka-Eval, Bourg-la Reine, France. 2Department of Diabetology, Endocrinology and Nutrition, Grenoble University Hospital Center, Grenoble, France ; University Joseph Fourier, Grenoble, France. 3Novartis Pharma SAS, Market Access Department, Rueil-Malmaison, France. 4Novartis Pharma SAS, Medical and Scientific Affairs, Rueil Malmaison, France ; Department of Diabetology, Metabolism and Endocrinology, Piti√©-Salp√©tri√®re Hospital, Paris, France.
Publications: 
Vasc Health Risk Manag. 2015 Jul 17;11:417-25
Document Types: , Article
Countries: , France
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514348/
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
√Čvaluation d‚Äôune base de donn√©es issue des dossiers m√©dicaux informatis√©s d‚Äôun panel d‚Äôendocrinologues fran√ßais
Authors: Christine Hellard, Sophie L. Jouaville, Simon Pilet, Adeline Meilhoc
Affiliations: QuintilesIMS, Boulogne-Billancourt, France
Publications: 
Rev Epidemiol Sante Publique, 2016 ; 64 (5) : S280-S281
Document Types: , Abstract
Countries: , France
Condition Year Language Analysis type
, Database Validity and methodology, Diabetes 2015 French , Retrospective database analysis
 
 
Coverage Limits on Blood Glucose Test Strip Reimbursement for Diabetics in Canada: Utilization Impact for Diabetic Patients in the Ontario Public Drug Program (OPDP)
Authors: Bosnic N1, Goodfield J1, Robertson C1, Zhang Y1
Affiliations: 1 Health Economics and Outcomes Research, IMS Brogan Health, Ontario, Canada
Publications: 
ISPOR 20th Annual International Meeting,
Document Types: , Presentation
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/ispor-bosnic-deck-impact-of-diabetes-test-strip-coverage-limits-in-canada.pdf
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
Authors: Foos V1, Varol N, Curtis BH, Boye KS, Grant D, Palmer JL, McEwan P
Affiliations: 1 IMS Health , Basel , Switzerland
Publications: 
J Med Econ., 2015, 18(6): 420-32
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2015 English , Economic evaluation
 
 
Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan.
Authors: Shortridge EF1, Polzer P2, Donga P3, Wade RL3
Affiliations: 1 Spine and Biologics, Medtronic Inc., Memphis, TN, USA. 2 Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA. 3 Health Economics and Outcomes Research, IMS Health, Plymouth Meeting, PA, USA.
Publications: 
Int J Clin Pract. 2015 Jul;69(7):783-90.
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Diabetes, Endocrinology 2015 English , Retrospective database analysis
 
 
Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors
Authors: Cea Soriano L, Johansson S, Stefansson B, Rodr√≠guez LA
Affiliations: Spanish Centre for Pharmacoepidemiologic Research (CEIFE); AstraZeneca R&D
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR)
Authors: de Lusignan S, Liaw ST, Dedman D, Khunti K, Sadek K, Jones S
Affiliations: University of Surrey, Guildford; University of New South Wales; Clinical Practice Research Datalink, London; University of Leicester, Leicester
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Database Validity and methodology, Diabetes 2015 English , Retrospective database analysis
 
 
A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK
Authors: Idris I, Gordon J, Tilling C, Vora J
Affiliations: Division of Medical Sciences & Graduate Entry Medicine, University of Nottingham
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes, Health economics 2015 English , Retrospective database analysis
 
 
New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
Authors: Lu Y, Garc√≠a Rodr√≠guez LA, Malgerud L, Gonz√°lez-P√©rez A, Mart√≠n-P√©rez M, Lagergren J, Bexelius TS
Affiliations: Department of Molecular Medicine and Surgery, Karolinska Institutet; 2Department of Epidemiology and Biostatistics, Imperial College London; 3Centro Espanňú ol de Investigacio¬ī n Farmacoepidemiolo¬ī gica; 4Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet; 5Division of Cancer Studies, King¬ī s College London; 6Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes, Miscellaneous, Oncology 2015 English , Retrospective database analysis
 
 
Diabetes, Cardiovascular Morbidity, and Risk of Age-Related Macular Degeneration in a Primary Care Population
Authors: Vassilev ZP, Ruig√≥mez A, Soriano-Gabarr√≥ M, Garc√≠a Rodr√≠guez LA
Affiliations: Bayer Pharma; Spanish Centre for Pharmacoepidemiologic Research (CEIFE)
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Miscellaneous, Ophthalmology 2015 English , Retrospective database analysis
 
 
Managing diabetes in primary care: how does the configuration of the workforce affect quality of care?
Authors: Trevor Murrells, Jane Ball, Jill Maben, Gerry Lee, Graham Cookson, Peter Griffiths
Affiliations: King‚Äôs College London
Publications: 
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Cost and co-morbidities associated with hypoglycemic inpatients in Belgium.
Authors: Chevalier P1, Vandebrouck T2, De Keyzer D2, Mertens A3, Lamotte M1
Affiliations: 1. IMS Health HEOR, Vilvoorde, Belgium 2. Novo Nordisk, Brussels, Belgium 3. University Hospitals of Leuven, Leuven, Belgium
Publications: 
The Journal of Medical Economics, Volume 19, 2016 - Issue 1
Document Types: , Article
Countries: , Belgium
Abstract: http://dx.doi.org/10.3111/13696998.2015.1086775
Condition Year Language Analysis type
, Diabetes 2015 English
 
 
Bladder Cancer Risk in Relation to Exposure to Pioglitazone among Patients with T2DM in the Pan European Multi-Database Bladder Cancer Risk Characterisation Study
Authors: Korhonen P, Haukka J, Tayler M, Haddad PM, Patel MX, Tiihonen J
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
American Diabetes Association's 75th Scientific Session, Boston, USA, 5-9 June, 2015
Document Types: 
Countries: , Finland, Netherlands, Sweden, UK
Abstract: https://ada.scientificposters.com/epsAbstractADA.cfm?id=1
Condition Year Language Analysis type
, Diabetes 2015 English , Population Based Study, Retrospective database analysis
 
 
Validating the UKPDS 82 Risk Equations to Contemporary Outcomes Studies In Type 2 Diabetes
Authors: Grant D1, Foos V2, McEwan P3
Affiliations: 1IMS Health, London, United Kingdom, 2IMS Health, Basel, Switzerland, 3HEOR Consulting, Monmouth, United Kingdom
Publications: 
ISPOR, 19th Annual International Meeting, Montreal, Canada - PDB81
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2014 English , Epidemiological study
 
 
Contrasting Cost Effectiveness Results Derived From the UKPDS 68 And 82 Risk Equations in Type 2 Diabetes
Authors: McEwan P1, Foos V2, Grant D3
Affiliations: 1HEOR Consulting, Monmouth, United Kingdom, 2IMS Health, Basel, Switzerland, 3IMS Health, London, United Kingdom
Publications: 
ISPOR, 19th Annual International Meeting, Montreal, Canada, May 31 - June 4th 2014 - PDB79
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2014 English , Cost effectiveness
 
 
Illustrating the Relationship between the Number of Hypoglycaemia Events, Event Rate Reduction and the Impact on Estimates of Quality Of Life Improvement in Health Economic Studies
Authors: Foos V1, McEwan P2, Grant D3
Affiliations: 1IMS Health, Basel, Switzerland, 2HEOR Consulting, Monmouth, United Kingdom, 3IMS Health, London, United Kingdom
Publications: 
ISPOR, 19th Annual International Meeting, Montreal, Canada, May 31 - June 4th 2014 - PDB80
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2014 English , Quality of life
 
 
Assessing Simulation Run Time Requirements to Achieve Stabilized Absolute and Incremental Cost Effectiveness Results in Type 2 Diabetes: A Study Using the IMS Core Diabetes Model
Authors: Foos V1, Grant D2, McEwan P3
Affiliations: 1IMS Health, Basel, Switzerland, 2IMS Health, London, United Kingdom, 3HEOR Consulting, Monmouth, United Kingdom
Publications: 
ISPOR, 19th Annual International Meeting, Montreal, Canada, May 31 - June 4th 2014 - PDB82
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2014 English , Cost effectiveness
 
 
Macro- and microvascular outcomes in patients with type 2 diabetes treated with rapid-acting insulin analogues or human regular insulin: a retrospective database analysis.
Authors: Rathmann W1, Schloot NC2, Kostev K3, Reaney M4, Zagar AJ5, Haupt A2
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 Lilly Deutschland GmbH, Bad Homburg, Germany 3 IMS Health, Frankfurt, Germany 4 Lilly Research Centre, Windlesham, Surrey, UK 5 Eli Lilly and Company, Indianapolis, US
Publications: 
Exp Clin Endocrinol Diabetes., 2014 Feb;122(2):92-9
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24558019
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Prevalence and risk factors of neuropathy in newly diagnosed type 2 diabetes in primary care practices: A retrospective database analysis in Germany and UK.
Authors: Kostev K1, Jockwig A2, Hallwachs A3, Rathmann W4
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 Praxis for Internal Medicine and Nephrology, Munich, Germany 4 Institute of Biometrics and Epidemiology, German Diabetes Center, Duesseldorf, Germany
Publications: 
Prim Care Diabetes., 2014, Feb 13. pii: S1751-9918(14)00012-6. doi: 10.1016/j.pcd.2014.01.011. [Epub ahead of print]
Document Types: , Article
Countries: , Germany, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Prevalence+and+Risk+Factors+of+Neuropathy+in+Newly+Diagnosed+Type+2+Diabetes+in+Primary+Care+Practices%3A+A+Retrospective+Database+Analysis+in+Germany+and+UK
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Use of antidiabetic agents in the treatment of gestational dia-betes mellitus in Germany: developments between 2008 and 2012.
Authors: Heilmaier C1, Thielscher C1, Ziller M2, Altmann V3, Kostev K3
Affiliations: 1 FOM University, Essen, Germany 2 Phillips-University of Marburg, Marburg, Germany 3 IMS Health, Frankfurt, Germany
Publications: 
Journal of Obstetrics and Gynaecology Research, 2014, Jun; 40(6): 1592-7
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Risk factors for discontinuation of insulin pump therapy in pediatric and young adult patients.
Authors: Kostev K1, Rockel T1, Rosenbauer J2, Rathmann W2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Institute of Biometrics and Epidemiology, German Diabetes Center, Duesseldorf, Germany
Publications: 
Prim Care Diabetes., 2014
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2014 English , Burden of illness
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Belgium.
Authors: Lamotte M1, Wyffels V2, Knudsen M3, Troelsgaard A4, Hemels M4
Affiliations: 1 IMS Health, Vilvoorde, Belgium 2 Janssen, Belgium 3 IMS Health, London, UK 4 Janssen A/S, Denmark
Publications: 
ISPOR 19th Annual International Meeting, Montreal, QC, Canada, 31 May‚Äď4 June, 2014
Document Types: , Abstract, Poster
Countries: , Belgium
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
Association of diabetes and cancer diagnosis in primary care practices in France
Authors: Grandfils N, Ricarte C, Solomiac A
Affiliations: IMS Health, Paris La D√©fense, France
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Abstract, Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes, Oncology 2014 English , Retrospective database analysis
 
 
Using an innovative approach to build a prospective Diabetes Cohort Registry Of Patients with type 2 Diabetes in Germany: Diareg (PRM 61)
Authors: Garcia Alvarez L1, Rathmann W2, Bode-Greuel K3, Engelhard J3, Busch S4, Schr√∂der-Bernhardi D3, Hiller J1
Affiliations: 1IMS Health, London, UK, 2German Diabetes Center, Duesseldorf, Germany, 3IMS Health, Frankfurt am Main, Germany, 4AstraZeneca, Hamburg Area, Germany
Publications: 
ISPOR 17th Annual European Conference, Amsterdam 8 - 12 November 2014
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes, Methodology 2014 English , Methodology
 
 
Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in UK primary care
Authors: Nyeland,ME1, Ploug,UJ1, Richards,A1, Garcia Alvarez L2, Demuth D2, Muthutantri A2, Skovgaard R1, Evans M3 R. Skovgaard,1 M. Evans3
Affiliations: 1 Novo Nordisk A/S, S√łborg,Denmark 2 Real-World Evidence Solutions and Health Economics & Outcomes Research, IMS Health, London, UK 3 University Hospital Llandough, Cardiff, Wales, UK
Publications: 
Int J Clin Pract doi: 10.1111/ijcp.12575
Document Types: , Article
Countries: , UK
Abstract: http://onlinelibrary.wiley.com/doi/10.1111/ijcp.12575/pdf
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Assessing the relationship between improved life expectancy due to better cardiovascular risk factor management and the likelihood of microvascular complications in type 2 diabetes mellitus
Authors: McEwan P1, Grant D2, Foos V
Affiliations: Health Economics and Outcomes Research Ltd., Cardiff, UK, 2IMS Health, London, UK, 3IMS Health, Basel, Switzerland
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , Database Study
 
 
Epidemiology and unmet medical need in diabetes mellitus type 2 in Germany ‚Äď results of a literature search
Authors: Greiner R, Paulus G, Driedger J, Schr√∂der C, Timtschenko V, Batscheider A, Eheberg D, Vosgerau S
Affiliations: IMS Health, Munich, Germany,
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2014 English , Epidemiological study
 
 
Progression of physiological parameters over time in type 1 diabetes mellitus patients in France
Authors: Beaudet A, Ong RC
Affiliations: IMS Health, Basel, Switzerland
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
Burden of non-adherence to type 1 diabetes mellitus therapeutic guidelines in France
Authors: Beaudet A, Ong RC
Affiliations: IMS Health, Basel, Switzerland
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2014 English , Burden of illness
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Czech Republic
Authors: Troelsgaard A1, Pitcher A2, Vesel√° ҆3, Lovato E2, Hemels M1
Affiliations: Janssen A/S, Birker√łd, Denmark, 2IMS Health, London, UK, 3Janssen-Cilag Czech Republic, Prague, Czech Republic
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Czech
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Portugal
Authors: Troelsgaard A1, Knudsen M2, Maia-Lopes S3, Luz M3, Hemels M1
Affiliations: 1Janssen A/S, Birker√łd, Denmark, 2IMS Health, Hellerup, Denmark, 3Janssen-Cilag Farmac√™utica, Barcarena, Portugal
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Portugal
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in France
Authors: Granados D1, Maurel F2, Knudsen M3, Troelsgaard A4, Hemels M4
Affiliations: 1Janssen, Paris, France, 2IMS Health, Paris, France, 3IMS Health, Hellerup, Denmark, 4Janssen A/S, Birker√łd, Denmark
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2014 English , Cost effectiveness, Economic evaluation
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Slovakia
Authors: Troelsgaard A1, Pitcher A2, Binder R3, Stetka R4, Ondrusova M5, Lovato E2, Hemels M1
Affiliations: Janssen A/S, Birker√łd, Denmark, 2IMS Health, London, UK, 3Janssen, Bratislava, Slovak Republic, 4Pharm-In, Ltd, Bratislava, Slovak Republic, 5Pharm-In Ltd, Bratislava, Slovak Republic
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Slovakia
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Norway
Authors: Troelsgaard A1, Huetson P2, Kjellberg J3, Hemels M1, Knudsen M4
Affiliations: Janssen A/S, Birker√łd, Denmark, 2IMS Health, Stockholm, Sweden, 3Zefferin Farma AB, Stockholm, Sweden, 4IMS Health, Hellerup, Denmark
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Norway
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
The cost-effectiveness of canagliflozin compared with liraglutide in patients with type 2 diabetes inadequately controlled with metformin and sulfonylurea in France
Authors: Troelsgaard A1, Pitcher A2, Granados D3, Hemels M1, Lloyd A
Affiliations: 1Janssen A/S, Birker√łd, Denmark, 2IMS Health, London, UK, 3Janssen, Paris, France
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2014 English , Economic evaluation
 
 
Cost-effectiveness analysis of flash glucose monitoring for type 2 diabetes patients receiving insulin treatment in the UK
Authors: Li H1, Bilir SP2, Donga P3, Samiian A4, Munakata J2
Affiliations: 1IMS Health, Alexandria, CA, USA, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Plymouth Meeting, PA, USA, 4Abbott Diabetes Care, Alameda, CA, USA
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2014 English , Cost effectiveness
 
 
Quantifying nonlinear effects in stochastic Markov simulation using UKPDS 68 and UKPDS 82 equations in type 2 diabetes modeling analysis with the IMS CORE Diabetes Model (CDM)
Authors: McEwan P1, Grant D2, Lamotte M3, Foos V4
Affiliations: 11HEOR Consulting, Monmouth, UK 2 IMS Health, London,UK 3 IMS Health, Vilvoorde, Belgium, 4 IMS Health, Basel, Switzerland
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , Meta analysis
 
 
Impact of single risk factor changes on long term outcomes and cost in a type 2 diabetes modeling study contrasting projections with UKPDS 68 versus UKPDS 82 risk equations
Authors: Foos V1, McEwan P2, Grant D3
Affiliations: 1 IMS Health, Basel, Switzerland 2 HEOR Consulting, Monmouth, UK 3 IMS Health, London, UK
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2014 English , Budget impact
 
 
All-cause mortality validation of the CORE Diabetes Model against predictions of the Charlson Comorbidity Index
Authors: Foos V1, McEwan P2, Lamotte M3, Grant D4
Affiliations: 1 IMS Health, Basel, Switzerland 2 HEOR Consulting, Monmouth, UK 3 IMS Health, Vilvoorde, Belgium, IMS Health, London, UK
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , Burden of illness
 
 
Review of utility values for economic modeling in type 2 diabetes
Authors: Beaudet A1, Clegg J1, Thuresson PO1, Lloyd A2, McEwan P3
Affiliations: 1 IMS Health, Basel, Switzerland, 2 IMS Health, London, UK 3 4Centre for Health Economics, Swansea University, Swansea, UK.
Publications: 
Value Health. 2014 Jun;17(4):462-70
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , Review
 
 
If we followed the National Institute of Health and Care Excellence (NICE) guidelines and treated people with diabetes earlier, patients and the National Health Service (NHS) would benefit from a reduction in complications, mortality and direct healthcare costs
Authors: Baxter M1, Hex N2, Samyshkin Y3, Hudson R1, Mahon J4, Alexiou D3, Bartlett C2
Affiliations: 1 Sanofi, Guildford, UK 2 York Health Economics Consortium (YHEC), UK 3 IMS Health, London, UK 4 Coldingham Economics, Galashiels, UK
Publications: 
Diabetes UK Professional Conference 2015
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2014 English , Population Based Study
 
 
Budget impact analysis of Biphasic Insulin Aspart in the treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective
Authors: Tan SC1, Matzen P2, Yeo LN2
Affiliations: 1 IMS Asia Pacific, Singapore 2 Novo Nordisk Pharma Malysia, Kuala Lumpur, Malaysia
Publications: 
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
Document Types: , Poster
Countries: , Malaysia
Condition Year Language Analysis type
, Diabetes 2014 English , Budget impact
 
 
Budget Impact analysis of wider adoption of Biphasic Insulin Aspart (Biasp) in the treatment of type 2 Diabetes Mellitus (T2dm): A perspective of patients treated by public providers in Singapore
Authors: Tan SC1, Matzen P2, Khoo SP2
Affiliations: 1 IMS Asia Pacific, Singapore 2 Novo Nordisk Pharma Malaysia, Kuala Lumpur, Malaysia 3 Novo Nordisk Pharma Singapore, Singapore
Publications: 
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
Document Types: , Poster
Countries: , Singapore
Condition Year Language Analysis type
, Diabetes 2014 English , Budget impact
 
 
Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
Authors: Bennett H, McEwan P, Bergenheim K & Gordon J
Affiliations: Health Economics and Outcomes Research Ltd
Publications: 
Diabetes Ther. 2014 Dec;5(2):567-78. doi: 10.1007/s13300-014-0079-6. Epub 2014 Sep 4
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25185770
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK.
Authors: Lind M, Pivodic A, Cea-Soriano L, Nerman O, Pehrsson NG & Garcia-Rodriguez LA
Affiliations: University of Gothenburg Institute of Medicine
Publications: 
Diabetologia. 2014 Aug;57(8):1586-94. doi: 10.1007/s00125-014-3250-8. Epub 2014 May 9.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24811709
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K
Authors: Guest JF, Panca M, Sladkevicius E, Taheri S & Stradling J
Affiliations: Catalyst Health Economics Consultants
Publications: 
Diabetes Care. 2014 May;37(5):1263-71. doi: 10.2337/dc13-2539. Epub 2014 Apr 4
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24705611
Condition Year Language Analysis type
, Diabetes, Mental health 2014 English , Retrospective database analysis
 
 
Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin.
Authors: Flory JH, Small DS, Cassano PA, Brillon DJ, Mushlin AI & Hennessy S
Affiliations: Weill Cornell Medical College
Publications: 
J Comp Eff Res. 2014 Jan;3(1):29-39. doi: 10.2217/cer.13.87
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24345255
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Distinguishing incident and prevalent diabetes in an electronic medical record database.
Authors: Mamtani R, Haynes K, Finkelman BS, Scott FI & Lewis JD
Affiliations: 
Publications: 
Pharmacoepidemiol Drug Saf. 2014 Feb;23(2):111-8. doi: 10.1002/pds.3557. Epub 2013 Dec 19.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24375925
Condition Year Language Analysis type
, Diabetes 2014 English , Epidemiological study
 
 
Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas.
Authors: Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ & Lewis JD
Affiliations: University of Pennsylvania Abramson Cancer Center
Publications: 
Diabetes Care. 2014 Jul;37(7):1910-7. doi: 10.2337/dc13-1489. Epub 2014 Feb 4
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24496803
Condition Year Language Analysis type
, Diabetes, Oncology 2014 English , Retrospective database analysis
 
 
Incidence of retinal complications in a cohort of newly diagnosed diabetic patients
Authors: Mart√≠n-Merino E, Fortuny J, Rivero-Ferrer Z & Garc√≠a-Rodr√≠guez LA
Affiliations: Centro Espa√Īol de Investigaci√≥n Farmacoepidemiol√≥gica
Publications: 
PLoS One. 2014 Jun 25;9(6):e100283. doi: 10.1371/journal.pone.0100283. eCollection 2014
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24963628
Condition Year Language Analysis type
, Diabetes, Ophthalmology 2014 English , Retrospective database analysis
 
 
Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.
Authors: Rho YH, Lu N, Peloquin CE, Man A, Zhu Y, Zhang Y & Choi HK
Affiliations: Boston University School of Medicine The Clinical Epidemiology Unit
Publications: 
2016;75:91-95
Ann Rheum Dis doi:10.1136/annrheumdis-2014-205827
Document Types: , Article
Countries: , UK
Abstract: http://ard.bmj.com/content/early/2014/09/02/annrheumdis-2014-205827.abstract
Condition Year Language Analysis type
, Diabetes, Rheumatology 2014 English , Retrospective database analysis
 
 
Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.
Authors: McEwan P, Bennett H, Ward T & Bergenheim K
Affiliations: Swansea University1Swansea Centre for Health Economics
Publications: 
Pharmacoeconomics. 2015 Feb;33(2):149-61. doi: 10.1007/s40273-014-0225-z
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25344660
Condition Year Language Analysis type
, Diabetes, Health policy 2014 English , Retrospective database analysis
 
 
Safety results from OCAPI: a European Observational Cohort Study of insulin glulisine-treated children aged 6-12 years with type 1 diabetes.
Authors: Konstantinova M1, Loizeau V2, Pilorget V3, Cali A3, Danne T4.
Affiliations: 1University Paediatric Hospital, Sofia, Bulgaria. 2Lincoln, Boulogne-Billancourt, France. 3Sanofi, Paris, France. 4"Auf der Bult" Children and Youth Hospital, Hannover, Germany.
Publications: 
Exp Clin Endocrinol Diabetes. 2014 Oct;122(9):523-7. doi: 10.1055/s-0034-1377005. Epub 2014 Jul 23.
Document Types: , Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25054310
Condition Year Language Analysis type
, Diabetes 2014 English , Prospective study
 
 
USAGE OF SELF-MONITORING OF BLOOD GLUCOSE (SMBG) BY DIABETES THERAPY TYPE IN INDIA.
Authors: Mast O1, Tan A2, Punjabi K3
Affiliations: 1Roche Diagnostics, Diabetes Care, Mannheim, Germany, 2Cegedim Strategic Data, Singapore, Singapore, 3Cegedim Strategic Data, Mumbai, India
Publications: 
ISPOR 17th Annual European Congress Amsterdam, The Netherlands November, 2014
Document Types: , Poster
Countries: , India
Abstract: http://www.ispor.org/ScientificPresentationsDatabase/Presentation/51144
Condition Year Language Analysis type
, Diabetes 2014 English
 
 
Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study
Authors: Mamza J, Mehta R, Idris I
Affiliations: University of Nottingham Division of Medical Sciences & Graduate Entry Medicine
Publications: 
BMJ Open Diab Res Care2014;2:e000021 doi:10.1136/bmjdrc-2014-000021
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://drc.bmj.com/content/2/1/e000021.abstract
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study
Authors: Dubreuil M, Rho YH, Man A, Zhu Y, Zhang Y, Love TJ, Ogdie A, Gelfand JM & Choi HK
Affiliations: Boston University School of Medicine Section of Rheumatology and the Clinical Epidemiology Unit
Publications: 
Rheumatology (Oxford). 2014 Feb;53(2):346-52. doi: 10.1093/rheumatology/ket343. Epub 2013 Oct 31.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894671/
Condition Year Language Analysis type
, Diabetes, Rheumatology 2014 English , Retrospective database analysis
 
 
Treatment maintenance duration of dual therapy with Metformin and Sitagliptin in type 2 Diabetes - Real-World data From ODYSEE Study
Authors: Leproust S1, Dallongeville J2, Valensi P3, Boutmy E4, Moisan C1, Chanut-Vogel C5, de Pouvourville G6
Affiliations: 1Merck (MSD France), Paris, France, 2INSERM U744, Lille, France, 3Service d‚ÄôEndocrinologie-Diab√©tologie-Nutrition, Bondy, France, 4Cegedim Strategic Data, Boulogne-Billancourt, France, 5Laboratoires MSD France, Courbevoie, France, 6ESSEC, Cergy-Pontoise, France
Publications: 
Ispor 17th Annual European Congress, 8-12 November 2014, Amsterdam RAI, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2014 English , Prospective study, Retrospective database analysis
 
 
Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins [Type 2 diabetes: which therapeutic objectives according to the new recommendations of the HAS? Analysis of 6,680 patients followed by doctors].
Authors: Larger E1, Ansolabehere X2, Grandfils N2, Le Jeunne P2
Affiliations: 1 GH Cochin H√ītel-Dieu, Paris 2 IMS Health HEOR, La D√©fense
Publications: 
Congrès annuel de la Société Francophone du Diabète (SFD). 11-14 mars 2014 Paris
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes, Endocrinology, Metabolic Disorders 2014 French , Retrospective database analysis
 
 
Regional variation in fasting and hypoglycemia experiences in MOSAIc study patients with T2DM taking insulin.
Authors: Seeger JD, Patrick AR, Shrank WH, Avorn J, Choudhry NK, Polinski JM
Affiliations: 
Publications: 
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Diabetes knowledge, distress, and glycemic control: global insights from the MOSAIc study
Authors: Rogers JR, Curtis BH, Polonsky WH, Cos X, Newton T, Rodriguez-Vigil E, Zagar A, Polinski JM
Affiliations: 
Publications: 
Poster presentation. American Diabetes Association Scientific Sessions. San Francisco, CA, June 13 ‚Äď 17, 2014
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Geographic patterns of patient demographics and insulin usage: a global perspective from the MOSAIc study
Authors: Polinski JM, Zagar A, Funnell MM, Hassoun A, Shrank WH, Curtis BH
Affiliations: 
Publications: 
Poster presentation. American Diabetes Association Scientific Sessions. San Francisco, CA, June 13 ‚Äď 17, 2014
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Cross-national variation in physicians’ characteristics and their goals for patients taking insulin: evidence from the MOSAIc study
Authors: Xie J, Suzuki S, Cos X, Hassoun A, Matsuba I, Polinski JM
Affiliations: 
Publications: 
Poster presentation. American Diabetes Association Scientific Sessions. San Francisco, CA, June 13 ‚Äď 17, 2014.
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Diabetes-related resource use, provider communication, and perceived support: cross-national comparisons from MOSAIc
Authors: Shrank WH, Seeger JD, Avorn J, Newton T, Funnell MM, Choudhry NK, Polinski JM
Affiliations: 
Publications: 
Poster presentation. American Diabetes Association Scientific Sessions. San Francisco, CA, June 13 ‚Äď 17, 2014
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Depression, type 2 diabetes, and glycemic control: global patterns in the MOSAIc study
Authors: Fischer MA, Rogers JR, Seeger JD, Choudhry NK, Avorn J, Shrank WH, Brill G, Polinski JM
Affiliations: 
Publications: 
Abstract publication. American Diabetes Association Scientific Sessions. San Francisco, CA, June 13 ‚Äď 17, 2014
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Cross-national variation in insulin use among patients with diabetes taking Insulin: the MOSAIc study
Authors: Patrick AR, Seeger JD, Shrank WH, Matsuba I, Polinski JM
Affiliations: 
Publications: 
Abstract publication. American Diabetes Association Scientific Sessions. San Francisco, CA, June 13 ‚Äď 17, 2014
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2014 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012
Authors: Turner LW, Nartey D, Stafford RS, Singh S, Alexander GC.
Affiliations: Bloomberg School of Public Health, Baltimore
Publications: 
Diabetes Care 2014;37(4):985-992.
Document Types: , Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24198301
Condition Year Language Analysis type
, Diabetes 2014 French , Real World Evidence
 
 
Association of Changes In Body Weight With Health Care Costs Among Patients With Newly-Diagnosed Type-2 Diabetes In Sweden
Authors: U. Sabale1, J. Bodeg√•rd1, J. Sundstr√∂m2, B. Svennblad3, C.J. √Ėstgren4, P. Nilsson5, G. Johansson3, M. Henriksson1
Affiliations: 1 AstraZeneca Nordic-Baltic, S√∂dert√§lje, Sweden, 2 Uppsala University, Uppsala, Australia, 3 Uppsala University, Uppsala, Sweden, 4 Link√∂ping University, Link√∂ping, Sweden, 5 Lund University, Malm√∂, Sweden
Publications: 
Value in Health
Document Types: , Abstract
Countries: , Sweden
Abstract: http://www.sciencedirect.com/science/article/pii/S109830151402590X
Condition Year Language Analysis type
, Diabetes 2014 English , Real World Evidence
 
 
Using Electronic Medical Records as Real World Evidence to Understand the Impact of Flu Vaccinations on Patient Health
Authors: Gillman A1
Affiliations: 1 IMS Brogan, Toronto, Canada
Publications: 
CAPT 2014
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/capt2014-conference-poster-final-corrected.pdf
Condition Year Language Analysis type
, Diabetes, Infectious disease 2014 English , Longitudinal study
 
 
Diabetes complexities drive resource consumption in Canada
Authors: Borrelli R, Mokin S, Sung M
Affiliations: IMS Brogan
Publications: 
Accesspoint, 2014, 5(9): 15-19
Document Types: , Article
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries.
Authors: Divino V., DeKoven M., Hallinan S., Varol N., Wirta SB., Lee WC., Reaney M.
Affiliations: Lilly. IMS authors: Divino V, DeKoven M
Publications: 
Diabetes Ther.
Document Types: , Article
Countries: , Belgium, France, Germany, Netherlands, Sweden, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25366334
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Regional Assessment of Severe Hypoglycemic Coma Events in Finland
Authors: Hoti F, Vattulainen P, Mushnikov V, Saukkonen T, Korhonen P
Affiliations: EPID Research, Espoo, Finland
Publications: 
Value in Health (2014);17(7):A332
Document Types: , Poster
Countries: , Finland
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02557-1/fulltext
Condition Year Language Analysis type
, Diabetes 2014 English , Epidemiological study, Observational study, Population Based Study
 
 
Lower Risk of Mortality in Patients with Type 2 Diabetes Using Insulins Detemir or Glargine Compared to NPH: A Propensity Score Matched Nationwide Register Study in Finland
Authors: M√§kimattila S, Hoti F, Christopher S, Haukka J, Korhonen P, Saukkonen T
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
Diabetes (2014);63 (Suppl 1):A343-A425
Document Types: , Poster
Countries: , Finland
Abstract: http://diabetes.diabetesjournals.org/mwg-internal/de5fs23hu73ds/progress?id=tLDZcQ3XmqwM1R5WmUnmnK6ZYf5Vk0j-7PYr0VdNiOQ,&dl
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Lower Risk of Mortality in Patients with Type 2 Diabetes Using Insulins Detemir or Glargine Compared to NPH: A Propensity Score Matched Nationwide Register Study in Finland
Authors: M√§kimattila S, Hoti F, Christopher S, Haukka J, Korhonen P, Saukkonen T
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
American Diabetes Association 74th Scientific Session, San Francisco, USA, 13-17 June, 2014
Document Types: , Poster
Countries: , Finland
Abstract: https://ada.scientificposters.com/epsAbstractADA.cfm?id=1
Condition Year Language Analysis type
, Diabetes 2014 English , Retrospective database analysis
 
 
Uses of Electronic Patient Information Systems and National Registers ‚Äď Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland
Authors: Prami T, Sulamaa A, Sipil√§ R, Linna M, Hahl J, Miettinen T, Lepp√§ E, Haukka J, Tuomilehto J, Enlund H, Niskanen L, Korhonen P
Affiliations: EPID Research, Espoo, Finland
Publications: 
Value in Health. (2014);17(7): A336
Document Types: , Abstract
Countries: , Finland
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02579-0/fulltext
Condition Year Language Analysis type
, Diabetes 2014 English , Population Based Study
 
 
ASSOCIATION OF CHANGES IN BODY WEIGHT WITH HEALTH CARE COSTS AMONG PATIENTS WITH NEWLY-DIAGNOSED TYPE-2 DIABETES IN SWEDEN
Authors: Sabale U, Bodeg√•rd J, Sundstr√∂m J, Svennblad B, √Ėstgren CJ, Nilsson P, Johansson G, Henriksson M
Affiliations: AstraZeneca Nordic-Baltic, S√∂dert√§lje, Sweden
Publications: 
Value in Health (2014);17(7): A338
Document Types: , Abstract
Countries: , Sweden
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02590-X/fulltext
Condition Year Language Analysis type
, Diabetes 2014 English , Cost analysis, Population Based Study, Retrospective database analysis
 
 
Regional assessment of severe hypoglycemic coma events in Finland
Authors: Vattulainen P, Mushnikov V, Hoti F, Saukkonen T, Korhonen P.
Affiliations: EPID Research, Espoo, Finland
Publications: 
Value Health. (2014) 17(7): A332
Document Types: , Poster
Countries: , Finland
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02557-1/fulltext
Condition Year Language Analysis type
, Diabetes 2014 English , Epidemiological study, Observational study, Population Based Study
 
 
Evaluation of the pharmacy budget impact of alogliptin plus pioglitazone fixed dose combination in the treatment of Type-2 diabetes mellitus.
Authors: Bron M1, Ferrufino CP2, Samyshkin Y3, Munakata J4
Affiliations: 1Takeda Pharmaceuticals, Deerfield, IL, USA, 2IMS Health, Alexandria, VA, USA, 3IMS Health, London, UK, 4IMS Health, Redwood City, CA, USA
Publications: 
ISPOR 18th Annual International Meeting to be held May 18-22, 2013 New Orleans, LA, USA. Abstract ID# 42951
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2013 English , Budget impact, Economic evaluation
 
 
Cardiovascular Event Rates in a Type 2 Diabetes Population in a Real-World UK Setting: A Large Database Study Using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)
Authors: McDonell A1, DeVore S2, Muthutantri A1, Demuth D1, Richards C1, Wu Y2, Kim J2
Affiliations: 1 IMS Health, London, UK 2 AstraZeneca, Wilmington, DE, USA
Publications: 
American Diabetes Association Scientific Sessions, June 21 - 25, Chicago, US
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Drivers of cost-effectiveness in type-2 diabetes mellitus
Authors: McEwan P1, Foos V2, Grant D3, Lamotte M4, Palmer JL5, Lloyd A3
Affiliations: 1Swansea University, Cardiff, United Kingdom, 2IMS Health, Basel, Switzerland, 3IMS Health, London, United Kingdom, 4IMS Health, Vilvoorde, Belgium, 5IMS Health, Allschwil, Basel-Landschaft, Switzerland
Publications: 
ISPOR 18th Annual International Meeting, May 18-22, 2013 New Orleans, LA, USA. Abstract ID# 42422
Document Types: , Podium presentation, Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2013 English , Cost analysis, Cost effectiveness, Cost utility
 
 
Do existing risk equations fail to adequately account for the relationship between body mass index and mortality in subjects with type-2 diabetes?
Authors: McEwan P1, Foos V2, Grant D3, Palmer JL4, Lamotte M5, Lloyd A3
Affiliations: 1Swansea University, Cardiff, United Kingdom, 2IMS Health, Basel, Switzerland, 3IMS Health, London, United Kingdom, 4IMS Health, Allschwil, Basel-Landschaft, Switzerland, 5IMS Health, Vilvoorde, Belgium
Publications: 
ISPOR 18th Annual International Meeting, May 18-22, 2013 New Orleans, LA, USA.
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2013 English , Methodology
 
 
Assessing the consistency of absolute cardiovascular risk prediction and relative risk reduction in type-2 diabetes mellitus
Authors: McEwan P1;Lamotte M2;Grant D3;Palmer JL4;Lloyd A3, Foos V5
Affiliations: 1Swansea University, Cardiff, United Kingdom, 2IMS Health, Vilvoorde, Belgium, 3IMS Health, London, United Kingdom, 4IMS Health, Allschwil, Basel-Landschaft, Switzerland, 5IMS Health, Basel, Switzerland
Publications: 
ISPOR 18th Annual International Meeting, May 18-22, 2013 New Orleans, LA, USA.
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2013 English , Quality of life
 
 
The cost and productivity consequences of non-severe hypoglycaemic episodes (nshe) in patients treated with sulfonylurea or dpp4 dual combination oral therapy
Authors: Foos V1, McEwan P2, Grant D3, Palmer JL4, Lamotte M5, Lloyd A3
Affiliations: 1IMS Health, Basel, Switzerland, 2Swansea University, Cardiff, United Kingdom, 3IMS Health, London, United Kingdom, 4IMS Health, Allschwil, Basel-Landschaft, Switzerland, 5IMS Health, Vilvoorde, Belgium
Publications: 
ISPOR 18th Annual International Meeting, May 18-22, 2013 New Orleans, LA, USA.
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2013 English , Cost consequence
 
 
The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ‚Č• 30 kg/m2 in Spain
Authors: Fonseca T1, Clegg J2, Caputo G3, Norrbacka K4, Dilla T5, Alvarez M5
Affiliations: 1IMS Health, London,UK, 2IMS Health, Basel, Switzerland, 3IMS Health, Keppel Towers, Singapore, 4dEli Lilly Finland Ab, , Helsinki, Finland, 5eLilly SA, Spain
Publications: 
J Med Econ. 2013 Jul;16(7):926-38
Document Types: , Abstract
Countries: , Spain
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696998.2013.803110
Condition Year Language Analysis type
, Diabetes 2013 English , Cost effectiveness
 
 
The CANARD Project (project CANARD) ‚Äď Cost-effectiveness ANAlysis of Real-world outcomes in a Diabetic population
Authors: Sutherland CS 1,2, Gillet M2, Brennan A2, Duran A1 , Ansolabehere, X3
Affiliations: 1IMS Health, London, United Kingdom, 2University of Sheffield, Sheffield, United Kingdom, 3IMS Health, Paris, France
Publications: 
ISPOR 18th Annual International Meeting , New Orleans, 18th ‚Äď 22nd May, 2013. Poster ID: PCV74
Document Types: , Poster
Countries: , France, UK
Condition Year Language Analysis type
, Diabetes 2013 English , Cost effectiveness
 
 
Direct Medical Costs of Treating Diabetes-Related Complications In Argentina
Authors: Elgart J, De la Llave G, Camillucci C, Vega-Hernandez G, Watkins M, Hammerby E, Nikolajsen A, Gagliardino JJ
Affiliations: IMS Health, London, UK
Publications: 
ISPOR 4th Latin America Conference
Value in Health 2013
Document Types: , Abstract
Countries: , Argentina
Condition Year Language Analysis type
, Diabetes 2013 English , Cost analysis, Cost of illness, Pricing & Reimbursement
 
 
Direct Costs of Type 2 Diabetes from fhe Brazilian Public Healthcare Sector Perspective
Authors: Hnoosh A1, Babineaux SM2, Piras de Oliveira C3, McDonell A1, Vega-Hernandez G1
Affiliations: 1IMS, London, England, 2Eli Lilly & Company, Indianapolis, IN, USA, 3Eli Lilly do Brasil, Sao Paulo, Brazil
Publications: 
ISPOR 4th Latin America Conference.
Value in Health 2013
Document Types: , Poster
Countries: , Brazil
Condition Year Language Analysis type
, Diabetes 2013 English , Burden of illness, Cost analysis, Cost of illness
 
 
Direct Costs of Type 2 Diabetes in Mexico from the Public Healthcare Sector Perspective
Authors: Chatzitheofilou I1, Babineaux SM2, Ram√≠rez-G√°mez J3, McDonell A1, Vega-Hernandez G1
Affiliations: 1IMS, London, England, 2Eli Lilly & Company, Indianapolis, IN, USA, 3Eli Lilly and Company, M√©xico, Mexico
Publications: 
ISPOR 4th Latin America Conference.
Value in Health 2013
Document Types: , Poster
Countries: , Mexico
Condition Year Language Analysis type
, Diabetes 2013 English , Burden of illness, Cost analysis, Cost of illness
 
 
Direct medical costs for complications among adults with type 2 diabetes in a US commercial payer setting
Authors: Yeaw J1, Halinan S1, Hines D1, DeLozier A2, Perez M2, Boye M2, Boye KS2, Blanchette CM1
Affiliations: 1 IMS Health, Alexandria, USA 2 Eli Lilly and Company, Indianapolis, USA
Publications: 
Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting, May 18-22, 2013 in New Orleans, LA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2013 English , Cost of illness
 
 
Review of cost of diabetes complications in four European countries
Authors: Beaudet A1, Grabbi E2, Maurel F3, Ramos M4, Lebioda A2
Affiliations: 1 IMS Health, Basel, Switzerland, 2 IMS Health, London, UK, 3 IMS Health, Paris, France, 4 IMS Health, Barcelona, Spain
Publications: 
ISPOR 16th annual European congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Europe
Condition Year Language Analysis type
, Diabetes 2013 English , Cost of illness, Review
 
 
The burden of hospitalizations due to hypoglycemia in Belgium.
Authors: Lamotte M1, Chevalier P1, Vandebrouck T2
Affiliations: 1 IMS Health, Vilvoorde, Belgium 2 NovoNordisk, Brussels, Belgium
Publications: 
American Diabetes Association (ADA) 73rd Scientific Sessions, 2013, June 21-25, Chicago, IL, USA
Document Types: , Poster
Countries: , Belgium
Condition Year Language Analysis type
, Diabetes 2013 English , Burden of illness
 
 
Estimating the cost of hospitalization for hypoglycemia in Belgium.
Authors: Lamotte M1, Chevalier P1, Vandebrouck T2
Affiliations: 1 IMS Health, Vilvoorde, Belgium 2 NovoNordisk, Brussels, Belgium
Publications: 
ISPOR 18th Annual International Meeting, 2013, May 18-22, New Orleans, LA, USA
Document Types: , Poster
Countries: , Belgium
Condition Year Language Analysis type
, Diabetes 2013 English , Cost analysis
 
 
Screening characteristics and diabetes biomarkers in French and UK patient-level databases
Authors: Cabrera C1, Le Jeunne P2, Lee A3, Thomas F4, Mian N3, McDonell A5
Affiliations: 1AstraZeneca, M√∂lndal, Sweden, 2IMS Health, Paris, France, 3AstraZeneca GMD UK, Cheshire, England, 4AstraZeneca France, GMD, Paris, France, 5IMS Health, London, England
Publications: 
ISPOR 16th Annual European Congress, 2-6 November 2013, Abstract #45156
Document Types: , Poster
Countries: , France, UK
Condition Year Language Analysis type
, Diabetes 2013 English , Real World Data
 
 
The CANARD Project (project CANARD) ‚Äď Cost-effectiveness ANAlysis of Real-world outcomes in a Diabetic population The impact of baseline characteristics in France
Authors: Sutherland CS 1,2, Gillet M2, Brennan A2, Duran A1 , Ansolabehere, X3
Affiliations: 1- IMS Health, London, United Kingdom, 2 - University of Sheffield, Sheffield, United Kingdom, 3 - IMS Health, Paris, France
Publications: 
ISPOR 18th annual international meeting, New Orleans - May 2013
Document Types: , Poster
Countries: , France, UK
Condition Year Language Analysis type
, Diabetes, Diabetes 2013 English , Cost effectiveness
 
 
Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34‚Ää009 primary care patients.
Authors: Sundstr√∂m J, Sheikhi R, Ostgren CJ, Svennblad B, Bodeg√•rd J, Nilsson PM, Johansson G.
Affiliations: IMS Health (Formally Pygargus)
Publications: 
J Hypertens. 2013 Aug;31(8):1603-10
Document Types: , Abstract, Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23625112
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2013 English , Retrospective cohort analysis
 
 
Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
Authors: √Ėstgren CJ, Sundstr√∂m J, Svennblad B, Lohm L, Nilsson PM, Johansson G.
Affiliations: IMS Health, Stockholm, Sweden (Formally Pygargus)
Publications: 
Diabet Med. 2013 May;30(5):e170-7
Document Types: , Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23350893
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2013 English , Retrospective cohort analysis
 
 
Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8,486 primary care patients
Authors: Bodegard J, Sundstr√∂m J, Svennblad B, √Ėstgren CJ, Nilsson PM, Johansson G
Affiliations: IMS Health, Stockholm, Sweden (Formally Pygargus)
Publications: 
Diabetes Metab. 2013 Sep;39(4):306-13
Document Types: , Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23871502
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2013 English , Retrospective cohort analysis
 
 
Consistency of current type 2 diabetes (T2DM) treatmeent patterns in general practice versus the 2013 French HAS T2DM guidelines : a transversal study based on the French IMS LifelinkTM prospective diabetes cohort
Authors: 1. Larger E, 2.Ansolabehere X, 2.Le Jeunne P, 2.Grandfils N, 3.Briand Y, 3.Gibelin B
Affiliations: 1. Hotel Dieu Paris, Paris France 2. IMS Health, Paris La D√©fense France, 3. Boehringer Ingelheim France, Paris France.
Publications: 
16th annual European ISPOR
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2013 English , Real World Data, Retrospective cohort analysis
 
 
Do fixed-dose combinations improve antidiabetic treatment compliance? A study based on French IMS Lifelink disease analyszer database
Authors: 1. Grandfils N, 1. Le Jeunne P, 1. maillard C, 1. Solomiac A, 1. Besson A
Affiliations: 1. IMS Health, Paris La D√©fense France
Publications: 
16th Annual European ISPOR
Document Types: , Abstract
Countries: , France
Condition Year Language Analysis type
, Diabetes 2013 English , Compliance, Retrospective cohort analysis
 
 
Lower incidence of recorded cardiovascular outcomes in patients with Type 2 Diabetes using Insulin Aspart versus those on human regular insulin: Observational evidence from General Practices.
Authors: Rathmann W1, Kostev K2
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 IMS Health, Frankfurt, Germany
Publications: 
Diabetes Obes Metab., 2013, Apr;15(4):358-63
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23137345
Condition Year Language Analysis type
, Diabetes 2013 English , Observational study
 
 
Influence of macro- and microvascular comorbidity on time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany, France, and UK.
Authors: Kostev K1, Rathmann W2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany
Publications: 
Prim Care Diabetes., 2013, Jul;7(2):167-71
Document Types: , Article
Countries: , France, Germany, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=influence%20of%20macro%20and%20microvascular%20comorbidity%20on%20time%20to%20insulin%20initiation%20in%20type%202%20diabetes%20patients%20a%20retrospective%20database%20analysis%20in%20germany,%20france,%20and%20uk&cmd=correctspelling
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010).
Authors: Kostev K1, Rathmann W2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany
Publications: 
Prim Care Diabetes., 2013, Oct;7(3):229-33
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23608219
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Different injection frequencies of basal insulins in type 2 diabetes patients under real-life conditions: a retrospective database analysis.
Authors: Rathmann W1, Dippel FW2, Kostev K3
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health, Frankfurt, Germany
Publications: 
J Diabetes Sci Technol., 2013, September, 7(5): 1354‚Äď1358
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Different+injection+frequencies+of+basal+insulins+in+type+2+diabetes+patients+under+real-life+conditions%3A+A+retrospective+database+analysis
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
Authors: Kostev K1, Dippel FW2, Rathmann W3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany
Publications: 
Prim Care Diabetes., 2013, Oct 30. pii: S1751-9918(13)00117-4. doi: 10.1016/j.pcd.2013.10.001. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Predictors+of+Hypoglycaemia+in+Insulin-treated+Type+2+Diabetes+Patients+in+Primary+Care%3A+A+Retrospective+Database+Analysis+Primary+Care+Diabetes
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis.
Authors: Rathmann W1, Kostev K2, Gruenberger JB3, Dworak M3, Bader G3, Giani G1
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 IMS Health, Frankfurt, Germany 3 Novartis Pharma, Basel, Switzerland
Publications: 
Diabetes Obes Metab., 2013, Jan;15(1):55-61
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Treatment+Persistence%2C+Hypoglycemia%2C+and+Clinical+Outcomes+in+Type+2+Diabetes+Patients+with+DPP-4+Inhibitors+and+Sulfonylureas%3A+A+Primary+Care+Database+Analysis
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Resource consumption and costs of treatment in patients with type 1 diabetes under intensified conventional therapy under German real-life conditions.
Authors: Kostev K1, Dippel FW2, Bierwirth R3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Sanofi Deutschland GmbH, Berlin, Germany 3 Ambulantes Diabeteszentrum am Elisabeth-Krankenhaus, Essen, Germany
Publications: 
J Diabetes Sci Technol., 2013, May 1;7(3):736-42
Document Types: , Article
Countries: , Germany
Abstract: http://jdst.org/May2013/PDF/Abstracts/VOL-7-3-ORG12-KOSTEV-ABSTRACT.pdf
Condition Year Language Analysis type
, Diabetes 2013 English , Cost analysis
 
 
Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis.
Authors: Kostev K1, Rathmann W2
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 IMS Health, Frankfurt, Germany
Publications: 
Diabetologia, 2013, Jan;56(1):109-11
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Diabetic+retinopathy+at+diagnosis+of+type+2+diabetes+in+UK&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Glucose lowering therapeutic strategies for type 2 diabetic patients with chronic kidney disease in primary care setting in France: a cross-sectional study.
Authors: Grandfils N1, Detournay B2, Attali C3, Joly D4, Simon D5, Verg√®s B6, Toussi M1, Briand Y8, Delaitre O8
Affiliations: 1 IMS Health, Paris, France 2 Cemka-Eval, Bourg-la-Reine, France 3 Medical office, Epinay sous Senart, France 4 H√īpital Necker-Enfants Malades, Paris, France 5 H√īpital de la Piti√©-Salp√©tri√®re, Paris, France 6 INSERM CESP, Villejuif, France 7 H√īpital du Bocage, Dijon, France 8 Boehringer-Ingelheim, Paris, France
Publications: 
International Journal of Endocrinology, 2013, 640-632.
Document Types: , Article
Countries: , France
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638677/
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Hypoglycemic treatment in type 2 diabetes patients suffering from moderate to severe renal failure in France. Aim of the study.
Authors: Bou√©e S1, Gaudin AF, Amelineau E, Bonnet F.
Affiliations: 1Cemka-Eval, Bourg la Reine, France
Publications: 
Therapie. 2013 Jan-Feb;68(1):19-26. doi: 10.2515/therapie/2013002. Epub 2013 Mar 14
Document Types: , Article
Countries: , France
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23484656
Condition Year Language Analysis type
, Diabetes, Nephrology 2013 English , Retrospective database analysis
 
 
A new "Comparative Effectiveness" assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone.
Authors: Tannen R, Xie D, Wang X, Yu M & Weiner MG
Affiliations: University of Pennsylvania School of Medicine
Publications: 
Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):86-97. doi: 10.1002/pds.3360. Epub 2012 Oct 16
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23070833
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study
Authors: Lind M1, Garcia-Rodriguez LA, Booth GL, Cea-Soriano L, Shah BR, Ekeroth G & Lipscombe LL
Affiliations: 1 Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg Institute of Medicine Department of Molecular and Clinical Medicine
Publications: 
Diabetologia. 2013 Dec;56(12):2765. doi: 10.1007/s00125-013-2949-2. Epub 2013 Jun 22
Document Types: , Article
Countries: , Canada, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/24114114
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK.
Authors: Hall GC, McMahon AD, Dain MP, Wang E, Home PD
Affiliations: Grimsdyke House
Publications: 
Diabet Med. 2013 Jun;30(6):681-6. doi: 10.1111/dme.12137.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23330649
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study.
Authors: Hwang A, Narayan V & Yang YX
Affiliations: University of Pennsylvania Department of Gastroenterology
Publications: 
Cancer. 2013 Jan 15;119(2):404-10. doi: 10.1002/cncr.27731. Epub 2012 Aug 1.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23292900
Condition Year Language Analysis type
, Diabetes, Oncology 2013 English , Retrospective database analysis
 
 
Metformin and survival in pancreatic cancer: a retrospective cohort study
Authors: Hwang AL, Haynes K, Hwang WT, Yang YX
Affiliations: 
Publications: 
Pancreas. 2013 Oct;42(7):1054-9. doi: 10.1097/MPA.0b013e3182965a3c.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779343/
Condition Year Language Analysis type
, Diabetes, Oncology 2013 English , Retrospective database analysis
 
 
Distinguishing incident and prevalent diabetes in an electronic medical record database
Authors: Mamtani R, Haynes K, Finkelman BS, Scott FI & Lewis JD
Affiliations: University of Pennsylvania Abramson Cancer Center
Publications: 
Pharmacoepidemiology and Drug Safety [ahead of print]
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24375925
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Motifs de non intensification th√©rapeutique chez des patients DT2 non contr√īl√©s par une monoth√©rapie en M√©decine G√©n√©rale en France ‚Äď Phase prospective √©tude DIAttitude
Authors: Halimi S, BlickleJF, Balkau B, Attali C, Avignon A, Tocque E, Geoffroy MA, Chartier I, Verg√®s B
Affiliations: Department of Endocrinology,Department of Diabetology Pole DIGIDUNE, Grenoble University Hospital, Grenoble, France.
Publications: 
Diabetes Metab. 2013 Mar;39 (S1):A32
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Anti-diabetic treatment compliance with regards to the fixed or free treatments combination
Authors: Grandfils N, Le Jeunne P, Maillard C, Solomiac A, Besson A
Affiliations: IMS Health, Paris La D√©fense France
Publications: 
Ispor 16th Annual European Congrès 2-6 Novembre 2013 the convention centre Dublin
Document Types: , Poster
Countries: , France
Abstract: www.ispor.org
Condition Year Language Analysis type
, Diabetes 2013 English
 
 
La diffusion des nouveaux antidiabétiques : une comparaison internationale
Authors: Pichetti S1, Sermet C1, Saskia van der Erf2
Affiliations: 1IRDES, 2CNAMTS
Publications: 
Points de rep√®re n¬į 40 - mai 2013
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Diabetes 2013 French
 
 
Anti-diabetic treatment compliance with regards to the fixed or free treatments combination
Authors: Grandfils N, Le Jeunne P, Maillard C, Solomiac A, Besson A
Affiliations: IMS Health, Paris La D√©fense France
Publications: 
ISPOR 16th Annual European Congress, 2-6 November 2013
Document Types: , Poster
Countries: , France
Abstract: www.ispor.org
Condition Year Language Analysis type
, Diabetes 2013 English , Retrospective database analysis
 
 
Perspectives on complementary data sources in diabetes health technology assessment: an enrolling practice-based research network and a large commercial health plan
Authors: Dalal MR; Frimpter J; Pan C; Stewart J; Johnstone B; Gemmen E; Reed J, Vlajnic A
Affiliations: 
Publications: 
Poster, ISPOR 18th Annual International Meeting, New Orleans, LA 2013
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2013 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
A cross-national comparison of safety and efficacy information in insulin glargine drug labels
Authors: Polinski JM, Kesselheim AS, Seeger JD, Connolly JG, Choudhry NK, Shrank WH
Affiliations: 
Publications: 
American Diabetes Association, 73nd Scientific Session, Chicago, June 21-25, 2013
Document Types: , Conference
Countries: 
Condition Year Language Analysis type
, Diabetes 2013 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
A practice-based research network focused on comparative effectiveness research in type 2 diabetes management
Authors: Anderson JE, Rhinehart AS, Reid TS, Cuddihy RM, Vlajnic A, Dalal MR, Gemmen E, Johnstone B, Abbaszadeh B, Reed J, Sheller J, Stewart J, Mozaffari E, Diabetes FORWARD Investigators
Affiliations: 
Publications: 
Postgrad Med. 2013 May;125(3):172-80
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2013 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Using Anonymized Longitudinal Patient Data to Monitor the Impact of Reimbursement Policies on Patient Compliance
Authors: Gillman, A
Affiliations: IMS Brogan, Toronto, Canada
Publications: 
CAPT 2013
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/capt-agillman-final.pdf
Condition Year Language Analysis type
, Diabetes 2013 English , Longitudinal study
 
 
Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study
Authors: Haukka J, Hoti F, Er√§st√∂ P, Saukkonen T, M√§kimattila S, Korhonen P
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
Pharmacoepidemiology and drug safety (2013); 22: 1326-1335
Document Types: , Article
Countries: , Finland
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265848/
Condition Year Language Analysis type
, Diabetes 2013 English , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis
 
 
Assessing the relationship between the effect of glycemic control and avoided symptomatic Hypoglycemia on quality of life in the management of type 2 Diabetes
Authors: Foos V1, McEwan P2, Lloyd A3, Palmer JL1, Lamotte M4, Grant D3
Affiliations: 1 IMS Health, Basel, Basel-Stadt, Switzerland 2 HEOR Consulting, Monmouth, Monmouthshire, UK 3 IMS Health, London, UK 5 IMS Health, Vilvoorde, Belgium
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Podium presentation
Countries: 
Abstract: http://www.ispor.org/congresses/Berlin1112/Podiums.aspx#sessionI
Condition Year Language Analysis type
, Diabetes 2012 English , Quality of life
 
 
Medication adherence and medical costs associated with exenatide BID versus liraglutide: A retrospective database analysis.
Authors: Pelletier EM1, Pawaskar M2, Chapman R3
Affiliations: 1IMS Health, Watertown, MA, USA, 2Eli Lilly and Company and Lilly USA, LLC, Indianapolis, IN, USA, 3IMS Health, Alexandria, VA, USA
Publications: 
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual International Meeting, 2012, June, Washington, DC, USA
Document Types: , Abstract, Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2012 English , Cost analysis, Retrospective cohort analysis, Retrospective database analysis
 
 
Long-term cost-consequence analysis of exenatide once weekly versus sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States.
Authors: Guillermin AL1, Lloyd A1, Best JH2, Beth Deyoung M2, Samyshkin Y1, Aledort Gaebler J2.
Affiliations: 1 IMS Health, London, UK 2 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA
Publications: 
J Med Econ. 2012 Mar 12. [Epub ahead of print]
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Guillermin+A%5Bfirst+author%5D+AND+exenatide&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2012 English , Cost consequence
 
 
Long-term clinical and economic benefit associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a Core Diabetes Model study.
Authors: Lee WC1, Samyshkin Y2, Langer J3, Palmer J4
Affiliations: 1IMS Health, Alexandria, VA, USA, 2IMS Health, London, UK, 3Novo Nordisk, Inc., Princeton, NJ, USA, 4IMS Health, Allschwil, Basel, Switzerland
Publications: 
ISPOR 17th Annual International Meeting. June 2-6, 2012 Washington, DC, USA.
Document Types: , Abstract, Poster
Countries: , USA
Abstract: http://www.ispor.org/meetings/washingtondc0512/Posters4.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Cost benefit
 
 
Economic outcomes of exenatide versus liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
Authors: Pelletier EM1, Pawaskar M2, Smith PJ1, Best JH3, Chapman RH4
Affiliations: 1IMS Health Inc., Watertown, MA, USA, 2Eli Lilly and Company and Lilly USA, LLC, Indianapolis, IN, USA, 3Amylin Pharmaceuticals Inc., San Diego, CA, USA, 4IMS Health Inc., Alexandria, VA, USA
Publications: 
J Med Econ 2012 [in press]; 2012 Apr 26 [Epub ahead of print]
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2012 English , Cost analysis, Retrospective cohort analysis, Retrospective database analysis
 
 
Cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes (T2DM)
Authors: Fonda SJ, Graham C, Samyshkin Y, Munakata J, Powers J, Vigersky RA
Affiliations: 
Publications: 
American Diabetes Association, 2012, June 8-12, Philadelphia, PA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2012 English , Cost effectiveness
 
 
Direct Medical Costs of Treating Diabetes Related Complications in Mexico
Authors: Vega-Hernandez G1, Jugrin A1, Radford M1, Bloomfield E1, Todorova L2, Hansen BB3
Affiliations: 1 IMS Health, HEOR London, UK 2 Novo Nordisk International Operations, Zurich, Switzerland 3 Novo Nordisk A/S, S√łborg, Denmark
Publications: 
ISPOR 17th Annual International Meeting, June 2-6 2012, Washington, USA
Document Types: , Poster
Countries: , Mexico
Condition Year Language Analysis type
, Diabetes 2012 English , Cost of illness
 
 
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
Authors: Mitchell P1, Annemans L2, Gallagher M3, Hasan R3, Thomas S4, Gairy K5, Knudsen M6, Onwordi H6
Affiliations: 1 Centre for Vision Research,Westmead Millennium Institute,University of Sydney, NSW, Australia 2 Ghent University, Ghent,Belgium 3 Novartis Pharma AG, Basel, Switzerland 4 Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA 5 Novartis Pharmaceuticals, Frimley, UK 6 IMS Health, London, UK
Publications: 
Br J Ophthalmol 2012;96:688e693. (epub ahead of print)
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2012 English , Cost effectiveness
 
 
Direct Medical Costs of Diabetes-Related Complications in Saudi Arabia
Authors: Hnoosh A1; Vega-Hern√°ndez G1; Jugrin A1; Todorova L2
Affiliations: 1 IMS Health, HEOR, London, UK; 2 Novo Nordisk International Operations, Zurich, Switzerland
Publications: 
ISPOR 17th Annual International Meeting, June 2-6 2012, Washington, USA
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , Cost analysis
 
 
Direct Medical Costs Of Diabetes-Related Complications In India
Authors: Todorova L1, Hnoosh A2, Korde G3, Shiu ML4
Affiliations: 1 Novo Nordisk International Operations, Zurich, Switzerland, 2 IMS Health, London, UK, 3 IMS Health Consulting Group, Mumbai, India, 4 Novo Nordisk Pharma Operations (BAOS) Sdn. Bhd., Kuala Lumpur, Malaysia
Publications: 
ISPOR 5th Asia-Pacific Conference, 2-4 September 2012, Taipei, Taiwan.
Document Types: , Abstract
Countries: , India
Abstract: http://www.ispor.org/conferences/Taipei0912/Posters2.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Cost analysis
 
 
Estimating the Direct Medical Costs associated with Diabetes-Related Complications in Indonesia
Authors: Todorova L1, Hnoosh A2, Bloomfield E2, Shiu ML3
Affiliations: 1 Novo Nordisk International Operations, Zurich, Switzerland, 2 IMS Health Consulting Group, London, United Kingdom, 3 Novo Nordisk Pharma Operations (BAOS) Sdn. Bhd., Kuala Lumpur, Malaysia
Publications: 
ISPOR 5th Asia-Pacific Conference, 2-4 September 2012, Taipei, Taiwan. PDB20
Document Types: , Abstract
Countries: , Indonesia
Abstract: http://www.ispor.org/conferences/Taipei0912/Posters2.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Cost analysis
 
 
Estimating the Costs of Diabetes Mellitus: An Analysis in Malaysia
Authors: Todorova L1, Hnoosh A2, Bloomfield E2, Shiu ML3
Affiliations: 1 Novo Nordisk International Operations, Zurich, Switzerland 2 IMS Health, London, UK 3 Novo Nordisk Pharma Operations (BAOS) Sdn. Bhd., Kuala Lumpur, Malaysia
Publications: 
ISPOR 5th Asia-Pacific Conference, 2-4 September 2012, Taipei, Taiwan.
Document Types: , Abstract
Countries: , Malaysia
Abstract: http://www.ispor.org/conferences/Taipei0912/Posters2.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Cost analysis
 
 
Direct Medical Management Costs of Diabetes-Related Complications in Algeria
Authors: Hnoosh A1; Vega-Hern√°ndez G1; Jugrin A1; Todorova L2
Affiliations: 1 IMS Health, HEOR, London, UK; 2 Novo Nordisk International Operations, Zurich, Switzerland
Publications: 
ISPOR 17th Annual International Meeting, June 2-6 2012, Washington, USA
Document Types: , Abstract
Countries: , Algeria
Condition Year Language Analysis type
, Diabetes 2012 English , Cost analysis
 
 
Direct Medical Management Costs of Diabetes-Related Complications in Brazil
Authors: Vega-Hern√°ndez G1; Hnoosh A1; Jugrin A1; Todorova L2; Hansen BB3
Affiliations: 1 IMS Health, HEOR, London, UK; 2 Novo Nordisk International Operations, Zurich, Switzerland; 3 Novo Nordisk A/S, Soeborg, Denmark
Publications: 
ISPOR 17th Annual International Meeting, June 2-6 2012, Washington, USA
Document Types: , Abstract
Countries: , Brazil
Condition Year Language Analysis type
, Diabetes 2012 English , Cost analysis
 
 
Validation and Evaluation of the Risk-To-Benefit Ratio of Glucose Lowering Therapies in High Cardiovascular Risk Type 2 Diabetes Patients; Projections using the IMS CORE Diabetes Model.
Authors: Foos V1, Freemantle N2, Palmer J1, Grant D3, Lloyd A3, Evans M4, Mcewan P
Affiliations: 1 IMS Health, Basel, Switzerland 2 UCL Medical School, London, UK 3 IMS Health, London, UK 4 University of Cambridge, UK, 5 Swansea Centre for Health Economics, Swansea University, UK
Publications: 
72nd Scientific Sessions, American Diabetes Association, Philadelphia, PA, June 8‚Äď12 2012
Document Types: , Oral presentation
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , Economic evaluation
 
 
Long-Term Validation of the IMS CORE Diabetes Model in Type 1 and Type 2 Diabetes.
Authors: Grant D1, Foos V2 , Palmer J2 , Lloyd A1, Evans M3, Mcewan P4
Affiliations: 1 IMS Health, London, UK 2 IMS Health, Basel, Switzerland 3 University of Cambridge, UK, 4 Swansea Centre for Health Economics, Swansea University, UK
Publications: 
72nd Scientific Sessions, American Diabetes Association, Philadelphia, PA, June 8‚Äď12 2012
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , Economic evaluation
 
 
The Cost and Productivity Consequences of Non-Severe Hypoglycaemic Episodes (NSHE) in Patients Receiving Sulfonylurea or DPP4 Dual Combination Oral Therapy
Authors: McEwan P1, Evans M2, Foos V3, Lloyd A4, Grant D4
Affiliations: 1 Swansea Centre for Health Economics, Swansea University, UK 2 University of Cambridge, UK 3 IMS Health, Basel, Switzerland 4 IMS Health, London, UK
Publications: 
72nd Scientific Sessions, American Diabetes Association, Philadelphia, PA, June 8‚Äď12 2012
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , Burden of illness
 
 
Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes (T2DM)
Authors: Fonda SJ, Graham C, Samyshkin Y, Munakata –ě, MS, Powers J, Price D, Vigersky RA,
Affiliations: 
Publications: 
ADA 72nd Scientific Sessions, June 8 - 12, 2012, Pennsylvania Convention Center, Philadelphia, PA
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , Cost effectiveness
 
 
Long-term clinical and economic benefit associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a Core Diabetes Model study.
Authors: Lee WC1, Samyshkin Y2, Langer J3, Palmer J4
Affiliations: 1IMS Health Consulting Group, Alexandria, VA, USA, 2IMS Health Consulting Group, London, UK, 3Novo Nordisk, Inc., Princeton, NJ, USA, 4IMS Health Consulting Group, Allschwil, Basel-Land, Switzerland
Publications: 
ISPOR 17th Annual International Meeting, Washington, DC, USA, June 2-6, 2012
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , Cost benefit
 
 
Long-Term Cost-utility analysis of Exenatide once weekly versus insulin Glargine for the treatment of Type 2 diabetes patients in the United States.
Authors: Samyshkin Y1, Guillermin A-L1, Best JH2, Brunell SC2, Lloyd A1
Affiliations: 1 IMS Health, London, UK 2 Amylin Pharmaceuticals, San Diego, CA, USA
Publications: 
Journal of Medical Economics, 2012;15(6):1-8
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2012 English , Cost utility
 
 
Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes
Authors: Yeaw J1, Lee WC1, Aagren M2, Christensen T2
Affiliations: 1 IMS Health, Redwood City, CA, US 2 Novo Nordisk, Copenhagen, Denmark
Publications: 
J Manag Care Pharm. 2012 Jan-Feb;18(1):21-32.
Document Types: , Article
Countries: , USA
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22235952
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
Cost of self-monitoring of blood glucose in Canada among patients on an insulin regimen for diabetes
Authors: Yeaw J1, Lee WC1, Wolden ML2, Christensen T2, Groleau D2
Affiliations: 1 IMS Health, Redwood City, CA, US 2 Novo Nordisk, Copenhagen, Denmark
Publications: 
Diabetes Ther. 2012 Nov;3(1):7. Epub 2012 Jun 27.
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/22736405
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective cohort analysis
 
 
Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis
Authors: Lee WC1, Samyshkin Y2, Langer J3, Palmer JL4
Affiliations: 1IMS Health, Alexandria, VA, USA, 2IMS Health, London, UK, 3Novo Nordisk, Inc., Princeton, NJ, USA, 4IMS Health, Allschwil, Basel, Switzerland
Publications: 
Journal of Medical Economics
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , Cost effectiveness
 
 
How hypoglycaemicn events can influence diabetic patients'weight and affect HBA1C control
Authors: Ansolabehere X, Grandfils N, Le Jeunne P, Morlet-Vigier D
Affiliations: IMS Health, Puteaux, France
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective cohort analysis
 
 
The burden of diabetes mellitus in Belgium: a retrospective database study.
Authors: Lamotte M1, Chevalier P1, Gerlier L1
Affiliations: 1 IMS Health, Vilvoorde, Belgium
Publications: 
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , Belgium
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
The cost of diabetes complications in Belgium.
Authors: Lamotte M1, Chevalier P1
Affiliations: 1 IMS Health, Vilvoorde, Belgium
Publications: 
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , Belgium
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2012 English , Cost consequence, Cost of illness
 
 
Burden of Chronic Kidney Disease in German Diabetes Patients, a Systematic Literature Review and Data Gap Analysis.
Authors: Korolewa V1, Hengst N1, Wolff M1, Berger K2, Ehlken B2, Greiner RA2, Eheberg D2, Pfiffner C2
Affiliations: 1 Abbott GmbH & Co.KG, Wiesbaden, Germany 2 IMS Health, Munich, Germany
Publications: 
ISPOR 15th Annual European Congress
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2012 English , Literature Review
 
 
Long-term validation of the IMS Core Diabetes Model in Type 1 and Type 2 Diabetes
Authors: Foos V1, Palmer JL2, Grant D3, Lloyd A3, Lamotte M4, McEwan P5
Affiliations: IMS Health, Basel, Basel-Stadt, Switzerland, 2IMS Health, Allschwil, Basel-Landschaft, Switzerland, 3IMS Health, London, UK, 4IMS Health, Vilvoorde, Belgium, 5HEOR Consulting, Monmouth, Monmouthshire, UK
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: 
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Methodology
 
 
Systematic literature review of utility values associated with Type 2 Diabetes-related complications
Authors: Beaudet A1, Clegg JP1, Lloyd A2
Affiliations: IMS Health, Basel, BS, Switzerland, 2IMS Health, London, UK
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: 
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Literature Review
 
 
HBA1C testing frequency in primary care Diabetes patients in Germany and in the United Kingdom
Authors: Kostev K, Grunow S, Rockel T
Affiliations: IMS Health, Frankfurt am Main, Germany
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters5.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
Direct medical costs of Diabetes Mellitus in China: Annual cost of illness and long-term projections using a validated diabetes model
Authors: Palmer JL1, Caputo J2, Foos V1, Grant D3, Lamotte M4, Lloyd A3, McEwan P5
Affiliations: 1 IMS Health, Basel, Switzerland, 2 IMS Health, Singapore, Singapore, 3 IMS Health, London, UK, 4 IMS Health Consulting Group, Vilvoorde, Belgium, 5 HEOR Consulting, Monmouth, Monmouthshire, UK
Publications: 
ISPOR 5th Asia-Pacific Conference, Taipei, Taiwan, September 2nd ‚Äď 4th 2012
Document Types: , Poster
Countries: , China
Abstract: http://www.ispor.org/conferences/Taipei0912/Posters2.aspx
Condition Year Language Analysis type
, Diabetes 2012 English , Cost of illness
 
 
Understanding the importance of more insightful HTA submissions
Authors: Grant D1, McEwan P1
Affiliations: 1IMS Health, London, UK
Publications: 
AccessPoint, Nov 2012; Vol 3(5); 37-41
Document Types: , Article
Countries: 
Abstract: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Services/Pharma%20Commercial%20Effectiveness/Health%20Economics%20_%20Outcomes%20Research/AccessPoint-5-281012%20F.pdf
Condition Year Language Analysis type
, Diabetes 2012 English
 
 
A retrospective database study of insulin initiation in patients with Type 2 diabetes in UK primary care.
Authors: Blak BT1, Smith HT, Hards M, Maguire A & Gimeno V
Affiliations: 1Cegedim Strategic Data Medical Research Ltd, London, UK. betina.blak@gmail.com
Publications: 
Diabet Med. 2012 Aug;29(8):e191-8. doi: 10.1111/j.1464-5491.2012.03694.x.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22507537
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study.
Authors: Mamtani R, Haynes K, Bilker WB, Vaughn DJ, Strom BL, Glanz K & Lewis JD.
Affiliations: Sherwood Forest Hospitals Foundation Trust University of Pennsylvania Department of Medicine
Publications: 
J Natl Cancer Inst. 2012 Sep 19;104(18):1411-21. Epub 2012 Aug 9.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529598/pdf/djs328.pdf
Condition Year Language Analysis type
, Diabetes, Oncology 2012 English , Retrospective database analysis
 
 
Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.
Authors: Idris I, Warren G, Donnelly R.
Affiliations: 
Publications: 
Arch Intern Med. 2012 Jul 9;172(13):1005-11. doi: 10.1001/archinternmed.2012.1938.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22688528
Condition Year Language Analysis type
, Diabetes, Ophthalmology 2012 English , Retrospective database analysis
 
 
Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study.
Authors: Hall GC, McMahon AD, Carroll D, Home PD.
Affiliations: Grimsdyke House
Publications: 
Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):305-13. doi: 10.1002/pds.2345. Epub 2012 Jan 23.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22271442
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Authors: Blak BT1, Smith HT, Hards M, Curtis BH & Ivanyi T
Affiliations: 1Cegedim Strategic Data Medical Research Ltd, London, UK. betina.blak@cegedim.com
Publications: 
Diabet Med. 2012 Jul;29(7):e13-20. doi: 10.1111/j.1464-5491.2012.03586.x.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22268988
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies.
Authors: Lo Re V 3rd, Haynes K, Ming EE, Wood Ives J, Horne LN, Fortier K, Carbonari DM, Hennessy S, Cardillo S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Roy J, Freeman CP, Razzaghi H, Holick CN, Esposito DB, Van Staa TP, Bhullar H & Strom BL.
Affiliations: Cegedim
Publications: 
Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1202-15. doi: 10.1002/pds.3318. Epub 2012 Jul 5.
Document Types: , Article
Countries: , UK, USA
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22763953
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2012 English , Retrospective database analysis
 
 
The impact of treatment non-compliance on mortality in people with type 1 diabetes.
Authors: Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM & Evans M
Affiliations: Cardiff University Department of medicine
Publications: 
J Diabetes Complications. 2013 May-Jun;27(3):219-23. doi: 10.1016/j.jdiacomp.2012.10.006. Epub 2012 Nov 13.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22511257
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010: the DIAttitude Study.
Authors: Halimi S1, Balkau B, Attali C, Detournay B, Amelineau E, Blickle JF.
Affiliations: 1CHU Grenoble - Clinique Diab√©tologie Nutrition P√īle DigiDUNE University Hospital Grenoble University Joseph Fourier
Publications: 
Diabetes Metab. 2012 Mar;38 Suppl 3:S36-46. doi: 10.1016/S1262-3636(12)71533-1.
Document Types: , Article
Countries: , France
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22541601
Condition Year Language Analysis type
, Diabetes 2012 English , Prospective study, Retrospective database analysis
 
 
Type 2 diabetes treatment intensification in general practice in France in 2008-2009: the DIAttitude Study.
Authors: Balkau B1, Bou√©e S, Avignon A, Verg√®s B, Chartier I, Amelineau E, Halimi S.
Affiliations: 1Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease Over the Lifecourse and Determinants of Early Nutrition, Villejuif, France
Publications: 
Diabetes Metab. 2012 Mar;38 Suppl 3:S29-35. doi: 10.1016/S1262-3636(12)71532-X.
Document Types: , Article
Countries: , France
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22541600
Condition Year Language Analysis type
, Diabetes 2012 English , Prospective study, Retrospective database analysis
 
 
Usage of Self-Monitoring of Blood Glucose (SMBG) by Diabetes Therapy Type in Larger Cities in China.
Authors: Mast O1, Tan A2, Zweyer S2, Perridy D2.
Affiliations: 1Roche, Mannheim, Germany 2Cegedim Strategic Data, Shanghai, China
Publications: 
ISPOR 5TH ASIA-PACIFIC CONFERENCE , TAIPEI, TAIWAN
Document Types: , Poster
Countries: , China
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)01865-7/abstract
Condition Year Language Analysis type
, Diabetes 2012 English , Compliance, Retrospective database analysis
 
 
UTILIZATION OF FPG, HBA1C AND SELF-MONITORING OF BLOOD GLUCOSE (SMBG) IN COMMUNITY HEALTH CENTERS IN THE SHANGHAI AREA.
Authors: Mast O1, Tan A2
Affiliations: 1Roche, Mannheim, Germany 2Cegedim Strategic Data, Shanghai, China
Publications: 
ISPOR 5TH ASIA-PACIFIC CONFERENCE, TAIPEI, TAIWAN
Document Types: , Poster
Countries: , China
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)01866-9/abstract
Condition Year Language Analysis type
, Diabetes 2012 English , Compliance, Survey research
 
 
Validation of diabetic retinopathy and maculopathy diagnoses recorded in a U.K. primary care database.
Authors: Mart√≠n-ME, Fortuny J, Rivero E & Garc√≠a LA
Affiliations: Centro Espa√Īol de Investigaci√≥n Farmacoepidemiol√≥gica
Publications: 
Diabetes Care. 2012 Apr;35(4):762-7. doi: 10.2337/dc11-2069. Epub 2012 Feb 22.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22357184
Condition Year Language Analysis type
, Diabetes, Ophthalmology 2012 English , Retrospective database analysis
 
 
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
Authors: Renehan AG, Yeh HC, Johsnon JA, Wild SH, Gale EA, Moller H, Diabetes and Cancer Research Consortium
Affiliations: University of Manchester Department of Surgery, School of Cancer and Enabling Sciences
Publications: 
Diabetologia. 2012 Jun;55(6):1619-32. doi: 10.1007/s00125-012-2526-0. Epub 2012 Apr 4.
Document Types: , Article
Countries: , UK
Abstract: http://link.springer.com/article/10.1007/s00125-012-2526-0/fulltext.html
Condition Year Language Analysis type
, Diabetes, Oncology 2012 English , Retrospective database analysis
 
 
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.
Authors: Johnson JA1, Carstensen B2 3, Witte D2, Bowker SL1, Lipscombe L4 & Renehan AG5
Affiliations: 1 School of Public Health, University of Alberta, 2 Steno Diabetes Center, 3 2 Department of Biostatistics, University of Copenhagen 4 Women‚Äôs College Hospital, University of Toronto, 5 School of Cancer and Enabling Sciences, University of Manchester
Publications: 
Diabetologia. 2012 Jun;55(6):1607-18. doi: 10.1007/s00125-012-2525-1. Epub 2012 Apr 4.
Document Types: , Article
Countries: , Canada, UK
Abstract: http://link.springer.com/article/10.1007/s00125-012-2525-1/fulltext.html
Condition Year Language Analysis type
, Diabetes, Oncology 2012 English , Retrospective cohort analysis, Retrospective database analysis
 
 
Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease
Authors: Hall GC, McMahon AD, Carroll D & et al
Affiliations: Grimsdyke House
Publications: 
PLoS One. 2012;7(11):e49908. doi: 10.1371/journal.pone.0049908. Epub 2012 Nov 14.
Document Types: , Article
Countries: , UK
Abstract: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0049908
Condition Year Language Analysis type
, Diabetes, Vascular disease 2012 English , Retrospective database analysis
 
 
GLP-1 Receptor Agonist (GLP1ra) and Insulin Efficacy in Primary Health Care
Authors: Hall GC, McMahon AD, Dain M-P & et al
Affiliations: Sanofi
Publications: 
Diabetes 61(S1):A276
Document Types: , Article
Countries: , UK
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2012 English , Retrospective database analysis
 
 
Evaluation of Methods to Estimate Days’ Supply of Oral Antidiabetic Drugs in The Health Improvement Network
Authors: Haynes K, Fortier K, Newcomb C, Roy J, Ming E, Horne L, Wood-Ives J, Strom B &Lo Re V
Affiliations: University of Nottingham
Publications: 
28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Barcelona, Spain
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
A new "Comparative Effectiveness" assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone.
Authors: Tannen R, Xie D, Wang X, Yu M & Weiner MG
Affiliations: University of Pennsylvania School of Medicine
Publications: 
Pharmacoepidemiology and Drug Safety 22(1):86-96
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23070833
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
Better analyze the determinants of therapeutic inertia to overcome it
Authors: Halimia S, Balkaub B.
Affiliations: Department of Diabetology,Grenoble University Hospital Center, Grenoble, France
Publications: 
Diabetes Metab. 2012 Mar;38 Suppl 3:S27-8. doi: 10.1016/S1262-3636(12)71531-8.
Document Types: , Article
Countries: , France
Abstract: http://www.em-consulte.com/en/article/709573
Condition Year Language Analysis type
, Diabetes 2012 English , Prospective study, Retrospective database analysis, Survey research
 
 
Direct medical costs of diabetes-related complications in Saudi Arabia
Authors: 1. Hnoosh A IMS Health, HEOR, London, UK 2. Vega-Hern√°ndez G IMS Health, HEOR, London, UK 3. Jugrin A IMS Health, HEOR, London, UK 4. Todorova L Novo Nordisk International Operations, Z√ľrich, Switzerland
Affiliations: IMS Health HEOR and Novo Nordisk International Operations, Zurich
Publications: 
ISPOR 17th Annual International Meeting, Washington, USA
Document Types: , Conference, Poster
Countries: , Saudi Arabia
Condition Year Language Analysis type
, Diabetes 2012 English , Literature Review
 
 
Ims LifeLinkTM cohorte diabète : validité et utilité
Authors: Le Jeunne P1
Affiliations: 1IMS Health, Paris La D√©fense France
Publications: 
Le revue du Praticien m√©decine g√©n√©rale 2012 Nov; 26: n¬į 889
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Diabetes 2012 French
 
 
Ims LifeLinkTM cohorte diabète : validité et utilité
Authors: Le Jeunne P1
Affiliations: 1IMS Health, Paris La D√©fense France
Publications: 
Le revue du Praticien m√©decine g√©n√©rale 2012 Nov; 26: n¬į 889
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Diabetes 2012 English , Retrospective database analysis
 
 
Optimisation of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin
Authors: Blak B, Hards M, Smith HT, Curtis BH, Ivanyi T
Affiliations: 
Publications: 
Diabetic Medicine 2012 Jul;29(7):e13-20
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Rationale and design of the Multinational Observational Study Assessing Insulin use: the MOSAIc study
Authors: Polinski JM, Curtis BH, Seeger JD, Choudhry NK, Zagar A, Shrank WH
Affiliations: 
Publications: 
BMC Endocr Dis 2012; 12: 20
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2012 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Weight gain within the first year after new onset diabetes is associated with risk of cardiovascular mortality: a cohort of 8,326 primary care patients.
Authors: Bodegard J1, Sundstr√∂m J2, Svennblad B3, √Ėstgren C4, Nilsson PM5, Johansson G2
Affiliations: 1 Medical Department, AstraZeneca, Oslo, Norway, 2 Uppsala University, Sweden, 3 Uppsala Clinical Research Center, Sweden, 4 Link√∂ping University, Sweden, 5Lund University, Sweden
Publications: 
48th EASD Annual Meeting of the European Association for the Study of Diabetes; 2012; Berlin, Germany
Document Types: , Abstract
Countries: , Sweden
Abstract: http://www.easdvirtualmeeting.org/resources/weight-gain-within-the-first-year-after-new-onset-diabetes-is-associated-with-risk-of-cardiovascular-mortality-a-cohort-of-8-326-primary-care-patients
Condition Year Language Analysis type
, Diabetes 2012 English , Real World Evidence
 
 
The risk of first severe hypoglycaemia depends on the type of basal insulin but does not differ between patients with type 1 and type 2 diabetes: The EpiHypo Study
Authors: Korhonen P, Haukka J, Hoti F, Er√§st√∂ P, M√§kimattila S, Saukkonen T
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
Diabetologia (2012);55: (Suppl 1): S254
Document Types: , Poster
Countries: , Finland
Abstract: https://www.easd.org/virtualmeeting/home.html#!resources/the-risk-of-first-severe-hypoglycaemia-depends-on-the-type-of-basal-insulin-but-does-not-differ-between-patients-with-type-1-and-type-2-diabetes-the-epihypo-study--2
Condition Year Language Analysis type
, Diabetes 2012 English , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis
 
 
Type of Insulin and Age are Predictors of Hospitalization due to Severe Hypoglycemia: The EpiHypo Study
Authors: M√§kimattila S, Korhonen P, Haukka J, Hoti F, Pajunen P, Saukkonen T
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
Diabetes (2012);61:A101-A102
Document Types: , Poster
Countries: , Finland
Abstract: http://diabetes.diabetesjournals.org/content/diabetes/61/Supplement_1/A99.full.pdf
Condition Year Language Analysis type
, Diabetes 2012 English , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis
 
 
Automated data extraction‚ÄĒA feasible way to construct patient registers of primary care utilization
Authors: Martinell M, Stalhammar J, Hallqvist J
Affiliations: Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden
Publications: 
Upsala Journal of Medical Sciences (2012);117(1):52-56
Document Types: , Article
Countries: , Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282243/
Condition Year Language Analysis type
, Diabetes 2012 English , Clinical setting: Primary care, Real World Evidence
 
 
Risk of First Severe Hypoglycaemic (SH) Coma Event among Patients with Diabetes Who Initiate the Use of Detemir (IDet), Glargine (IGla) and NPH Insulins: A Nationwide Register-Linkage Study in Finland
Authors: Korhonen P, Hoti F, Er√§st√∂ P, M√§kimattila S, Saukkonen T, Haukka J
Affiliations: EPID Research Ltd, Espoo, Finland
Publications: 
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012) 21: (Suppl 3): 27-27
Document Types: , Abstract
Countries: , Finland
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.3324
Condition Year Language Analysis type
, Diabetes 2012 English , Population Based Study, Retrospective database analysis
 
 
Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden.
Authors: Valentine WJ1, Aagren M2, Haglund M3-4, Ericsson A3, Gschwend MH5
Affiliations: 1Ossian Health Economics and Communication, Basel, Switzerland, 2Novo Nordisk Inc., Princeton, NJ, USA, 3Novo Nordisk Scandinavia AB, Malmo, Sweden, 4NeuroSearch A/S, Ballerup, Denmark and 5IMS Health, Basel, Switzerland
Publications: 
Scandinavian journal of public health
Document Types: , Manuscript in preparation
Countries: , Switzerland
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20688795
Condition Year Language Analysis type
, Diabetes 2011 English , Cost effectiveness
 
 
Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis
Authors: Guillermin A1, Samyshkin Y1, Wright D1, Nguyen T1, Villeneuve J2
Affiliations: 1 IMS Health, London, UK 2 Sanofi-Aventis, Laval, Canada
Publications: 
Journal of Medical Economics 2011; 14(2):207-216
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/21361858
Condition Year Language Analysis type
, Diabetes 2011 English , Cost minimization, Meta analysis
 
 
Cost of all-cause and cardiovascular disease-related hospitalization in patients with type 2 diabetes treated with exenatide BID, sulfonylureas, or insulin: a retrospective analysis of the LifeLink‚ĄĘ Database.
Authors: Best JH1, Pelletier EM2, Smith DB2
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Watertown, MA, USA
Publications: 
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual International Meeting, 2011, May, Baltimore, MD, USA
Document Types: , Abstract, Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2011 English , Cost analysis, Retrospective cohort analysis, Retrospective database analysis
 
 
Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the GLP-1 receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink‚ĄĘ database.
Authors: Best JH1, Hoogwerf BJ2, Herman WH3, Pelletier EM4, Smith DB4, Wenten M1, Hussein MA5
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA, 3University of Michigan, Ann Arbor, MI, USA, 4IMS Health, Watertown, MA, USA, 5IMS Health, Falls Church, VA, USA
Publications: 
Diabetes Care 2011;34(1):90-95; 2012 Oct 7 (Epub ahead of print)
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2011 English , Cost analysis, Retrospective cohort analysis, Retrospective database analysis
 
 
Insulin glargin reduziert das Risiko f√ľr ein diabetisches Fu√üsyndrom und makrovaskul√§re Komplikationen [Insuline glargine reduces the risk of diabetic food syndorme and maro-vascular disease]
Authors: Siegmund T1, Dippel,FW2, Kostev,K3, Lauterbach, S4, Fuchs, S5, Kotowa, W5
Affiliations: 1 St√§dtisches Klinikum M√ľnchen GmbH 2 Sanofi-Aventis Deutschland GmbH, Berlin 3 IMS Health GmbH & Co, OHG, Frankfurt/Main 4 Apotheke Rotes-Kreuz-Krankenhaus, Kassel 5 IMS Health GmbH & Co, OHG, Health Economics & Outcomes Research, N√ľrnberg
Publications: 
Perfusion 2011; 24: 44‚Äď52
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2011 German , Retrospective database analysis
 
 
Exenatide (Bid) and Liraglutide (Qd) treatment patterns among type-2 diabetes patients in Germany.
Authors: Miller L, Burudpakdee C, Zagar A, Bhosle M, Reaney M, Schabert V
Affiliations: Eli Lilly and Company, Indianapolis, IN, USA; IMS Health Incorporated, Falls Church, VA, USA;Eli Lilly and Company, Windlesham, Surrey, UK
Publications: 
ISPOR 16th Annual International Meeting, Baltimore, MD, USA
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2011 English , Retrospective database analysis
 
 
Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US.
Authors: Lee WC1, Conner C2, Hammer M3.
Affiliations: 1 Health Economics & Outcomes Research, IMS Health, Falls Church, VA, USA 2 Novo Nordisk Inc., Princeton, New Jersey, USA 3 Novo Nordisk A/S, Soborg, Denmark
Publications: 
Curr Med Res Opin. 2011 Feb 25.
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2011 English , Cost effectiveness
 
 
Ermittlung der tatsächlichen Tagesdosierung von Liraglutid (PDD) unter realen Versorgungsbedingungen im Hinblick auf die Berechnung von Tagestherapiekosten
Authors: Fuchs S, Kostev K, Seitz L, Wohlleben M
Affiliations: 
Publications: 
46. Jahrestagung der Deutschen-Diabetes-Gesellschaft (Juni 2011)
Document Types: , Abstract, Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2011 German
 
 
Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK.
Authors: Beaudet A1, Palmer JL1, Timlin L2, Wilson B3, Bruhn D4, Boye KS4, Lloyd A5
Affiliations: 1 IMS Health, Basel, Switzerland, 2 Lilly UK, Windlesham, Surrey, UK, 3 Lilly UK, Basingstoke, UK, 4 Eli Lilly & Co, Indianapolis, IN, USA, 5 IMS Health, London, UK
Publications: 
Journal of Medical Economics
Document Types: , Manuscript in preparation
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2011 English , Cost effectiveness
 
 
Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany
Authors: Pfohl M1, Dippel F-W2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co, OHG, Frankfurt/Main, Germany 4 IMS Health GmbH & Co, OHG, Health Economics & Outcomes Research, N√ľrnberg, Germany
Publications: 
Health Outcomes Research in Medicine; 2(1):e39-e50
Document Types: , Article
Countries: , Germany
Abstract: http://www.healthoutcomesresearch.org/article/S1877-1319(11)00002-4/abstract
Condition Year Language Analysis type
, Diabetes 2011 English , Cost consequence
 
 
Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK
Authors: Beaudet A1, Palmer JL1, Timlin L2, Wilson B3, Bruhn D4, Boye KS4, Lloyd A5
Affiliations: 1 IMS Health, Basel, Switzerland 2 Lilly UK, Windlesham, Surrey, UK 3 Lilly UK, Basingstoke, UK 4 Eli Lilly & Co, Indianapolis, IN, USA 5 IMS Health, London, UK
Publications: 
Journal of Medical Economics 2011; 14(3):357-366
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Beaudet+A%5Bfirst+author%5D+AND+diabetes&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2011 English , Cost utility
 
 
Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany
Authors: Pfohl M1, Dippel F-W2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co, OHG, Frankfurt/Main, Germany 4 IMS Health GmbH & Co, OHG, Health Economics & Outcomes Research, N√ľrnberg, Germany
Publications: 
Health Outcomes Research in Medicine Volume 2, Issue 1, Pages e39-e50
Document Types: , Article
Countries: , Germany
Abstract: http://www.healthoutcomesresearch.org/article/S1877-1319(11)00002-4/abstract
Condition Year Language Analysis type
, Diabetes 2011 English
 
 
Comparison of ACCORD trial outcomes with outcomes estimated from modelled and meta-analysis studies.
Authors: Foos V1, Lloyd A2, Freemantle N3, Grant D2, Herman W4.
Affiliations: 1 IMS Health, Basel, Switzerland, 2 IMS Health, London, UK, 3 University College London, UK, 4 University of Michigan, Ann Arbor, MI, USA
Publications: 
47th EASD Annual Meeting, Lisbon, Portugal, 12 - 16 September 2011
Document Types: , Oral presentation
Countries: 
Condition Year Language Analysis type
, Diabetes 2011 English , Meta analysis
 
 
Estimating the impact of different methods of utility assessment on the value of interventions in Type 2 diabetes
Authors: Lloyd A1, Foos V2, Donatti C1, Grant D1, Herman W3
Affiliations: 1 IMS London, UK 2 IMS Basel, Switzerland 3 University of Michigan, Ann Arbor, MI, USA
Publications: 
47th EASD Annual Meeting, Lisbon, Portugal, 12 - 16 September 2011
Document Types: , Oral presentation
Countries: 
Condition Year Language Analysis type
, Diabetes 2011 English , Utility analysis
 
 
Duration of time off paid employment associated with diabetes-related complications
Authors: Beaudet A1, Myr√©n K-J2, Grant D3, Lloyd A3
Affiliations: 1 IMS Health, Basel, Switzerland, 2 IMS Health, Stockholm, Sweden, 3 IMS, Health, London, UK
Publications: 
47th EASD Annual Meeting, Lisbon, Portugal, 12 - 16 September 2011
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Diabetes 2011 English , Observational study
 
 
Projected cost-effectiveness of exenatide once weekly versus exenatide BID for the treatment of type 2 diabetes in the UK
Authors: Wilson BP1,Beaudet A2,Caputo J3, Timlin L1
Affiliations: 1 Eli Lilly and Company Ltd, Erl Wood, UK 2 IMS Consulting Group, Basel, Switzerland 3 IMS Consulting Group, London, UK
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2011 English , Cost effectiveness
 
 
Projected long-term clinical and economic outcomes of exenatide once weekly versus sitagliptin for the treatment of type 2 diabetes in the UK
Authors: Beaudet A1, Wilson BP2, Caputo J3, Timlin2
Affiliations: 1 IMS Consulting Group Basel, Switzerland 2 Eli Lilly and Company Ltd, Erl Wood, UK 3 IMS Consulting Group, London, UK
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2011 English , Cost effectiveness
 
 
Estimating the Real Life Daily Usage and Daily Cost of Glp-1 Receptor Agonists in the UK setting
Authors: McDonell A1, Zammit DC2, Haslam T1, Gregor Z3, Wilson BP4
Affiliations: 1IMS Health, London, United Kingdom 2 IMS Health, Basel, Switzerland 3 Eli Lilly & Company, Prague, Czech Republic 4 LILLY UK, Hampshire, United Kingdom
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Oral presentation, Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2011 English , Cost analysis
 
 
Estimating the Direct Costs of Type 2 Diabetes in Saudi Arabia
Authors: Babineaux S1, Fakhoury W2, McDonell A3, Kotchie R3, Ali M4.
Affiliations: 1 Eli Lilly and Company, Indianapolis, USA 2 Eli Lilly and Company, Erl Wood, UK 3 IMS Health, London, UK 4 IMS Health, Riyadh, Saudi Arabia
Publications: 
World Diabetes Congress, 4 - 8 December 2011, Dubai
Document Types: , Oral presentation
Countries: 
Condition Year Language Analysis type
, Diabetes 2011 English , Economic evaluation
 
 
Anti-diabetic therapeutic strategies for type 2 diabetes patients with chronic kidney disease in France.
Authors: Amalric F1, Attali C2, Joly D3, Simon D4, Verg√®s B5, Grandfils N1, Briand Y6
Affiliations: 1 IMS Health, Paris, France 2 Epinay-sous-D√©nart, France 3 H√īpital Necker, Paris, France 4 H√īpital Robert Debr√©, Paris, France 5. H√īpital du Bocage, Dijon, France 6. Boehringer Ingelheim France, Paris, France
Publications: 
Abstract - Presentation PDB63 for the 14th European congress of Ispor 2011
Document Types: , Abstract
Countries: , France
Condition Year Language Analysis type
, Clinical practice, Diabetes 2011 English , Retrospective database analysis
 
 
Healthcare costs associated with treatment modification in type 2 diabetes mellitus patients taking oral anti-diabetic drugs.
Authors: Krishnarajah G, Bhosle M, Chapman R.
Affiliations: Bristol Myers Squibb, IMS Health
Publications: 
Managed Care 2011; 20(6):42-48
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2011 English , Cost analysis
 
 
Economic evaluation of Ranibizumab in the treatment of visual impairment due to diabetic macular edema in Austria
Authors: Brennig C1, Sch√∂llbauer V1, Walter E1, Gallagher M2, Knudsen MS3
Affiliations: 1Institute for Pharmaeconomic Research, Vienna, Austria, 2Novartis Pharma AG, Basel, Switzerland, 3IMS Health, London, UK
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Austria
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PDB38
Condition Year Language Analysis type
, Diabetes 2011 English , Economic evaluation
 
 
Assessment of utility loss from diabetic macular edema based on RESTORE trial.
Authors: Knudsen MS1, Thomas S2, Gallagher M3, Mitchell P4
Affiliations: 1IMS Health, London, UK, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 3Novartis Pharma AG, Basel, Switzerland, 4University of Sydney, Westmead, Australia
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: 
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PSS30
Condition Year Language Analysis type
, Diabetes 2011 English , Cost utility
 
 
Cost-effectiveness of transferring Type-2 Diabetic patients from Neutral Protamine Hagedorn (NPH) To Detemir in Portugal settings
Authors: Carvalho D1, Lindner L2, Kozarzewski M3
Affiliations: 1S√£o Jo√£o Hospital, Porto, Porto, Portugal, 2IMS Health, Barcelona, Catalu√Īa, Spain, 3Novo Nordisk Portugal, Lisboa, Lisboa, Portugal
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Portugal
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PDB45
Condition Year Language Analysis type
, Diabetes 2011 English , Cost effectiveness
 
 
Development of a new measure for assessing Health Related Quality Of Life (HRQOL) in patients with Primary Hyperparathyroidism (PHPQOL)
Authors: Farrerons J1, Mu√Īoz M2, Puig M3, Villabona C4, Webb S5, Badia X6
Affiliations: 1Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2Hospital San Cecilio, Granada, Spain, 3Hospital Germans Trias i Pujol, Badalona, Spain, 4Hospital Universitari de Bellvitge, Hospitalet del Llobregat, Spain, 5Hospital de la Santa Creu i Sant Pau and CIBERER, Barcelona, Spain, 6IMS Health S.A, Barcelona, Spain
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: 
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PDB56
Condition Year Language Analysis type
, Diabetes 2011 English , Quality of life
 
 
Exenatide (BID) and liraglutide (QD) treatment patterns among patients with Type 2 diabetes in Germany.
Authors: Miller LA1, Burudpakdee C2, Zagar A1, Bhosle M3, Reaney M4, Schabert VF3.
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA, 2IMS Consulting, Falls Church, VA, USA, 3IMS Health, Falls Church, VA, USA, 4Eli Lilly and Company, Surrey, UK
Publications: 
16th Annual International Society of Pharmacoeconomics and Outcomes Research (ISPOR)
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters2.aspx
Condition Year Language Analysis type
, Diabetes 2011 English
 
 
Relative Risk of Acute Pancreatitis in Initiators of Exenatide BID Compared to Other Antidiabetic Medication: A Follow-up Study.
Authors: Wenten M1, Gaebler JA1, Hussein M2, Pelletier EM2, Smith DB2, Girase P2, Noel RA3, Braun DK3, Bloomgren GL1
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health Incorporated, Watertown, MA, USA, 3Eli Lilly and Company, Indianapolis, IN, USA
Publications: 
Diabet Med 2012 [in press]; 2012 Mar 12 [Epub ahead of print]
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2011 English , Retrospective cohort analysis, Retrospective database analysis
 
 
Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes (T2DM)
Authors: Fonda J.S1, Graham C2, Samyshkin Y3, Munakata J3, Powers J3, Price D2, Vigersky R.A1
Affiliations: 1Diabetes Institute, Endocrinology Service, Walter Reed National Military Medical Center (Washington ,DC), 2Dexcom, Inc. (San Diego), 3IMS Health, (London, Redwood City, & Alexandria)
Publications: 
Document Types: , Poster
Countries: 
Abstract: http://www.dexcom.com/research/create-clinical-research-2
Condition Year Language Analysis type
, Diabetes 2011 English , Cost effectiveness
 
 
Systolic and diastolic blood pressure levels associated with lowest risk in type 2 diabetes: a cohort study of 37,798 primary care patients
Authors:  Sundstr√∂m1 J2, √Ėstgren CJ3, Svennblad B2, Sheikhi R1, Bodeg√•rd J4, Nilsson PM5, Johansson G6
Affiliations: 1Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 2Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden, 3Department of Medical and Health Sciences, Link√∂ping University, Link√∂ping, Sweden, 4AstraZeneca Nordic, S√∂dert√§lje, Sweden, 5Department of Clinical Sciences, Lund University, Lund, Sweden, 6Department of Public Health & Caring Sciences, Uppsala University, Uppsala, Sweden
Publications: 
47th EASD Annual Meeting, Lisbon, Portugal. Presentation 53, Tuesday, Sep 13, 2011.
Document Types: , Presentation
Countries: , Sweden
Abstract: http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=237d5d03-5ca2-4781-b2af-ae93644fb307&cKey=e87414dc-b005-45f9-a81e-84610372dcf1&mKey=%7bBAFB2746-B0DD-4110-8588-E385FAF957B7%7d
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2011 English , Retrospective cohort analysis
 
 
Type II diabetes cost of illness study
Authors: S. Babineaux1, W. Fakhoury2, A. McDonell3, R. Kotchie3, M. Ali4.
Affiliations: 1Eli Lilly and Company, Global Health Outcomes, Indianapolis IN, USA. 2Eli Lilly and Company, Global Health Outcomes, Erl Wood, United Kingdom. 3IMS Health, UK, London, United Kingdom. 4IMS Health, Saudi Arabia, Riyadh, Saudi Arabia.
Publications: 
World Diabetes Congress December 2011, Dubai, UAE
Document Types: , Conference, Poster
Countries: , Saudi Arabia
Condition Year Language Analysis type
, Diabetes 2011 English , Literature Review
 
 
External validation of QDSCORE(¬ģ) for predicting the 10-year risk of developing Type 2 diabetes.
Authors: Collins GS & Altman DG
Affiliations: 
Publications: 
Diabet Med. 2011 May;28(5):599-607. doi: 10.1111/j.1464-5491.2011.03237.x.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21480970
Condition Year Language Analysis type
, Diabetes 2011 English
 
 
Les pratiques d’intensification thérapeutique dans le diabète de type 2, en France, en médecine générale.
Authors: Balkaua Ba,b, Avignonc Ac, Verg√®sd Bd, Bou√©ee Se, Chartierf If, Amelineaug Eg, Halimih Sh
Affiliations: INSERM U1018, Center for Research in Epidemiology and Population Health, Villejuif, France Paris-South University, Villejuif, France University of Versailles Saint-Quentin-en-Yvelines, Versailles, France.
Publications: 
Diabetes & Metabolism 03/2011; 59. DOI: 10.1016/j.respe.2011.08.050
Document Types: , Oral communication
Countries: , France
Abstract: http://www.researchgate.net/publication/251590567_Les_pratiques_dintensification_thrapeutique_dans_le_diabte_de_type_2_en_France_en_mdecine_gnrale
Condition Year Language Analysis type
, Diabetes 2011 French , Prospective study, Retrospective database analysis
 
 
The Use of Large GPs Longitudinal Database in the Reasearch of Causal Associations Among Pathologies: The Case of Diabetes and Cancer Incidence.
Authors: Katz P, Ripellino C., Heiman F., Chatenoud F.
Affiliations: 
Publications: 
Value in Health. 11/2011; 14(7). DOI: 10.1016/j.jval.2011.08.1293
Document Types: , Article
Countries: 
Abstract: http://www.researchgate.net/publication/238509387_PCN194_The_Use_of_Large_GPs_Longitudinal_Database_in_the_Reasearch_of_Causal_Associations_Among_Pathologies_The_Case_of_Diabetes_and_Cancer_Incidence
Condition Year Language Analysis type
, Diabetes, Oncology 2011 English
 
 
A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes
Authors: Hall GC, McMahon AD, Dain MP & Home PD
Affiliations: Grimsdyke House, London
Publications: 
Diabetes Res Clin Pract. 2011 Dec;94(3):442-8. doi: 10.1016/j.diabres.2011.09.003. Epub 2011 Oct 2.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21963105
Condition Year Language Analysis type
, Diabetes 2011 English , Retrospective database analysis
 
 
Changes and predictors for change to thiazolidinedione prescribing in UK primary care following the rosiglitazone safety warning
Authors: Hall GC, Smith HT, Curtis B & McMahon AD
Affiliations: Grimsdyke House, London
Publications: 
Int J Clin Pract. 2011 May;65(5):586-91. doi: 10.1111/j.1742-1241.2011.02648.x.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21489082
Condition Year Language Analysis type
, Diabetes 2011 English , Retrospective database analysis
 
 
The use of large GPs longitudinal database in the research of causal associations among pathologies : the case of diabetes and cancer incidence
Authors: Katz P 1, Ripellino C 1, Heiman F 1, Chatenoud L. 2
Affiliations: 1 CSD Medical Research srl, Milan, Italy, 2 Istituto di Ricerche Farmacologiche, Milan, Italy
Publications: 
ISPOR Annual European Congress, Madrid, 2011
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Diabetes, Oncology 2011 English , Retrospective database analysis
 
 
A national survey on aspirin patterns of use and persistence in community outpatients in Italy.
Authors: Filippi A1, Bianchi C, Parazzini F, Cricelli C, Sessa E, Mazzaglia G.
Affiliations: 1Italian College of General Practitioners, Florence, Italy.
Publications: 
Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):695-703
Document Types: , Abstract
Countries: , Italy
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2011 English , Retrospective Field Study
 
 
The European network of centres for pharmacoepidemiology and pharmacovigilance: Application to diabetes and vascular disease
Authors: Blake KV, Smeraldi C, Kurz X, Arlett P, Blackburn S, Fitt H
Affiliations: 
Publications: 
British Journal of Diabetes and Vascular Disease. 2011;11(6):304-7
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2011 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Association of HbA1c with the risk of cardiovascular events in patients with type 2 diabetes: a cohort study of 40, 204 patients in primary care.
Authors: √Ėstgren C1, Sundstrom C2, Svennblad B3, Lohm L4, Nilsson P5, Johansson G2
Affiliations: 1 Link√∂ping University, Link√∂ping, Sweden 2 Uppsala University, Uppsala, Sweden 3 Uppsala Clinical Research Center, Uppsala, Sweden 4 AstraZeneca Nordic, S√∂dert√§lje, Sweden 5 Malm√∂ University Hospital, Malm√∂, Sweden
Publications: 
European Association for Study of Diabetes, Annual Meeting 2011, Lisbon, Portugal
Document Types: , Oral presentation
Countries: , Sweden
Abstract: http://www.easdvirtualmeeting.org/resources/association-of-hba1c-with-the-risk-of-cardiovascular-events-in-patients-with-type-2-diabetes-a-cohort-study-of-40-204-patients-in-primary-care
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2011 English , Real World Evidence
 
 
Kosteneffektivität von Pioglitazon bei Patienten mit Typ-2-Diabetes und makrovaskulären Vorerkrankungen in Deutschland [Cost-Effectiveness of Pioglitazone in Patients with Type 2 Diabetes and a History of Macrovascular Disease in Germany]
Authors: Bierwirth R1, Liebl A2, Gschwend MH3
Affiliations: 1 Diabetes-Praxis, Essen 2 Diabetes- und Stoffwechselzentrum, m & i-Fachklinik Bad Heilbrunn 3 IMS Health, Allschwil, Schweiz
Publications: 
Diabetologie und Stoffwechsel 2010;5(1):32-39
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: https://www.thieme-connect.de/DOI/DOI?10.1055/s-0029-1224723
Condition Year Language Analysis type
, Diabetes 2010 German , Cost effectiveness
 
 
Glycaemic control and insulin utilization in UK patients with type 2 Diabetes initiated on either Biphasic Insulin Aspart 30 or Biphasic Human Insulin 30
Authors: Fakhoury W1, Richter H2, Christensen T3, Thomsen TL4, Irwin D5, Anderson P1
Affiliations: 1IMS Health, London, UK, 2IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany, 3Novo Nordisk, Virum, Denmark, 4Novo Nordisk A/S, Virum, Denmark, 5University of North Carolina ‚Äď Chapel Hill, Chapel Hill, NC, USA
Publications: 
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA
Document Types: , Poster
Countries: , UK
Abstract: http://www.ispor.org/meetings/atlanta0510/Posters1.aspx
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Risk of cardiovascular events in patients with diabetes treated with exenatide or thiazolidinediones: a retrospective analysis of the pharmetrics database.
Authors: Best JH1, Pelletier EM2, Hoogwerf BJ3, Herman WH4, DeYoung MB1, Smith DB2, Yushmanova I1, Hussein M5
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Watertown, MA, USA, 3Eli Lilly and Company, Indianapolis, IN, USA, 4University of Michigan, Ann Arbor, MI, USA, 5IMS Health, Falls Church, VA, USA
Publications: 
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA
Document Types: , Poster
Countries: , USA
Abstract: http://www.ispor.org/meetings/atlanta0510/Posters1.aspx
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis, Retrospective database analysis
 
 
PDB78 Randomized clinical trial (RCT) design and analytic issues impacting assumed clinical effects and results of cost-effectiveness analyses: Illustration from a recent Canadian report on the cost-effectiveness of blood glucose test strips for type 2 diabetes.
Authors: Tunis S
Affiliations: IMS Health Inc., Falls Church, VA, USA
Publications: 
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA
Value in Health, 2010, 13(3): A68
Document Types: , Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)72320-2/abstract
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Cost-effectiveness of switching to biphasic insulin aspart from human premix insulin in a US setting.
Authors: Palmer JL1, Knudsen MS2, Aagren M3, Thomsen TL4.
Affiliations: 1 IMS Health, Basel, Switzerland 2 IMS Health, London, UK 3 Novo Nordisk Inc., Princeton, NJ, USA 4 Novo Nordisk A/S, Virum, Denmark
Publications: 
J Med Econ. 2010;13(2):212-20.
Document Types: , Article
Countries: , USA
Abstract: http://www.ncbi.nlm.nih.gov/sites/entrez
Condition Year Language Analysis type
, Diabetes 2010 English , , Cost effectiveness
 
 
Risk of cardiovascular events in patients with diabetes treated with exenatide or other glucose-lowering therapies: a retrospective analysis of the PharMetrics database.
Authors: Best JH1, Pelletier EM2, Herman WH3, Hoogwerf BJ4, Smith DB2, Wenten M1, Hussein MA2
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Watertown, MA, USA, 3University of Michigan, Ann Arbor, MI, USA, 4Eli Lilly and Company, Indianapolis, IN, USA, 5IMS Health, Falls Church, VA, USA
Publications: 
American Diabetes Association (ADA) 70th Scientific Sessions, June 25-29, 2010, Orlando, FL, USA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis, Retrospective database analysis
 
 
Krebsinzidenz bei insulinpflichtigen Diabetikern in Deutschland ‚Äď eine Analyse der Publikation von Hemkens et al. anhand der STROBE-Qualit√§tskriterien [Cancer incidence for insulin-dependent diabetics in Germany - an analysis of the publication of Hemkens et al. based on the STROBE criteria]
Authors: Fuchs S1, Fricke F-U1,2, Pirk O1
Affiliations: 1 IMS Health GmbH & Co. OHG, Nuremberg, Germany 2 Georg Simon Ohm University, Nuremberg, Germany
Publications: 
Perfusion 2010; 23: 4-10
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes, Oncology 2010 German , Literature Review
 
 
Starting an insulin therapy with glargine leads to lower long-term treatment costs compared to detemir in German type-2-diabetics: Results of a model approach
Authors: Pfohl M1, Dippel F-W2, Reichelt A3, Kostev K4, Fuchs S3, Kotowa W3
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 4 IMS HEALTH GmbH & Co. OHG, Frankfurt, Germany
Publications: 
American Diabetes Association, 70th Scientific Sessions Abstract Book, 2010
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Pr√§diktoren f√ľr die Initiierung einer basalunterst√ľtzten oralen Therapie (BOT) bei Patienten mit Diabetes mellitus Typ 2 unter realen Versorgungsbedingungen [Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions]
Authors: Hammer H1, Dippel F-W2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Facharzt f√ľr Innere Medizin und Diabetologie, Bremen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt/Main, Germany 4 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany
Publications: 
45th annual conference of the DDG, Stuttgart, Germany, 12. ‚Äď 15. May, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 German , Retrospective cohort analysis
 
 
Insulin Glargin reduziert das Risiko eines diabetischen Fußsyndroms sowie makrovaskulärer Komplikationen bei Typ-2-Diabetikern [Insulin glargine reduces the risk of a diabetic foot syndrome and macrovascular complications of type 2 diabetes]
Authors: Martin S1, Dippel FW2, Kostev K3, Lauterbach S4, Fuchs S5, Kotowa W5
Affiliations: 1 Sana Kliniken D√ľsseldorf GmbH, D√ľsseldorf, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt/Main, Germany 4 Apotheke Rotes-Kreuz-Krankenhaus, Kassel, Germany 5 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany
Publications: 
45th annual congress of the DDG, Stuttgart, Germany, 12. -15. May, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 German , Retrospective cohort analysis
 
 
L√§ngere Verweildauer auf einer basalunterst√ľtzten oralen Therapie mit Insulin glargin (BOT) im Vergleich zu einer Kombinationstherapie aus Insulindetemir und oralen Antidiabetika [Longer length of stay for a basal supporting oral therapy with insulin glargine compared to a combination therapy of insulin detemir and oral antidiabetics]
Authors: Pfohl M1, Dippel F-W2, Kostev K¬≥, Pirk O4, Reichelt A4, Kotowa W4
Affiliations: 1Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3IMS Health GmbH & Co. OHG, Frankfurt, Germany 4 IMS Health GmbH & Co. OHG, N√ľrnberg, Germany
Publications: 
2nd annual conference of the Deutschen Gesellschaft f√ľr Gesundheits√∂konomie (dgg√∂) [German Association for Health Economics], Berlin, Germany, 1.-2.- March, 2010
Document Types: , Abstract
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 German , Retrospective database analysis
 
 
A retrospective cohort study to assess the relative risk of acute pancreatitis among initiators of exenatide compared to initiators of other anti-diabetic medication: a follow-up study.
Authors: Wenten M1, Gaebler JA1, Pelletier EM2, Smith DB2, Girase P2, Noel R3, Braun D3, Bloomgren G1, Hussein MA4
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Watertown, MA, USA, 3Eli Lilly and Company, Indianapolis, IN, USA, 4IMS Health, Falls Church, VA, USA
Publications: 
ISPE 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 19-22, 2010, Brighton, England, UK
Document Types: , Podium presentation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis, Retrospective database analysis
 
 
German real-life data indicate lower costs for basal supported oral therapy (BOT) with insulin glargine compared to combination therapy with exenatide and oral antidiabetic drugs
Authors: Fuchs S1, Dippel FW2, Kostev K3, Kotowa W1
Affiliations: 1 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG, Frankfurt/Main, Germany
Publications: 
46th EASD Annual Meeting, Stockholm, Sweden, 20.-24. September, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis
 
 
Resource utilization and diabetes-related treatment costs of type-1-diabetics treated with ICT based on insulin glargine, insulindetemir or NPH insulin in Germany
Authors: Bierwirth R1, Dippel FW2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Ambulantes Diabeteszentrum am Elisabth-Krankenhaus, Essen, Germany, 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG, Frankfurt, Germany 4 IMS Health GmbH & Co. OHG, Nuremberg, Germany
Publications: 
46th EASD Annual Meeting, Stockholm, Sweden, September 20-24, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 English , Cost analysis
 
 
Ressourcenverbrauch und Behandlungskosten unter einer intensivierten konventionellen Therapie (ICT) mit Insulin glargin, Insulindetemir oder NPH-Insulin bei Patienten mit Typ-1-Diabetes [Resource utilization and diabetes-related treatment costs of type-1-diabetics treated with ICT based on insulin glargine, insulin detemir or NPH insulin in Germany]
Authors: Bierwirth R1, Dippel FW2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Ambulantes Diabeteszentrum am Elisabeth-Krankenhaus, Essen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG, Frankfurt, Germany 4 IMS Health GmbH & Co. OHG, Nuremberg, Germany
Publications: 
Perfusion, 2010, 23: pp. 96-103
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 German , Cost analysis
 
 
Retrospective cohort studies of the risk of acute pancreatitis: initiators of exenatide compared to other antidiabetic drugs in two commercial US health insurance databases.
Authors: Bloomgren G1, Wenten M1, Dore D2, Hussein M3, Pelletier E4, Smith D4, Noel R5, Braun D5, Seeger J2
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2i3 Drug Safety, Waltham, MA, USA, 3IMS Health, Falls Church, VA, USA, 4IMS Health, Watertown, MA, USA, 5Eli Lilly and Company, Indianapolis, IN, USA
Publications: 
EASD 46th Annual Meeting, September 20-24, 2010, Stockholm, Sweden.
Document Types: , Podium presentation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Risk of cardiovascular events in patients with type 2 diabetes treated with exenatide or other glucose-lowering therapies: a retrospective analysis of the LifeLinkTM database.
Authors: Best JH1, Hoogwerf BJ2, Pelletier EM3, Smith DM3, Wenten M1, Hussein MA3
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA, 3IMS Health, Watertown, MA, USA, 4IMS Health, Falls Church, VA, USA
Publications: 
EASD 46th Annual Meeting, September 20-24, 2010, Stockholm, Sweden.
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
A retrospective cohort study to assess the relative risk of acute pancreatitis among initiators of exenatide compared to initiators of other anti-diabetic medication: a follow-up study.
Authors: Wenten M1, Gaebler J1, Hussein M2, Pelletier E3, Smith D3, Girase P3, Noel R4, Braun D4, Bloomgren G1
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, Falls Church, VA, USA, 3IMS Health, Watertown, MA, USA, 4Eli Lilly and Company, Indianapolis, IN, USA
Publications: 
American Diabetes Association (ADA) 70th Scientific Sessions, June 25-29, 2010, Orlando, FL, USA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes
Authors: Fakhoury WKH1, LeReun C1, Wright D1
Affiliations: 1 IMS Health, London, UK
Publications: 
Pharmacology 2010 Jul 12;86(1):44-57
Document Types: , Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20616619
Condition Year Language Analysis type
, Diabetes 2010 English , Literature Review, Meta analysis
 
 
A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes
Authors: Fakhoury WKH1, LeReun C1, Wright D1
Affiliations: 1 IMS Health, London, UK
Publications: 
Pharmacology 2010 Jul 12;86(1):44-57
Document Types: , Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20616619
Condition Year Language Analysis type
, Diabetes 2010 English , Meta analysis
 
 
Risk of cardiovascular events in patients with type 2 diabetes treated with exenatide BID or other glucose-lowering therapies: a retrospective analysis of the LifeLinkTM Database.
Authors: Pelletier EM1, Hoogwerf BJ2, Smith DB1, Best JH3
Affiliations: 1IMS Health, Watertown, MA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA, 3Amylin Pharmaceuticals, Inc., San Diego, CA, USA
Publications: 
American Heart Association (AHA) Scientific Sessions, November 13-17, 2010, Chicago, IL, USA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis, Retrospective database analysis
 
 
Long-term clinical outcomes of Exenatide once-weekly versus Insulin Glargine for the treatment of Type 2 Diabetes projected using the Core Diabetes Model
Authors: Timlin L1, Beaudet A2, Wilson B3, Bruhn D4, Boye KS5, Palmer JL2, Lloyd A6
Affiliations: 1Lilly, Windlesham, Surrey, UK, 2IMS Health, Allschwil, Basel-Landschaft, Switzerland, 3Lilly, Basingstoke, Hampshire, UK, 4Eli Lilly & Company, Indianapolis, IN, USA, 5Lilly, Indianapolis, IN, USA, 6IMS Health, London, UK
Publications: 
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic
Document Types: , Poster
Countries: 
Abstract: http://www.ispor.org/congresses/Prague1110/posters1.aspx
Condition Year Language Analysis type
, Diabetes 2010 English , Prospective study
 
 
Long-Term cost-consequence analysis of Exenatide once weekly versus Sitagliptin or Pioglitazone in Type 2 Diabetes patients in the United States
Authors: Aledort Gaebler J1, Samyshkin Y2, Guillermin ALG2, Lloyd A2
Affiliations: 1Amylin Pharmaceuticals, Inc., San Diego, CA, USA, 2IMS Health, London, UK
Publications: 
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic
Document Types: , Poster
Countries: , USA
Abstract: http://www.ispor.org/congresses/Prague1110/posters1.aspx
Condition Year Language Analysis type
, Diabetes 2010 English , Cost consequence
 
 
Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany
Authors: Hammer H1, Dippel F-W2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Facharzt f√ľr Innere Medizin und Diabetologie, Bremen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt/Main, Germany 4 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany
Publications: 
Perfusion 2010; 23: 132-140
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis
 
 
Clinical and cost effectiveness of biphasic insulin aspart 30 once or twice daily versus insulin glargine in type 2 diabetes mellitus: a modeling analysis in the Chinese setting
Authors: Palmer JL1, Beaudet A1, White,J2, Plun-Favreau J3,Smith-Palmer J1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk I/O, Zurich, Switzerland; 3 Novo Nordisk A/S, Copenhagen, Denmark
Publications: 
ISPOR 4th Asia-Pacific Conference, 5-7 September 2010, Hilton Phuket, Phuket, Thailand
Document Types: , Poster
Countries: , China
Abstract: http://www.ispor.org/conferences/Phuket0910/posters.aspx
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Insulin glargine is associated with a lower incidence of diabetic foot syndrome and macrovascular complications compared to NPH insulin in type 2 diabetics under German real-life conditions
Authors: Siegmund T1, Dippel FW2, Kostev K3, Lauterbach S4, Fuchs S3, Kotowa W3
Affiliations: 1 St√§dt. Klinikum M√ľnchen GmbH, Klinikum Bogenhausen, 81925 M√ľnchen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG. Frankfurt/Main & N√ľrnberg, Germany 4 Apotheke Rotes-Kreuz-Krankenhaus, Hansteinstra√üe 29, 34121 Kassel, Germany
Publications: 
ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis
 
 
Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions
Authors: Hammer H1, Dippel FW2, Kostev K3, Fuchs S3, Kotowa W3
Affiliations: 1 Practice for internal medicine and diabetology, Bremen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG, Frankfurt/Main & N√ľrnberg, Germany
Publications: 
ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis
 
 
Insulin glargin und Exenatide bei Typ-2-Diabetes: Ein Kostenvergleich in Kombination mit oralen Antidiabetika [Cost comparison between insulin glargine and exenatide in type-2-diabetes both in combination with oral antidiabetics]
Authors: Fuchs S1, Kostev K2, W. Kotowa W1, Dippel F-W3
Affiliations: 1 IMS Health, Nuremberg, Germany 2 IMS Health, Frankfurt/Main, Germany 3 Sanofi-Aventis Deutschland GmbH, Berlin, Germany
Publications: 
Monitor Versorgungsforschung 2010: 3. Jahrgang 11.10.2010
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 German , Retrospective cohort analysis
 
 
Different persistence on initial basal supported oral therapy in type-2-diabetics results in unequal distributions of insulin treatment regimens under real-life conditions in Germany
Authors: Pfohl M1, Dippel F-W2, Kostev K3, Fuchs S3, Kotowa W3
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt/Nuremberg, Germany
Publications: 
International Journal of Clinical Pharmacology and Therapeutics, Vol. 48 ‚Äď No. 11/2010 (761-766)
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective cohort analysis
 
 
Modellierung der Langzeit-Behandlungskosten insulinpflichtiger Typ-2-Diabetiker in Abhängigkeit von der Art des Insulineinstiegs: Vergleich zwischen Insulin glargin und NPH-Insulin [Modelling of long-term treatment costs of type-2-diabetes patients depending on the initial insulin therapy: A comparison of insulin glargine vs. NPH-insulin.]
Authors: Pfohl M1, Dippel FW2, Kostev K3, Kotowa W3
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health, Frankfurt/N√ľrnberg, Germany
Publications: 
Gesundh √∂kon Qual manag 2010; 15: 1‚Äď7
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2010 German , Retrospective cohort analysis
 
 
Cost-Effectiveness of Biphasic Insulin Aspart versus Insulin Glargine in Patients with Type 2 Diabetes in China
Authors: Palmer JL1, Beaudet A1, White J2, Plun-Favreau J3, Smith‚ÄĎPalmer J1
Affiliations: 1 IMS Health, Theaterstrasse 4, 4051, Basel, Switzerland 2 Novo Nordisk I/O, Zurich, Switzerland 3 Novo Nordisk A/S, Copenhagen, Denmark
Publications: 
Adv Ther. 2010 Nov;27(11):814-27
Document Types: , Manuscript in preparation
Countries: , China
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21061114
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Clinical and cost effectiveness of testosterone replacement in patients with type 2 diabetes mellitus and hypogonadism
Authors: Beaudet A1, Gilmour L2, Church N2, Lloyd A3, McLeod E3, Jones TH4,5
Affiliations: 1IMS Health, Basel, Switzerland, 2Bayer Schering Pharma, Newbury, UK, 3IMS Health, London, UK 4Barnsley NHS Foundation Trust Hospital, Barnsley, UK, 5University of Sheffield, UK
Publications: 
Journal of Men's Health 2010; 7(3):289
Document Types: , Poster
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21061114
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Cost-effectiveness of Exenatide Versus Insulin Glargine and Versus Biphasic Insulin Aspart for the Treatment of Type 2 Diabetes in Portugal: A Long-term Health Economic Analysis
Authors: Palmer JL1, Pinto CG2, Duarte R3, Miguel LS2, Gregor Z4
Affiliations: 1 IMS Health, Basel, Switzerland 2 Centro de Investiga√ß√£o sobre Economia Portuguesa, Lisbon, Portugal 3 Associa√ß√£o Protectora dos Diab√©ticos, Lisbon, Portugal 4 Eli Lilly and Company, European Health Outcomes Research, Prague, Czech Republic
Publications: 
ISPOR 13thAnnual European Congress; Prague, Czech Republic; November 6‚Äď9, 2010
Document Types: , Manuscript in preparation
Countries: , Portugal
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Utility values for Diabetes complications
Authors: Donatti C1, Lloyd A1, Henry N1, Grant D1
Affiliations: 1 IMS Health, London, UK
Publications: 
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic
Document Types: , Poster
Countries: 
Abstract: http://www.ispor.org/congresses/Prague1110/posters1.aspx
Condition Year Language Analysis type
, Diabetes 2010 English , Utility analysis
 
 
Cost-effectiveness of liraglutide versus exenatide added to metformin, sulfonylurea or both for the treatment of type 2 diabetes in the U.S.
Authors: Lee WC1, Conner C2, Hammer M.
Affiliations: 1 Health Economics & Outcomes Research, IMS Health, Falls Church, Virginia, USA 2 Novo Nordisk Inc., Princeton, New Jersey, USA 3 Novo Nordisk A/S, Soborg, Denmark
Publications: 
Clinical Therapeutics. 2010 Sep;32(10):1756-67.
Document Types: , Article
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2010 English , Cost effectiveness
 
 
Real-life dosage and clinical efficacy of biphasic insulin preparations in patients with type 2 diabetes.
Authors: Fakhoury WK1, Richter H2, Christensen TE3.
Affiliations: 1 IMS Health, London, UK. 2 IMS Health, Frankfurt, Germany 3 Novo Nordisk A/S, Virum, Denmark
Publications: 
Adv Ther. 2010 Nov;27(11):859-69. Epub 2010 Oct 14.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20949340
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes
Authors: Ringborg A, Lindgren P, Yin DD, Martinell M, St√•lhammar J.
Affiliations: IMS Health, Stockholm (Formally Pygargus)
Publications: 
Diabetes Metab. 2010 Jun;36(3):198-203. doi: 10.1016/j.diabet.2009.11.006. Epub 2010 Mar 28
Document Types: , Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20347376
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Costs of glaucoma in Sweden‚Äď a pilot study
Authors: Svensson J, Berdeaux G, Bergstr√∂m A, Forsby M, Ghatnekar O
Affiliations: IMS Health, Stockholm (Formally Pygargus)
Publications: 
Poster PSS9. ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic. Value in Health Volume 13, Issue 7, November 2010, Pages: A250‚ÄďA480.
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Diabetes 2010 English , Cost consequence, Pricing & Reimbursement
 
 
Resource consumption and costs of care the year before and after initiation of insulin therapy in Swedish patients with type 2 diabetes
Authors: Pettersson B, Lindgren P, Ringborg A, Martinell M, St√•lhammar J
Affiliations: IMS Health, Stockholm. (Formally Pygargus)
Publications: 
Value in Health, ISSN 1098-3015, E-ISSN 1524-4733, Vol. 13, no 3, p. A58-A58
Document Types: , Article
Countries: , Sweden
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)72270-1/abstract
Condition Year Language Analysis type
, Diabetes 2010 English , Burden of illness, Cost analysis
 
 
Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes
Authors: Gunathilake W, Song S, Sridharan S, Fernando DJ & Idris I
Affiliations: Sherwood Forest Hospitals Foundation Trust, Nottinghamshire
Publications: 
QJM. 2010 Nov;103(11):881-4. doi: 10.1093/qjmed/hcq135. Epub 2010 Jul 30
Document Types: , Article
Countries: , UK
Abstract: http://qjmed.oxfordjournals.org/content/103/11/881.long
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2010 English , Retrospective database analysis
 
 
A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
Authors: Gordon J, Pockett RD, Tetlow AP, McEwan P & Home PD
Affiliations: School of Population Health and Clinical Practice, University of Adelaide
Publications: 
Int J Clin Pract. 2010 Nov;64(12):1609-18. doi: 10.1111/j.1742-1241.2010.02520.x. Epub 2010 Oct 4.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036815/
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Impact of diabetes against the future risk of developing gout
Authors: Rodr√≠guez LA, Soriano LC & Choi HK
Affiliations: Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain
Publications: 
Ann Rheum Dis. 2010 Dec;69(12):2090-4. doi: 10.1136/ard.2010.130013. Epub 2010 Jun 22.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136217/
Condition Year Language Analysis type
, Diabetes, Rheumatology 2010 English , Retrospective database analysis
 
 
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes
Authors: Owen V, Seetho I & Idris I
Affiliations: East Midlands Research Support Unit, University of Nottingham
Publications: 
Diabetes Obes Metab. 2010 Oct;12(10):865-70. doi: 10.1111/j.1463-1326.2010.01239.x.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20920038
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study
Authors: Gonzalez-Perez A, Schlienger RG & Garc√≠a Rodr√≠guez LA.
Affiliations: Centro Espa√Īol de Investigaci√≥n Farmacoepidemiol√≥gica, Madrid, Spain
Publications: 
Diabetes Care. 2010 Dec;33(12):2580-5. doi: 10.2337/dc10-0842. Epub 2010 Sep 10.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992194/
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Incidence of Diabetic Retinopathy and Diabetic Macular Edema in Newly Diagnosed Type 1 and Type 2 Diabetic Patients
Authors: Martin-Merino E, Fortuny J, Plana E, Rivero E & Garcia-Rodriguez L
Affiliations: CEIFE
Publications: 
ICPE 2010
Pharmacoepidemiology and Drug Safety (19): S1-S347
Document Types: , Abstract, Poster
Countries: , UK
Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/19
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2010 English , Retrospective database analysis
 
 
Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007
Authors: Currie CJ, Gale EA & Poole CD
Affiliations: Department of Medicine, School of Medicine, Cardiff University
Publications: 
Diabet Med. 2010 Aug;27(8):938-48. doi: 10.1111/j.1464-5491.2010.03040.x.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20653753
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
DURATION OF FIRST INSULIN THERAPY IN PREVIOUSLY UNCONTROLLED TYPE 2 DIABETES: COMPARISON OF INSULINS GLARGINE, DETEMIR AND NPH AND ASSOCIATION WITH GLYCEMIC CONTROL
Authors: Hall G, McMahon A, Dain M & Home PD
Affiliations: Grimsdyke House, London,
Publications: 
Value in Health 13(7):A298
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(11)72137-4/abstract
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Insulin usage in type 2 diabetes mellitus patients in UK clinical practice: a retrospective cohort-based analysis using the THIN database
Authors: Evans ML, Sharplin P, Owens DR, Chamberlain GH, Longman AJ & McEwan P
Affiliations: University Hospital Llandough, Cardiff
Publications: 
British Journal of Diabetes & Vascular Disease 2010 10: 178: DOI: 10.1177/1474651410370659
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://dvd.sagepub.com/content/10/4/178.refs.html
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Explorative analysis about the potential of a large GPs longitudinal database on searching causal associations among pathologies
Authors: Katz P, Heiman F.
Affiliations: CSD Medical Research srl
Publications: 
ISPOR Annual European Congress, Prague, 2010
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Diabetes, Oncology 2010 English , Retrospective database analysis
 
 
Risk of acute pancreatitis in association with type 2 diabetes mellitus
Authors: Gonzalez-Perez A, Schlienger RG & Garcia Rodriguez A
Affiliations: Centro Espa√Īol de Investigaci√≥n Farmacoepidemiol√≥gica, Madrid, Spain
Publications: 
Pharmacoepidemiology and Drug Safety (19): S1-S347
Document Types: , Abstract
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Les pratiques d’intensification thérapeutique dans le diabète de type 2 en France en Médecine Générale
Authors: Halimi S, Balkau B, Blickle JF, Attali C, Verg√®s B, Avignon A, Andre l, Amelineau E, Detournay B
Affiliations: Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease Over the Lifecourse and Determinants of Early Nutrition, Villejuif, France
Publications: 
Bull Epidemiol Hebd (Paris). 2010 Nov;n¬į 42-43:436-40. [French
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Type 2 diabetes treatment intensification in general practice in France in 2008-2009
Authors: Balkau B1, Bou√©e S, Avignon A, Verg√®s B, Chartier I, Amelineau E, Halimi S.
Affiliations: 1Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease Over the Lifecourse and Determinants of Early Nutrition, Villejuif, France.
Publications: 
Diabetes Metab. 2012 Mar;38 Suppl 3:S29-35. doi: 10.1016/S1262-3636(12)71532-X.
Document Types: , Article
Countries: , France
Condition Year Language Analysis type
, Diabetes 2010 English , Retrospective database analysis
 
 
Cost effectiveness of Roux-En-Y gastric bypass for the treatment of type 2 diabetes mellitus.
Authors: Ikramuddin S, Klingman D1, Swan T, Gill M, Geraci D, Minshall ME2
Affiliations: 1 IMS Health, Falls Church, VA, USA 2 Covidien, North Haven, CT, USA
Publications: 
American Journal of Managed Care, 2009, 15(9): 607-615
Document Types: , Manuscript in preparation
Countries: 
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
Authors: St. Charles M, Minshall M, Pandya B, Baran R, Tunis S
Affiliations: 
Publications: 
Current Medical Research and Opinion, 2009, 25(6): 1343-53
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK
Authors: Lloyd,A1; Townsend,C2; Munro,V3; Twena,N3; Nielsen,S2; Holman,A1
Affiliations: 1 IMS Health, London, UK 2 Novo Nordisk A/S, Bagsvaerd, Denmark 3 Novo Nordisk Limited, Crawley, UK
Publications: 
Current Medical Research and Opinion 2009; Vol 25 No 3: 599-605
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19232034?dopt=Abstract
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Cost-effectiveness of insulin analogues for diabetes mellitus
Authors: Cameron C1, Bennett H1
Affiliations: 1 Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada
Publications: 
Canadian Medical Association Journal, 2009, 180(4): 400-407
Document Types: , Article
Countries: , Canada
Abstract: http://www.cmaj.ca/cgi/content/full/180/4/400
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Health economic comparison between continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) of insulin for the treatment of adult type 1 diabetes in Canada.
Authors: St. Charles M1, Sadri H2, Minshall M1, Tunis S3
Affiliations: 1 Formerly of IMS Health, Indianapolis, IN, US 2 Medtronic Canada Ontario 3 IMS Health, Indianapolis, IN, US
Publications: 
Clinical Therapeutics, 2009, 31(3): 657-67
Document Types: , Manuscript in preparation
Countries: , Canada
Abstract: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-4W4CMKG-N&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=bbc2be5b77a418d332505b1ea4e93261
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Economic outcomes associated with microvascular complications of diabetes mellitus: results from a US claims data analysis.
Authors: Pelletier EM1, Shim B1, Ben-Joseph R2, Caro JJ3
Affiliations: 1IMS Health, Watertown, MA, USA, 2sanofi-aventis, Bridgewater, NJ, USA, 3United BioSource Corp, Concord, MA, USA
Publications: 
Pharmacoeconomics, 2009, 27(6): 479-490
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://ideas.repec.org/a/wkh/phecon/v27y2009i6p479-490.html
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective database analysis
 
 
Kosten f√ľr antihyperglyk√§mische Arznei- und Verbrauchsmittel und Therapiezufriedenheit bei Typ-2-Diabetes: Ergebnisse der Versorgungsforschungsstudie LIVE-DE [Costs of antihyperglycemic treatment and consumables and treatment satisfaction in patients with type 2 diabetes: results of a cross-sectional cost-evaluation study of long-acting insulin glargine compared with NPH insulin in Germany (LIVE-DE)]
Authors: Hauner H1, Kohlmann T2, Landgraf W3, Holle R4, Pirk O5, Scholten T6
Affiliations: 1 ElseKr√∂ner-Fresenius-Zentrum f√ľr Ern√§hrungswissenschaft, TU M√ľnchen, Germany 2 Institut f√ľr Cummunity Medicine, Universit√§t Greifswald, Germany 3 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 4 Institut f√ľr Gesundheits√∂konomie und Management, Helmholtz-Zentrum M√ľnchen, Germany 5 IMS HEOR N√ľrnberg, Germany 6 Lehrstuhl f√ľr Innere Medizin, Universit√§t Witten/Herdecke, Germany
Publications: 
Dsch Med Wochenschr., 2009, 134: pp.1207-1213
Document Types: , Article
Countries: , Germany
Abstract: http://www.find-health-articles.com/rec_pub_19472091-costs-antihyperglycemic-drugs-consumables-treatment-satisfaction.htm
Condition Year Language Analysis type
, Diabetes 2009 German , Cost analysis
 
 
L√§ngere Verweildauer unter einer basalunterst√ľtzten oralen Thearpie mit Insulin Glargin (BOT) im Vergleich zu einer Kombinationstherapie aus NPH-Insulin und oralen Antidiabetika [Higher Persistence with basal supported oral therapy (BOT) with insulin glargine compared to NPH insulin therapy combined with oral antidiabetics]
Authors: Pfohl M1, Dippel FW2, Kostev K3, Maltz A4, Kotowa W4
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin 3 IMS Health GmbH&Co. OHG, Frankfurt, Germany 4 IMS GmbH&Co. OHG, N√ľrnberg, Germany
Publications: 
Diabetologie, 2009; 4: pp.1-6
Document Types: , Article
Countries: , Germany
Abstract: http://www.thieme-connect.com/ejournals/abstract/ds/doi/10.1055/s-0028-1098896
Condition Year Language Analysis type
, Diabetes 2009 German , Retrospective cohort analysis
 
 
Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries.
Authors: Gschwend MH1, Aagren M2, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland, 2 Novo Nordisk Inc., New Jersey, United States
Publications: 
Journal of Medical Economics, 2009; 12(2): 114‚Äď123
Document Types: , Manuscript in preparation
Countries: , Belgium, France, Germany, Italy, Spain
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696990903080344
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Literature review of the impact of obesity on adverse cardiovascular outcomes in the general population and in patients with type 2 diabetes.
Authors: Smith-Palmer J1, Kalsekar A2, Boye KS2, Goodall G1
Affiliations: 1IMS Health, Basel, Switzerland, 2Eli Lilly and Company, Indianapolis, USA
Publications: 
ISPOR 2009 14th Annual International Meeting
Document Types: , Poster
Countries: 
Abstract: http://www.la-press.com/the-impact-of-obesity-on-adverse-cardiovascular-outcomes-in-the-genera-a1719
Condition Year Language Analysis type
, Diabetes 2009 English , Literature Review
 
 
Evaluation of exenatide versus insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting.
Authors: Mittendorf T1, Happich M2, Smith-Palmer J3, Timlin L4, Goodall G3
Affiliations: 1Gottfried Wilhelm Leibniz University, Hannover, Germany, 2Lilly Deutschland GmbH, Bad Homburg, Germany, 3IMS Health, Basel, Switzerland, 4Lilly UK, Surrey, United Kingdom
Publications: 
Diabetes, Obesity and Metabolism (In press)
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19732121
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Estimating the long-term clinical and economic benefits of insulin lispro in type 1 diabetes in Germany: a cost-effectiveness analysis based on the results of a recent meta-analysis
Authors: Pratoomsoot C1, Smith HT2, Arellano J2, Goodall G1
Affiliations: 1IMS Health, Basel, Switzerland, 2Eli Lilly, Surrey, UK
Publications: 
Deutsche Diabetes-Gesellschaft, 20-23 Mai 2009, Leipzig, Germany
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2009 German , Cost effectiveness
 
 
An estimation of the long-term clinical and economic benefits of insulin lispro in type 1 diabetes in the UK.
Authors: 1. C. Pratoomsoot, H. 2. T. Smith, 3. A. Kalsekar, 3. K. S. Boye, 2. J. Arellano and 1. W. J. Valentine
Affiliations: 1. IMS Health, Allschwil, Switzerland, 2. Eli Lilly and Company, Surrey, UK, 3. ‚ĆEli Lilly and Company, Indianapolis, IN, USA.
Publications: 
Diabetic Medicine 2009 (in press)
Diabetic Medicine, 26; 803-814 (2009)
Document Types: , Manuscript in preparation
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19709151
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Insulin glargin mit oralen Antidiabetika: Vorteilhafter Einstieg in die Insulintherapie [Insulin glargine with oral antidiabetic agents: Advantageous access to the insulin therapy]
Authors: Kress S1, Dippel FW2, Kostev K3, Pirk O3, Reichelt A3, Kotowa W3
Affiliations: 1 Vinzentius-Krankenhaus, Landau, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health, Frankfurt/N√ľrnberg, Germany
Publications: 
Diabetes Stoffw Herz 2009; 18: pp.377-385
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2009 German , Retrospective database analysis
 
 
Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.
Authors: Robert J Straka1, Larry Z Liu2, Prafulla S Girase3, Allyson DeLorenzo4 and Richard H Chapman5
Affiliations: 1 University of Minnesota College of Pharmacy, Minneapolis, MN, USA, 2 Pfizer Inc, New York, NY, USA, 3 IMS Health, Watertown, MA, USA, 4 Columbia University, New York, NY, USA and 5 IMS Health, Falls Church, VA, USA
Publications: 
Cardiovascular Diabetology 2009; 8:53-63
Document Types: 
Countries: , USA
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2009 English , Cost analysis, Retrospective cohort analysis
 
 
Drug titration patterns and HbA1c levels in type 2 diabetes.
Authors: Maclean JR1, Chapman RH2, Ferrufino CP2, Krishnarajah S1
Affiliations: 1 IMS Health, Falls Church, VA, USA
Publications: 
International Journal of Clinical Practice
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984545/
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective cohort analysis
 
 
Patterns of up-titration in type 2 diabetes (T2DM) patients taking oral anti-diabetic drugs (OADs).
Authors: Krishnarajah G1, Bhosle M2, Chapman RH2
Affiliations: 1 Bristol-Myers Squibb, Princeton, NJ, USA 2 IMS Health, Inc., Falls Church, VA, USA
Publications: 
American Diabetes Association's 69th Scientific Sessions, 2009, June 5-9, New Orleans, LA, USA
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective cohort analysis
 
 
Total health care expenditures associated with treatment modification in type 2 diabetes mellitus (T2DM) patients taking oral anti-diabetic drugs (OADs).
Authors: Krishnarajah G1, Bhosle M2, Chapman RH2
Affiliations: 1 Bristol-Myers Squibb, Princeton, NJ, USA 2 IMS Health, Inc., Falls Church, VA, USA
Publications: 
20th World Diabetes Congress, 2009, October 18-22, Montreal, Quebec, Canada
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective cohort analysis
 
 
A standardized evidence based approach to assess non-traditional outcome measures for use in health-care decision making: the diabetes example.
Authors: Badia X1, Vieta A1, Sacrist√°n JA2
Affiliations: 1HEOR IMS Health, Spain 2Clinical Research Department, Lilly Spain
Publications: 
ISPOR 12th Annual European Congress 2009, 24 to 27 October, Paris, France
Document Types: , Oral presentation
Countries: 
Condition Year Language Analysis type
, Diabetes 2009 English , Methodology
 
 
Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective
Authors: Werner A Scherbaum1, Gordon Goodall2, Katrina M Erny-Albrecht2, Massimo Massi-Benedetti3, Erland Erdmann4, William J Valentine2
Affiliations: 1Universit√§t D√ľsseldorf, Klinik f√ľr Endokrinologie, Diabetologie und Rheumatologie, 2IMS Health, Basel, Switzerland, 3University of Perugia, Medicine and Metabolic Diseases, Perugia, Italy and 4Medizinische Klinik III der Universit√§t zu K√∂ln, K√∂ln, Germany
Publications: 
Cost Effectiveness and Resource Allocation
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: http://www.resource-allocation.com/content/pdf/1478-7547-7-9.pdf
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.
Authors: Straka RJ1, Liu LZ2, Girase PS3, DeLorenzo A4, Chapman RH5.
Affiliations: 1Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, USA 2Global Outcomes Research, Pfizer Inc, New York, NY and Weill Cornell Medical College, New York, NY, USA 3IMS Health, Watertown, MA, USA 4 Columbia University, New York, NY, USA 5 IMS Health, Falls Church, VA, USA
Publications: 
Cardiovasc Diabetol. 2009 Sep 26;8:53
Document Types: , Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Straka+R%5Bfirst+author%5D+AND+incremental&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2009 English , Cost of illness
 
 
The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
Authors: Ringborg A, Yin DD, Martinell M, St√•lhammar J, Lindgren P.
Affiliations: IMS Health, Stockholm. (Formally Pygargus)
Publications: 
Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):576-82. doi: 10.1097/HJR.0b013e32832d193b.
Document Types: , Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=The+impact+of+acute+myocardial+infarction+and+stroke+on+health+care+costs+in+patients+with+type+2+diabetes+in+Sweden&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2009 English , Burden of illness, Cost of illness
 
 
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Authors: Currie CJ, Poole CD & Gale EA
Affiliations: 
Publications: 
Diabetologia. 2009 Sep;52(9):1766-77. doi: 10.1007/s00125-009-1440-6. Epub 2009 Jul 2.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19572116
Condition Year Language Analysis type
, Diabetes 2009 English
 
 
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Authors: Currie CJ, Poole CD & Gale EA
Affiliations: School of Medicine, Cardiff University, The Pharma Research Centre, Cardiff MediCentre
Publications: 
Diabetologia. 2009 Sep;52(9):1766-77. doi: 10.1007/s00125-009-1440-6. Epub 2009 Jul 2.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19572116
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective database analysis
 
 
Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis.
Authors: Gribbin J, Hubbard R & Smith C
Affiliations: Division of Epidemiology and Public Health, University of Nottingham
Publications: 
Respir Med. 2009 Jun;103(6):927-31. doi: 10.1016/j.rmed.2008.11.001. Epub 2008 Dec 6.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19058956
Condition Year Language Analysis type
, Diabetes, Respiratory disease 2009 English , Retrospective database analysis
 
 
Trends in the prevalence and incidence of diabetes in the UK: 1996-2005
Authors: Gonz√°lez EL, Johansson S, Wallander MA & Rodr√≠guez LA.
Affiliations: Spanish Centre for Pharmacoepidemiological Research, Almirante 28, Madrid, Spain
Publications: 
J Epidemiol Community Health2009;63:332-336 doi:10.1136/jech.2008.080382
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://jech.bmj.com/content/63/4/332
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective database analysis
 
 
Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis
Authors: Sharplin P, Gordon J, Peters JR, Tetlow AP, Longman AJ & McEwan P
Affiliations: CHKS Health Economics Unit, Health Park, Cardiff
Publications: 
Cardiovasc Diabetol. 2009 Feb 16;8:9. doi: 10.1186/1475-2840-8-9.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19220880
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective database analysis
 
 
‚ÄúThe ‚Äúwho, how and then what‚Ķ‚ÄĚ of insulin initiation in UK primary care‚ÄĚ
Authors: Smith HT, Blak BT, Hards M & Arrelano J
Affiliations: Cegedim
Publications: 
Value in Health 12(7):A412
Document Types: , Abstract
Countries: , UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)75036-1/abstract
Condition Year Language Analysis type
, Diabetes, Miscellaneous 2009 English , Retrospective database analysis
 
 
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Authors: Sharplin P, Gordon J, Peters J R, Tetlow A P, Longman A J & McEwan P
Affiliations: CHKS Health Economics Unit, Health Park
Publications: 
Cardiovascular Diabetology 2009, 8:3
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.cardiab.com/content/8/1/3
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective database analysis
 
 
The clinical impact of identifying metabolic syndrome in patients with diabetes: a cross-sectional study.
Authors: Bulugahapitiya U, Siyambalapitiya S, Sithole J, Fernando DJ & Idris I
Affiliations: Sherwood Forest Hospitals Foundation Trust, Nottinghamshire
Publications: 
Diab Vasc Dis Res. 2009 Jan;6(1):21-4. doi: 10.3132/dvdr.2009.004.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19156624
Condition Year Language Analysis type
, Diabetes 2009 English , Retrospective database analysis
 
 
The impact of insulin detemir compared to Neutral Protamine Hagedorn insulin on long-term diabetes-related complications: a modeling analysis in type 1 diabetes patients in Belgium, France, Germany, Italy and Spain
Authors: Gschwend M1, Aagren M2, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland, 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Belgium, France, Germany, Italy, Spain
Condition Year Language Analysis type
, Diabetes 2008 English , Economic evaluation
 
 
Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and achieving glycemic control, when administered in addition to conventional oral antidiabetic therapy in the treatment of type 2 diabetes patients; a meta-analysis
Authors: Fakhoury W1, Lockhart I1, Kotchie RW1, Aagren M2, LeReun C3
Affiliations: 1 IMS Health, London, UK 2 Novo Nordisk A/S, Bagsvaerd, Denmark 3 MTAG, Sydney, N.S.W., Australia
Publications: 
Pharmacology 2008;82(2):156-163
Document Types: , Article
Countries: , UK
Abstract: http://www.karger.com/doi/10.1159/000149569
Condition Year Language Analysis type
, Diabetes 2008 English , Meta analysis
 
 
Canadian cost utility analysis comparing exenatide versus insulin glargine in patients with type two diabetes
Authors: Coyle D, Coyle K, Valentine WJ, Lee JB, Kisswani R, Boye KS
Affiliations: 
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2008 English , Cost utility
 
 
Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study.
Authors: Palmer JL1, Goodall G1, Nielsen S3, Kotchie RW,2 Valentine WJ1, Palmer AJ1, Roze S1.
Affiliations: 1IMS Health, Basel, Switzerland, 2Novo Nordisk, Bagsv√¶rd, Denmark, 3IMS Health, London, UK
Publications: 
Curr Med Res Opin. 2008; 24(5):1417-1428
Document Types: , Manuscript in preparation
Countries: , Italy, Poland, Spain, Sweden
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Cost-effectiveness of Insulin Detemir Compared to NPH Insulin for Type 1 Diabetes mellitus (T1DM) in the Canadian Payer Setting: Modeling Analysis using a Randomized Controlled Trial.
Authors: Minshall ME1, Tunis SL2, Conner C, McCormick JI, Kapor J, Groleau D
Affiliations: 1 Formerly of IMS Health, Falls Church, VA, USA IMS Health, Falls Church, VA, USA
Publications: 
ISPOR 2008 13th Annual International Congress
Value in Health, 2008; 11(3):A223-A224.
Document Types: , Manuscript in preparation, Poster
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Long-term clinical and cost outcomes of treatment with insulin detemir plus insulin aspart in type 1 diabetes patients in the Czech setting; data from the predictive study
Authors: 1Clegg JP, 1Valentine WJ, 2Rychna K, 3Honka M, 4DoleŇĺal T
Affiliations: 1IMS, Allschwil, Switzerland, 2Novo Nordisk s.r.o, Praha 6, Czech Republic, 3Faculty Hospital Ostrava, Ostrava, Czech Republic, 4Charles University in Prague, Prague 10, Czech Republic
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Czech
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Long-term cost-effectiveness of pioglitazone versus placebo in addition to existing diabetes treatment: a US analysis based on proactive
Authors: 1Valentine WJ, 1Tucker D, 1Palmer AJ, 2Minshall ME, 1Foos V, 3Silberman C
Affiliations: 1IMS-Health, Allschwil, Switzerland; 2IMSHealth, Noblesville, IN, USA; 3Takeda Global Research and Development, Ltd., Deerfield, IL, USA
Publications: 
Value in Health - Published Online: 24 Jul 2008
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a four year descriptive study from national primary care data.
Authors: Mazzaglia G1, Yurgin N2, Boye KS2, Trifir√≤ G34, Cottrell S5, Allen E5, Filippi A1, Medea G1, Cricelli C1
Affiliations: 1 Italian College of General Practitioners, Florence, Italy 2 Eli Lilly & Co, Indianapolis, IN, USA 3 IRCCS Centro Neurolesi ‚ÄúBonino-Pulejo‚ÄĚ, Messina, Italy 4 Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy 5 IMS Health, London, UK
Publications: 
Pharmacol Res. 2008 May;57(5):358-63. Epub 2008 Mar 29
Document Types: , Manuscript in preparation
Countries: , Italy
Condition Year Language Analysis type
, Diabetes 2008 English , Epidemiological study
 
 
Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United States
Authors: Tunis SL1, Minshall ME1
Affiliations: 1 IMS Health, Falls Church, VA, US
Publications: 
Am J Manag Care. 2008;14(3):131-140
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
The cost-effectiveness of aliskiren as add on to losartan and optimal antihypertensive therapy in patients with type 2 diabetes, hypertension and nephropathy in the United Kingdom setting.
Authors: Palmer JL1, Munk VC2, Kotchie R3, Vincze G2, Charney A4, Tucker D1, Annemans L5
Affiliations: 1 IMS Health, Basel, Switzerland 2 Novartis Pharma AG, Basel, Switzerland 3 IMS Health, London, UK 4 Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA 5 Ghent University, Ghent, Belgium
Publications: 
ISPOR 13th Annual International Meeting, 2008, May 3-7, Toronto, Canada
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
The Impact of Clinical Trial Design on Cost-Effectiveness Analyses: Illustration from a Published Study of the One-Touch¬ģ Ultrasmart¬ģ Blood Glucose Meter for Insulin-Using Diabetes Patients.
Authors: Tunis SL1, Minshall ME1
Affiliations: 1 IMS Health, Falls Church, VA, USA
Publications: 
Diabetes Technology & Therapeutics, 2008;10(3): 227-31
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://www.liebertonline.com/doi/abs/10.1089/dia.2007.0270
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Cost-Effectiveness of Switching to Biphasic Insulin Aspart in Poorly-Controlled Type 2 Diabetes Patients in China
Authors: Palmer JL1, Gibbs M2, Scheijbeler H3, Kotchie R3, Nielsen S4, White J5, Valentine WJ1
Affiliations: 1IMS Health, Basel, Switzerland, 2IMS Health, Shanghai, China, 3IMS Health, London, UK, 4Novo Nordisk A/S, Bagsv√¶rd, Denmark, 5Novo Nordisk International Operations A/S, Zurich, Switzerland
Publications: 
Adv Ther. 2008 Aug;25(8):752-74.
Document Types: , Article
Countries: , China
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD)
Authors: Grandy S1, Chapman RH2, Fox KM3, for the SHIELD Study Group
Affiliations: (1) AstraZeneca LP, Wilmington, DE, USA (2) IMS Health -US HEOR, Falls Church, VA, USA (3) Strategic Healthcare Solutions, LLC, Monkton, MD, USA
Publications: 
International Journal of Clinical Practice 2008; 62(4):562-568
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Survey research
 
 
Testing and control among type 2 diabetes mellitus patients on oral anti-diabetes drugs.
Authors: Chapman RH1, Ferrufino CP1, Maclean JR, Krishnarajah S
Affiliations: 1 IMS Health, Falls Church, VA, US
Publications: 
American Diabetes Association’s 68th Scientific Sessions, San Francisco, CA, June 6-10, 2008
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Retrospective cohort analysis
 
 
Modelling the cost-effectiveness of acarbose in preventing type 2 diabetes in a South Korean setting
Authors: JongMann K1, Clegg JP2, Chang K1, JuYeol P1, Wittrup-Jensen KU3, Palmer AJ2, Roze S2, Valentine WJ2
Affiliations: 1Bayer, Seoul, South Korea, 2IMS Health, Allschwil, Switzerland, 3Bayer Schering Pharma AG, Berlin, Germany,
Publications: 
ISPOR 3rd Asia-Pacific Conference
Document Types: , Oral presentation
Countries: , South Korea
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain.
Authors: Yurgin NR1, Boye KS1, Dilla T2, Lara N3, Badia X3
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA; 2Eli Lilly and Company, Spain; 3HEOR, IMS Health, Spain
Publications: 
Patient Preference and Adherence 2008:2 87‚Äď95.
Document Types: , Article
Countries: , Spain
Abstract: http://www.dovepress.com/physician-and-patient-management-of-type-2-diabetes-and-factors-relate-peer-reviewed-article-PPA
Condition Year Language Analysis type
, Diabetes 2008 English
 
 
Standardized type 2 diabetes complication costs from US commercial payers to be used in modeling the long-term economic outcomes of diabetes complications.
Authors: Minshall ME1, Pelletier EM2, Smith PJ2, Forma FM3
Affiliations: 1IMS Health, Noblesville, IN, USA, 2IMS Health, Watertown, MA, USA 3Novo Nordisk, Princeton, NJ, USA
Publications: 
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 11th Annual European Meeting, 2008, November 8-11, Athens, Greece
Document Types: , Oral presentation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Retrospective database analysis
 
 
Cost-Effectiveness of Insulin Detemir Compared to NPH Insulin for Type 1 (T1DM) and Type 2 Diabetes Mellitus (T2DM) in the Canadian Payer Setting: modeling analysis
Authors: Tunis S1, Minshall M2, Conner C, McCormick J, Kapor J, Yale J, Groleau D
Affiliations: 1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US
Publications: 
Current Medical Research and Opinion, 2009, 25(5): 1273-84
Document Types: , Manuscript in preparation, Poster
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/19366302
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Cost-Effectiveness Analysis of Continuous Subcutaneous Insulin Injection vs. Multiple Daily Injections in Type 1 Diabetes Patients: an International Comparison.
Authors: Graham C, Lynch P, St. Charles M, Minshall M
Affiliations: 
Publications: 
Value in Health, 2008; 11(3):A224. Value in Health, 2008; 11(3):A224.
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Long-Term Economic Value of a Hypothetical DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus: The Potential Impact of the Preservation of Beta-Cell Function.
Authors: Tunis S1, Minshall M2, Bron M, Baran R, Pandya B
Affiliations: 1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US
Publications: 
American Diabetes Association, 2008, June 6 - 10, San Francisco, USA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Cost utility
 
 
Direct medical costs for type 2 diabetes mellitus complications in the U.S. commercial payer setting: a resource for economic research.
Authors: Pelletier EM1, Smith P1, Boye KS2, Misurski DA2, Tunis SL3, Minshall ME3
Affiliations: 1IMS Health, Watertown, MA, USA, 2Eli Lilly & Company, Indianapolis, IN, USA, 3IMS Health, Noblesville, IN, USA
Publications: 
Diabetologia, 2008, 51(Suppl 1): S538
European Association for the Study of Diabetes (EASD) 44th Annual Meeting, 2008, September, Rome, Italy
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Retrospective database analysis
 
 
Long-term cost-effectiveness of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with type 1 diabetes using a basal‚Äďbolus regimen in Belgium, France, Germany, Italy and Spain.
Authors: Gschwend M, Aagren M, Valentine WJ
Affiliations: 
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Belgium, France, Germany, Italy, Spain
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Long-term cost-effectiveness of insulin detemir compared to neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal‚Äďbolus regimen in Sweden.
Authors: Valentine WJ1, Lammert M2, Aagren M3, Gschwend M1.
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk Scandinavia AB, Copenhagen, Denmark; 3 Novo Nordisk, Bagsv√¶rd, Denmark
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Biphasic insulin aspart 70/30 vs. insulin glargine in insulin na√Įve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting.
Authors: Goodall G1, Jendle JH2, Valentine WJ1, Munro V3, Brandt AB4, Ray JA1, Roze S1, Foos V1, Palmer AJ1
Affiliations: 1 IMS Health, Basel, Switzerland, 2 Department of Clinical Medicine, √Ėrebro University Hospital, √Ėrebro, Sweden, 3 Novo Nordisk Ltd, Crawley, West Sussex, UK, 4 Novo Nordisk Scandinavia AB, Malm√∂, Sweden
Publications: 
Int J Clin Pract. 2008 Jun;62(6):869-76.
Document Types: , Manuscript in preparation
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18479280?dopt=Abstract
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes.
Authors: Valentine WJ1, Goodall G1, Aagren M2, Nielsen S2, Palmer AJ1, Erny-Albrecht K1
Affiliations: 1 IMS Health, Allschwil, Switzerland, 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark
Publications: 
Adv Ther. 2008 Jun;25(6):567-84.
Document Types: , Manuscript in preparation
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Evaluation of long-term clinical benefits associated with early versus late initiation of insulin in type 2 diabetes patients in the UK.
Authors: E. Sarpong1, C. Pratoomsoot2, G. Goodall2, R. Hayes1, W.J. Valentine2
Affiliations: 1Gho-hta/policy, Eli Lilly and Company, Indianapolis, IN, United States, 2Health Economics and Outcomes Research, IMS Health, Basel, Switzerland
Publications: 
44th EASD Annual Meeting, Rome, 7-11 September 2008
EASD 2008 Annual Meeting, Rome
Document Types: , Oral presentation
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analyses in a Chinese setting.
Authors: Chen X1, Clegg JP2, Chen L1, Yu H3, Wittrup-Jensen KU4, Valentine WJ1
Affiliations: 1Fu Dan University, Shanghai, China, 2IMS Health, Basel, Switzerland, 3Bayer Healthcare Co. Ltd, Shanghai, China, 4Bayer Schering Pharma AG, Berlin, Germany
Publications: 
3rd Asia-Pacific Conference, 7-9 September 2008
Document Types: , Oral presentation
Countries: , China
Abstract: http://www.ingentaconnect.com/content/apl/cmro/2006/00000022/00000007/art00019?token=006718db3e1a03ae72752d455e4e2663433b393f6a3340257d7241255e437a63736a425b6b674c58662a702c2e6e49625371e31
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
El impacto de la obesidad en el manejo y evolución de la diabetes mellitus [The impact of obesity in the management and evolution of diabetes mellitus.]
Authors: Dilla T1, Costi M1, Boye KS2, Reviriego J1, Yurgin N2, Badia X3, Lara-Suri√Īach N3
Affiliations: 1Clinical Research Department. Eli Lilly and Company. Madrid. Espa√Īa. 2Global Health Outcomes. Eli Lilly and Company. Corporate Center. Indian√°polis. Estados Unidos. 3Health Economics and Outcomes Research (IMS Health). Barcelona. Espa√Īa.
Publications: 
Revista Cl√≠nica Espa√Īola 2008; 208(9):437-43
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19000471
Condition Year Language Analysis type
, Diabetes 2008 Spanish , Epidemiological study
 
 
Adding Insulin Glargine to oral Therapy in patients with type 2 diabetes results in longer persistence with treatment compared to NPH insulin
Authors: Pfohl M4, Dippel FW3, Kostev K2, Kotowa W1
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt, Germany 4 IMS Health HEOR, Nuremberg, Germany
Publications: 
ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2008 English , Retrospective database analysis
 
 
Cost advantages and improved patient treatment satisfaction with insulin glargine in type 2 diabetes patients. The long-acting insulin glergine vs NPH insulin cost evaluation study in germany (LIVE-DE)
Authors: Scholten T1, Kohlmann T2, Moock J2, Holle R3, Landgraf W4, Pirk O5, Hauner H6
Affiliations: 1 Internal Medicine, Univ. of Witten/Herdecke, Germany; 2 Institute of Community Medicine, Univ. of Greifswald, Germany; 3 Institute of Health Economics & Health Care Management, Helmholtz Centre Munich, Germany; 4 sanofi-aventis, Berlin, Germany; 5 IMS Health HEOR, Nuremberg, Germany; 6 Else Kr√∂ner-Fresenius-Centre for Nutritional Medicine, TU Munich, Germany
Publications: 
EASD 44th Annual Meeting, 7-11. September 2008, Rome, Italy
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Insulin Glargine and NPH Insulin based regimens reveal comparable total direct treatment costs in type 2 diabetes patients. The long-acting insulin Glargine vs. NPH insulin cost evaluaton study in germany (LIVE-DE)
Authors: Scholten T1, Holle R2, Dippel FW3, Spiesecke A4, Hauner H5
Affiliations: 1 University of Witten-Herdecke, Hagen, Germany 2 Institute of Health Economics & Health Care Management, Helmholtz Center Munich, Germany 3 sanofi-aventis, Berlin, Germany 4 IMS Health HEOR, Nuremberg, Germany 5 Else Kr√∂ner-Fresenius-Center for Nutritional Medicine, Technical University Munich, Munich, Germany
Publications: 
ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Abstract, Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness, Retrospective database analysis
 
 
Basal insulins (e. g. glargine) combined with oral antidiabetics are most commonly used to initiate insulin therapy in type-2-diabetes patients in Germany
Authors: Kress S4, Dippel FW3, Kostev K2, Kogler C1, Kotowa W1
Affiliations: 1 IMS Health, Nuremberg, Germany 2 IMS Health GmbH, Frankfurt, Germany 3 Sanofi-Aventis, Berlin, Germany 4 Vinzentius-Krankenhaus Landau
Publications: 
15. Annual Meeting GAA e.V., 20-21. November 2008, Bonn, Germany
Document Types: , Abstract
Countries: , Germany
Abstract: http://www.egms.de/en/meetings/gaa2008/08gaa22.shtml
Condition Year Language Analysis type
, Diabetes 2008 English , Retrospective database analysis
 
 
Basalinsuline in Kombination mit oralen Antidiabetika stellen den häufigsten Einstieg in die Insulintherapie bei Patienten mit Typ-2-Diabetes dar [Basal insulins (e. g. glargine) combined with oral antidiabetics are most commonly used to initiate insulin therapy in type-2-diabetes patients in Germany].
Authors: Kress S1, Dippel FW2, Kostev K3, Kogler C4, Kotowa W4
Affiliations: 1 Vinzentius-Krankenhaus Landau, Germany 2 Sanofi-Aventis Deutschland GmbH, Germany 3 IMS Health GmbH, Frankfurt, Germany 4 IMS Health, Nuremberg, Germany
Publications: 
15. Jahrestagung der Gesellschaft f√ľr Arzneimittelanwendungsforschung und Arzneimittelepidemiologie 20.11. - 21.11.2008, Bonn
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2008 German , Retrospective database analysis
 
 
Estimating the long-term clinical and economic benefits of insulin lispro in type 1 diabetes in the UK: a cost-effectiveness analysis based on the results of a recent meta-analysis
Authors: Smith HT1, Valentine WJ2, Boye KS3, Kalsekar A3, Pratoomsoot C2
Affiliations: 1Eli Lilly and Company, Surrey, UK, 2IMS Health, Basel, Switzerland, 3Eli Lilly and Company, Indianapolis, IN, USA
Publications: 
ISPOR 2008 11th Annual European Congress, Athens
Document Types: , Oral presentation
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Insulin glargine- and NPH insulin-based regimens reveal comparable total direct treatment costs in patients with type 2 diabetes. Results of the long-acting insulin glargine vs. NPH insulin cost evaluation study in Germany (LIVE-DE)
Authors: Scholten T1, Holle R2, Dippel FW3, Spiesecke A4, Hauner H5
Affiliations: 1 University of Witten-Herdecke, Hagen, Germany 2 Institute of Health Economics & Health Care Management, Helmholtz Center Munich, Germany 3 sanofi-aventis, Berlin, Germany 4 IMS Health HEOR, Nuremberg, Germany 5 Else Kr√∂ner-Fresenius-Center for Nutritional Medicine, Technical University Munich, Munich, Germany
Publications: 
ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD).
Authors: Grandy S, Chapman RH, Fox KM, for the SHIELD Study Group.
Affiliations: 2 IMS Health, Falls Church, VA, USA
Publications: 
International Journal of Clinical Practice 2008; 62(4):562-568.
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Survey research
 
 
Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US.
Authors: Tunis SL, Minshall ME, St. Charles M, Pandya BJ, Baran RW
Affiliations: 1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US 3 Formerly of IMS Health, Falls Church, VA, US 4 Takeda, Deerfield, IL, USA 5 Takeda, Deerfield, IL, US
Publications: 
Current Medical Research and Opinion 2008;24(11):3085-3096.
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Treatment failures in type 2 diabetes patients taking oral anti-diabetes drugs
Authors: Chapman R, Ferrufino C, Maclean JR, Krishnarajah G
Affiliations: 1 IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US 3 Bristol-Myers Squibb, Princeton, NJ, US 4 Bristol-Myers Squibb, Princeton, NJ, US 4
Publications: 
American Diabetes Association’s 68th Scientific Sessions, 2008, June San Francisco, CA, US
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Retrospective cohort analysis
 
 
Cost-effectiveness of blood glucose monitoring is controversial. Reply to Aspinall SL and Glassman PA
Authors: Tunis SL, Minshall ME
Affiliations: 1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US
Publications: 
American Journal of Managed Care, 2008;14(6):399-400.
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia
Authors: Mohammed Ali1, Jeremy White2, Chen-Hui Lee2, James L Palmer3, Jayne Smith-Palmer3, Walid Fakhoury4, William J Valentine3
Affiliations: 1 IMS Health, Riyadh, Saudi Arabia 2 Novo Nordisk International Operations A/S, Zurich, Switzerland 3 IMS Health, Basel, Switzerland 4 IMS Health, London, UK
Publications: 
Document Types: , Manuscript in preparation
Countries: 
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696990802589122
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Direct medical costs for type 2 diabetes mellitus complications in the U.S. commercial payer setting.
Authors: Pelletier EM1, Smith PJ1, Boye KS2, Misurski DA2, Tunis SL3, Minshall ME3
Affiliations: 1IMS Health, Watertown, MA, USA, 2Eli Lilly & Company, Indianapolis, IN, USA, 3IMS Health, Noblesville, IN, USA
Publications: 
Applied Health Economics and Health Policy, 2008, 6(2-3): 103-112
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Cost analysis
 
 
Cost-Effectiveness of Aliskiren in Addition to Losartan and Optimal Antihypertensive Therapy in Patients with Hypertension and Diabetic Nephropathy: A US Healthcare System Perspective
Authors: Thomas E Delea1; James L Palmer2; Lieven Annemans3; Helen Lau4; Veronica C Munk5; Jennifer Sung4; Alan Charney4; Sean D Sullivan6
Affiliations: 1 Policy Analysis Inc., Brookline, MA, USA; 2 IMS Health, Basel, Switzerland; 3 Ghent University, Ghent, Belgium; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 5 Novartis Pharma AG, Basel, Switzerland; 6 University of Washington, Seattle, WA, USA
Publications: 
Document Types: , Poster
Countries: , USA
Abstract: N/A
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Cost-effectiveness of aliskiren as add-on to losartan and optimal antihypertensive therapy in patients with type 2 diabetes, hypertension and nephropathy in the UK setting
Authors: James L. Palmer1, Veronica C. Munk2, Robert W. Kotchie3, Gabor Vincze2, Alan Charney4, Daniel M.D. Tucker1, Lieven Annemans5
Affiliations: 1IMS Health, Basel, Switzerland; 2Novartis Pharma AG Basel, Switzerland; 3IMS Health, London, UK; 4Novartis Pharmaceuticals Corporation, New Jersey, USA; 5Ghent University, Ghent, Belgium
Publications: 
Document Types: , Poster
Countries: , UK
Abstract: N/A
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Standardized type 2 diabetes complication costs from U.S. commercial payers to be used in modeling the long-term economic outcomes of diabetes complications.
Authors: Minshall ME1, Pelletier EM1, Smith PJ1, Forma FM2
Affiliations: 1IMS Health, Inc., Watertown, MA, USA, 2Eli Lilly and Company, Indianapolis, IN, USA
Publications: 
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 11th Annual European Meeting. Athens, Greece, November 2008.
Document Types: , Abstract, Podium presentation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2008 English , Retrospective cohort analysis, Retrospective database analysis
 
 
Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
Authors: Ringborg A, Martinell M, St√•lhammar J, Yin DD, Lindgren P.
Affiliations: IMS Health, Stockholm. (Formally Pygargus)
Publications: 
Int J Clin Pract. 2008 May;62(5):708-16. doi: 10.1111/j.1742-1241.2008.01716.x. Epub 2008 Mar 17.
Document Types: , Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Resource+use+and+costs+of+type+2+diabetes+in+Sweden+%E2%80%93+estimates+from+population-based+register+data&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2008 English , Cost consequence, Cost of illness
 
 
Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
Authors: Ringborg A, Lindgren P, Martinell M, Yin DD, Sch√∂n S, St√•lhammar J.
Affiliations: IMS Health, Stockholm. (Formally Pygargus)
Publications: 
Diabet Med. 2008 Oct;25(10):1178-86. doi: 10.1111/j.1464-5491.2008.02541.x.
Document Types: , Article
Countries: , Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Prevalence+and+incidence+of+Type+2+diabetes+and+its+complications+1996%E2%80%932003+%E2%80%93+estimates+from+a+Swedish+population-based+study.&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Diabetes 2008 English , Burden of illness
 
 
Association between serious ischemic cardiac outcomes and medications used to treat diabetes.
Authors: Margolis D J, Hoffstad O & Strom BL
Affiliations: Department of Dermatology, University of Pennsylvania School of Medicine
Publications: 
Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):753-9. doi: 10.1002/pds.1630.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18613215
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2008 English , Retrospective database analysis
 
 
Diabetes diagnosis, resource utilization, and health outcomes.
Authors: Gulliford MC, Latinovic R & Charlton J
Affiliations: King's College London, Public Health Sciences
Publications: 
Am J Manag Care. 2008 Jan;14(1):32-8.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18197743
Condition Year Language Analysis type
, Diabetes 2008 English , Retrospective database analysis
 
 
Risk of chronic end stage renal disease after use of ACE inhibitors compared to other antihypertensives or no-antihypertensive use in a cohort of diabetic patients in the United Kingdom
Authors: Laudati J, Motsko S & Jones J
Affiliations: 
Publications: 
Pharmacoepidemiology and Drug Safety 17(S233)
Document Types: , Abstract
Countries: , UK
Abstract: http://www.deggegroup.com/2008-ISPE%20-%20Diabetes-THIN.pdf
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes 2008 English , Retrospective database analysis
 
 
Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia
Authors: Mohammed Ali 1 , Jeremy White 2 , Chen-Hui Lee 2 , James L Palmer 3 , Jayne Smith-Palmer 3 , Walid Fakhoury 4 , William J Valentine 3
Affiliations: 1 IMS Health, Riyadh, Saudi Arabia 2 Novo Nordisk International Operations A/S, Zurich, Switzerland 3 IMS Health, Basel, Switzerland 4 IMS Health, London, UK
Publications: 
Journal of Medical Economics 2008; 11: 651‚Äď670
Document Types: , Abstract
Countries: , Saudi Arabia
Condition Year Language Analysis type
, Diabetes 2008 English , Cost analysis
 
 
The IMPROVE study ‚Äď a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts
Authors: Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y
Affiliations: 
Publications: 
Int J Clin Pract 2008;62(11):1809‚Äď1819
Document Types: , Article
Countries: 
Condition Year Language Analysis type
, Diabetes 2008 English , RWLPR (Real-World Late Phase Research-quintiles
 
 
Cost-Effectiveness of Insulin Detemir Compared to NPH Insulin for Type 2 Diabetes Mellitus (T2DM) in the Canadian Payer Setting: Modeling Analysis using an Observational Study
Authors: Minshall ME1, Tunis SL2, Conner C, McCormick JI, Kapor J, Groleau D
Affiliations: 1 Formerly of IMS Health, Falls Church, VA, USA IMS Health, Falls Church, VA, USA
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2008 English , Observational study
 
 
Frequency of Self-Monitoring of Blood Glucose in Type 2 Diabetes: A Cost-Effectiveness Modeling Study in the U.S. Setting.
Authors: Erny-Albrecht KM, Tunis SL1, Minshall ME2, Valentine W, Foos V, Palmer AJ.
Affiliations: 1 IMS Health, Falls Church, VA, US 2 Formerly of IMS Health, Falls Church, VA, US
Publications: 
American Diabetes Association 2007 Chicago, IL
Diabetes, 2007; 56 (Suppl. 1):A308-A309.
Document Types: , Abstract, Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
The Cost-Effectiveness of Pioglitazone Plus Metformin Compared with Rosiglitazone Plus Metformin: an Economic Evaluation Using a Previously Validated Economic Model from a Third Party Payer Perspective in the USA
Authors: Minshall ME, Donovan ME, Pandya BJ, Baran RW
Affiliations: 
Publications: 
Diabetes Technology Society. October, 2007 USA
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
The Cost-Effectiveness of Pioglitazone Compared with Sitagliptin: an Economic Evaluation Using a Validated Economic Model from a Third Party Payer Perspective in the USA
Authors: Minshall ME, Donovan ME, Pandya BJ, Baran RW, Bron MS
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Long-Term CEA on Actos‚ĄĘ for the USA from PROactive
Authors: Palmer A, Minshall M, Valentine W, Foos V, Baran R, and Silberman C
Affiliations: 
Publications: 
American Diabetes Association 2007 Chicago, IL
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Long-Term Cost-Effectiveness Analysis on Actos‚ĄĘ for the USA from PROactive.
Authors: Palmer AJ, Minshall ME, Valentine WJ, Foos V, Baran RW, Silberman C.
Affiliations: 
Publications: 
Diabetes, 2007; 56 (Suppl. 1):A314.
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Application of Cost-Effectiveness Analysis to Evaluate the Proposed Formulary Status of a Novel Antidiabetic Drug in a U.S. Commercial Health Plan.
Authors: Watkins J, Minshall M, Sullivan SD.
Affiliations: 
Publications: 
Value in Health, 2007; 10(3):A198.
Document Types: , Abstract
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-effectiveness of diabetes case management for low-income populations
Authors: Gilmer TP, Roze S, Valentine WJ, Emy-Albrecht K, Ray JA, Cobden D, Nicklasson L, Philis-Tsimikas A, Palmer AJ.
Affiliations: 
Publications: 
Health Serv Res. 2007 Oct;42(5):1943-59.
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://findarticles.com/p/articles/mi_m4149/is_5_42/ai_n21041659
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: an Adjunctive Treatment for Type 2 Diabetes mellitus.
Authors: Minshall ME, Oglesby AK, Wintle ME, Valentine WJ, Roze S, Palmer AJ.
Affiliations: 
Publications: 
Volume 11, Issue 1, Date: January/February 2008, Pages: 22-33
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://www.druglib.com/abstract/mi/minshall-me_value-health_20080100.html
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK.
Authors: Palmer AJ, Valentine WJ, Ray JA, Foos V, Lurati F, Smith I, Lammert M, Roze S.
Affiliations: 
Publications: 
Curr Med Res Opin. 2007 Apr;23(4):895-901.
Document Types: , Manuscript in preparation
Countries: , UK
Abstract: http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&ID=22007008078
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis.
Authors: Palmer AJ, Valentine WJ, Ray JA, Roze S, Muszbek N.
Affiliations: 
Publications: 
Eur J Health Econ. 2007 Jun;8(2):161-8. Epub 2007 Jan 20
Document Types: , Manuscript in preparation
Countries: , Hungary
Abstract: http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=22007008181
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain
Authors: Pi√Īola C, Roze S, Valentine W, Evers T.
Affiliations: 
Publications: 
Gaceta Sanitaria 2007;21(2):97-104
Document Types: , Manuscript in preparation
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17419924
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.
Authors: Joshua A. Ray1, Kristina S. Boye2, Nicole Yurgin2, William J. Valentine‌1, St√©phane Roze‌1, Jan McKendrick‌3, Daniel M. D. Tucker‌1, Volker Foos‌1 and Andrew J. Palmer‌1
Affiliations: 1IMS Health, Allschwil, Switzerland, 2Eli Lilly and Company, Indianapolis, IN, USA, 3Eli Lilly and Company, Basingstoke, UK
Publications: 
Curr Med Res Opin. 2007 Mar;23(3):609-22.
Document Types: , Manuscript in preparation
Countries: , UK
Abstract: http://pharmacy.researchtoday.net/archive/3/3/935.htm
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.
Authors: Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ.
Affiliations: 
Publications: 
Diabetes Obes Metab. 2007 Jan;9(1):103-13.
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://www.druglib.com/abstract/ra/ray-ja_diabetes-obes-metab_20070100.html
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
Authors: Valentine WJ, Bottomley JM, Palmer AJ, Brandle M, Foos V, Williams R, Dormandy JA, Yates J, Tan MH, Massi-Benedetti M; on behalf of the PROactive Study Group.
Affiliations: 
Publications: 
Diabet Med. 2007 Sep;24(9):982-1002.
Document Types: , Manuscript in preparation
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States.
Authors: Valentine WJ, Erny-Albrecht KM, Ray JA, Roze S, Cobden D, Palmer AJ.
Affiliations: 
Publications: 
Adv Ther. 2007 Mar-Apr;24(2):273-90.
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17565917/
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-effectiveness of insulin detemir versus NPH for type 1 diabetes patients in an Italian setting. A meta-analysis.
Authors: Aristides M1, Kotchie R1, Nielsen S2, Aagren M2, Valentine WJ3, Goodall G3
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark; 3 IMS Health, Basel, Switzerland.
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-Effectiveness Of Biphasic Insulin Aspart 30 Versus Human Premix Insulin For Type 2 Diabetes Patients In A Polish Setting
Authors: Aristides M1, Kotchie RW1, Nielsen S2, Townsend C2, Valentine WJ3, Scheijbeler HW1
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark; 3 IMS Health, Basel, Switzerland
Publications: 
ISPOR 2007 10th Annual European Congress
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20 - 23 October 2007
Document Types: , Poster
Countries: , Poland
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Mealtime insulin aspart reduces the long-term cost of complications compared to human insulin as part of basal-bolus therapy in Polish type 2 diabetes patients
Authors: Goodall G1, Nielsen S2, Townsend C2, Kotchie R3, Erny-Albrecht K1, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 NovoNordisk, Bagsv√¶rd, Denmark; 3 IMS Health, London, UK.
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Poland
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Long-term cost-utility analysis of insulin aspart (Novorapid¬ģ) versus human soluble insulin in type 2 diabetes patients in the German setting
Authors: Erny-Albrecht K1, Valentine WJ1, Townsend C2, Kotchie RW3, Nielsen S2, Goodall G1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 NovoNordisk, Bagsv√¶rd, Denmark; 3 IMS Health, London, UK.
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Oral presentation, Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness, Cost utility
 
 
Long-term clinical outcomes Of Insulin Detemir Versus NPH for Type I Diabetes Patients in Spain
Authors: Kotchie R1, Aagren M2, Nielsen S2, Valentine WJ3, Goodall G3
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagv√¶rd, Denmark; 3 IMS Health, Basel, Switzerland.
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-effectiveness of insulin detemir versus NPH for type 1 diabetes patients in a German setting. A modeling evaluation based upon results from a meta-analysis.
Authors: Kotchie RW1, Scheijbeler HW1, Aagren M2, Nielsen S3, Valentine WJ3 , Goodall G3
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark; 3 IMS Health, Basel, Switzerland.
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Oral presentation, Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Long-term cost-effectiveness analysis of a modern insulin in patients with poorly controlled type 2 diabetes in the German setting; data from the PREDICTIVE study
Authors: Palmer JL1, Goodall G1, Aagren M2, Nielsen S2, Kotchie RW3, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark; 3 IMS Health, London, UK.
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-effectiveness of detemir versus NPH for type 1 diabetes patients treated with basal-bolus therapy in a Belgium setting. A modeling evaluation based on results from a meta-analysis of three clinical trials.
Authors: Scheijbeler HW1, Aagren M2, Nielsen S2, Valentine WJ3, Goodall G3, Kotchie RW1
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark; 3 IMS Health, Basel, Switzerland.
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Belgium
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Evaluating the cost-effectiveness of Biphasic Insulin Aspart 30 Versus Human Premix Insulin for the Treatment of Type 2 Diabetes in a Spanish Setting
Authors: Tucker D1, Valentine WJ1, Nielsen S2, Townsend C2, Kotchie R3, Scheijbeler H3
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk, Bagsv√¶rd, Denmark; 3 IMS Health, London, UK.
Publications: 
ISPOR 2007 10th Annual European Congress, 2007 October 20-23, Dublin, Ireland
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Evaluating the long-term clinical and economic implications of converting type 2 diabetes patients to insulin detemir (¬Ī oral hypoglycemic agents) from insulin glargine based regimens in Germany; data from the PREDICTIVE study
Authors: Valentine WJ1, Goodall G1, Aagren M2, Nielsen S2, Kotchie RW3
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark; 3 IMS Health, London, UK.
Publications: 
ISPOR 2007 10th Annual European Congress
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Evaluating the long-term cost-effectiveness of insulin aspart (Novorapid¬ģ) versus human soluble insulin in patients with type 2 diabetes in Spain and Italy
Authors: Erny-Albrecht K1, Goodall G1, Townsend C2, Kotchie RW3, Nielsen S2, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk, Bagsv√¶rd, Denmark; 3 IMS Health, London, UK
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Italy, Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-effectiveness of biphasic insulin aspart 30 versus human premix insulin for type 2 diabetes patients in China
Authors: Lynch M1, Scheijbeler HW2, Kotchie R2, Valentine WJ3, Nielsen S4, White J5
Affiliations: 1IMS Health, Shanghai, China; 2IMS Health, London, UK; 3 IMS Health, Basel, Switzerland; 4Novo Nordisk, Bagsv√¶rd, Denmark; 5Novo Nordisk, Z√ľrich, Switzerland
Publications: 
ISPOR 2007 10th Annual European Congress, Athens, Greece, 8 ‚Äď 11 November 2008
Document Types: , Poster
Countries: , China
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-effectiveness of insulin detemir versus NPH for type 1 diabetes patients in an Italian setting. Long-term simulations based on a meta-analysis
Authors: Aristides M1, Kotchie RW1, Nielsen S2, Aagren M2, Valentine WJ3, Goodall G3
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark; 3 IMS Health, Basel, Switzerland
Publications: 
ISPOR 2007 10th Annual European Congress, Athens, Greece, 8 ‚Äď 11 November 2008
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Long-term economic outcomes associated with insulin aspart versus human bolus insulin in type 2 diabetes patients in the Swedish setting
Authors: Valentine WJ1, Goodall G1, Townsend C2, Kotchie RW3, Nielsen S2, Erny-Albrecht K1
Affiliations: 1 IMS Health, Basel, Switzerland 2 Novo Nordisk, Bagsv√¶rd, Denmark 3 IMS Health, London, UK
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Cost-utility of insulin detemir versus NPH for type 1 diabetes patients treated with basal-bolus therapy in a French setting. A modeling evaluation based on results from a meta-analysis of three clinical trials
Authors: Scheijbeler H1, Aagren M2, Nielsen S2, Valentine WJ3, Goodall G3, Kotchie R1
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagsv√¶rd, Denmark; 3 IMS Health, Basel, Switzerland
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2007 English , Cost utility
 
 
SMBG Cost-Effectiveness in Canada
Authors: Minshall M1, Tunis SL2, Tuttle, J, Ur E
Affiliations: 1 Formerly of IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US
Publications: 
Canadian Diabetes Association Professional Conference, Vancouver, October 24-27, 2007
Document Types: , Abstract
Countries: , Canada
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Health Related Quality of Life of Patients with Type 2 Diabetes in Primary Care in Spain: Self-reported and Proxy Assessment using the EQ-5D.
Authors: Boye K S, Yurgin N, Dilla T, Cordero LA, Badia X, Lara Suri√Īach L, Perez P
Affiliations: 
Publications: 
J Med Econ 2007;10:41-58
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Quality of life
 
 
The relationship of body mass index to diabetes, hypertension, and dyslipidemia: Comparison of data from two national surveys
Authors: Bays HE, Chapman RH, Grandy S for the SHIELD Investigators‚Äô Group
Affiliations: 
Publications: 
International Journal of Clinical Practice 2007; 61(5):737-747
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Survey research
 
 
Health-related quality of life and utilities of respondents with type 2 diabetes compared with those with differing levels of cardiometabolic risk
Authors: Chapman RH, Fox KM, Grandy S
Affiliations: 
Publications: 
Value in Health 2007; 10(3):A69 ISPOR 12th Annual International Meeting, Arlington, VA, May 19-23, 2007
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Survey research
 
 
Impact of obesity on work productivity among individuals with type 2 diabetes mellitus and varied levels of cardiometabolic risk
Authors: Stewart WF, Chapman RH, Gavin JR, Fox KM, Grandy S
Affiliations: 
Publications: 
Accepted at 67th Scientific Sessions of American Diabetes Association, Chicago, IL, June 22-26, 2007
Document Types: , Poster
Countries: , USA
Abstract: http://professional.diabetes.org/Abstracts_Display.aspx?TYP=1&CID=54373
Condition Year Language Analysis type
, Diabetes 2007 English , Survey research
 
 
Self-Monitoring of Blood Glucose in Type 2 Diabetes: Frequency of Testing and Diabetes-Related Complications in a Simulated Cohort.
Authors: Tunis SL, Erny-Albrecht KM, Minshall ME, Valentine W, Foos V, Palmer AJ.
Affiliations: 
Publications: 
American Diabetes Association 2007 Chicago, IL
Diabetes, 2007; 56 (Suppl. 1):A309.
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2007 English
 
 
Health Related Quality of Life of Patients with Type 2 Diabetes in Primary Care in Spain: Self-reported and Proxy Assessment using the EQ-5D.
Authors: Boye K S, Yurgin N, Dilla T, Cordero LA, Badia X, Lara Suri√Īach L, Perez P.
Affiliations: 
Publications: 
J Med Econ 2007;10:41-58
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Quality of life
 
 
Health Economic Comparison between Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Injections (MDI) of Insulin for the Treatment of Adult and Adolescent Type 1 Diabetes in Australia.
Authors: Cohen N, Minshall ME, Nash L, Zakrzewska, K, Valentine WJ, Palmer AJ.
Affiliations: 
Publications: 
In press, PharmacoEconomics, 2008.
Document Types: , Manuscript in preparation
Countries: , Australia
Abstract: http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=22007002138
Condition Year Language Analysis type
, Diabetes 2007 English
 
 
Proposed Formulary Status of a Novel Antidiabetic Drug in a U.S. Commercial Health Plan.
Authors: Watkins J, Minshall M, Sullivan SD. Application of Cost-Effectiveness Analysis to Evaluate the
Affiliations: 
Publications: 
Value in Health, 2007; 10(3):A198.
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English
 
 
Comparative study of annual treatment cost of glargine insulin and detemir insulin in patients with type 2 diabetes mellitus in Spain
Authors: Alvarez de Guisasola F, Casal Llorente C, Rubio C , Beteg√≥n L
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Cost analysis
 
 
Estimating the long-term clinical outcomes associated with switching to insulin aspart (novorapid¬ģ) from human soluble insulin in type 2 diabetes patients in the Polish setting
Authors: Goodall G1, Valentine WJ1, Townsend C2, Kotchie RW3, Nielsen S2, Erny-Albrecht K1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 NovoNordisk, Bagsv√¶rd, Denmark; 3 IMS Health, London, UK.
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Poland
Condition Year Language Analysis type
, Diabetes 2007 English , Cost utility
 
 
Costs And Neonatal Outcomes After Insulin Aspart Compared With Human Insulin In Pregnant Women With Type 1 Diabetes.
Authors: Lloyd A1, Twena N2, Townsend C3, Holman AJ1.
Affiliations: 1 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 2 Novo Nordisk Ltd, UK 3 Novo Nordisk A/S, Denmark
Publications: 
International Society for Pharmacoeconomics and Outcomes Research, Dublin. 23-27 October 2007
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2007 English , Cost of illness
 
 
Inpatient Costs and Health Outcomes for Pregnant Women with Type 1 Diabetes.
Authors: Holman AJ1, Munro V2, Nielsen S3, Lloyd AC1
Affiliations: 1 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 2 Novo Nordisk Ltd, UK 3 Novo Nordisk A/S, Denmark
Publications: 
International Society for Pharmacoeconomics and Outcomes Research, Dublin, 23-27 October 2007
Document Types: , Poster
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2007 English , Cost of illness
 
 
Treatment failures in type 2 diabetes patients taking oral anti-diabetes drugs
Authors: Chapman R, Ferrufino C, Maclean JR, Krishnarajah G
Affiliations: 
Publications: 
American Diabetes Association’s 68th Scientific Sessions, San Francisco, CA, June 6-10, 2008
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2007 English , Retrospective cohort analysis
 
 
Insulin Glargine and NPH Insulin based regimens reveal comparable total direct treatment costs in type 2 diabetes patients. The lon-acting insulin Glargine vs. NPH insulin cost evaluaton study in germany (LIVE-DE)
Authors: Scholten T2, Holle R3, Landgraf W5, Spiesecke A1, Hauner H4
Affiliations: 1 IMS Health, Nuremberg, Germany 2 University of Witten-Herdecke, Hagen, Germany 3 Institute of Health Economics & Health Care Management, Helmholtz Center Munich, Germany 4 Else Kr√∂ner-Fresenius-Center for Nutritional Medicine, Technical University Munich, Munich, Germany 5 sanofi-aventis, Berlin, Germany
Publications: 
ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Oral presentation
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK.
Authors: Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P.
Affiliations: RTI Heath Solutions, Manchester
Publications: 
Diabet Med. 2007 Dec;24(12):1412-8.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18042083
Condition Year Language Analysis type
, Diabetes 2007 English , Retrospective database analysis
 
 
The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
Authors: Currie CJ, Poole CD, Tetlow T, Holmes P & McEwan P
Affiliations: Department of Medicine, School of Medicine, Cardiff University
Publications: 
Current Medical Research & Opinion 23(1):33-9
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://informahealthcare.com/doi/abs/10.1185/030079907X167534
Condition Year Language Analysis type
, Diabetes 2007 English , Retrospective database analysis
 
 
The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
Authors: Poole C, Tetlow D, McEwan T, Holmes P, Currie P & Craig J
Affiliations: threesixtydegree Research Ltd, Penarth
Publications: 
Current Medical Research & Opinion (8):41-48
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://informahealthcare.com/doi/abs/10.1185/030079907X167589
Condition Year Language Analysis type
, Diabetes 2007 English , Retrospective database analysis
 
 
Combining Population Health and Baseline Risk Strategy by Determining an Age Cutoff for Initiating Statins in Patients With Diabetes A population-based study
Authors: Siyambalapitiya S, Bulugahapitiya U, Sithole J, Song S, Fernando D J S & Idris I
Affiliations: Department of Diabetes and Endocrinology, Sherwood Forest Hospitals Foundation Trust
Publications: 
Diabetes Care 30:2025-2029
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://care.diabetesjournals.org/content/30/8/2025.fulld
Condition Year Language Analysis type
, Diabetes 2007 English , Retrospective database analysis
 
 
Medical management and costs associated with staphylococcus aureus (SA) bacteraemia in haemodialysis patients: A cost-of-illness study.
Authors: Strens D, Moeremans K, Annemans L, Jadoul M, Cambier P, Billiouw JM
Affiliations: 
Publications: 
ISPOR 9th Annual European Congress, 2006, October 29-31, Copenhagen, Denmark
Document Types: , Oral presentation
Countries: , Belgium
Condition Year Language Analysis type
, Diabetes 2006 English , Cost of illness
 
 
Kosten-Effektivität der Acarbosetherapie bei Patienten mit gestörter Glukosetoleranz [Cost-effectiveness for acarbose therapy of patients with impaired glucose intolerance]
Authors: Liebl A, Lueddeke HJ, Kotowa W et al
Affiliations: IMS Health, Nuremberg, Germany
Publications: 
Gesundh ökon Qual manag 2006; 11:105-111
Document Types: , Article
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2006 German , Cost effectiveness
 
 
Cost-effectiveness of Acarbose in patients with type-2 diabetes in three countries
Authors: Evers T, Roze S, Palmer AJ, Valentine WJ, Tucker D, Hanefeld M
Affiliations: 
Publications: 
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2006 English , Cost effectiveness
 
 
Long-term cost-effectiveness analysis or repaglinide versus nateglinine in combination with metformin in type 2 diabetes patients failing monotherapy in the Swedish setting
Authors: Ray J1, Brandt AS2, Foos V1, Munro V3,Valentine WJ1, Roze S1,Palmer AJ1
Affiliations:  1 CORE‚ÄĒCenter for Outcomes Research, A Unit of IMS, Allschwil, Basel, Switzerland, 2 Novo Nordisk Scandinavia AB, Malmo, Sweden, 3 Novo Nordisk Ltd, Crawley, West Sussex, UK
Publications: 

Value in Health, Vol. 9, Issue 6, A227
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Diabetes 2006 English , Cost effectiveness
 
 
Cost-effectiveness analysis of acarbose in the prevention of type 2 diabetes in South Korea
Authors: JongMann Kim, Clegg John P, KyeungHee Chang, JuYeol Park, Wittrup-Jensen Kim, Valentine William J
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract
Countries: 
Condition Year Language Analysis type
, Diabetes 2006 English , Cost effectiveness
 
 
Self monitoring of blood glucose in patients with type 2 diabetes: cost utility analysis in a United States third-party payer setting
Authors: Palmer AJ, Minshall ME, Valentine WJ, Foos V, Tunis SL
Affiliations: 
Publications: 
Document Types: , Oral presentation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2006 English , Cost utility
 
 
Self monitoring of blood glucose in patients with type 2 diabetes: cost utility analysis in an Italian setting
Authors: Palmer AJ, Minshall ME, Valentine WJ, Foos V, Tunis SL
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Italy
Condition Year Language Analysis type
, Diabetes 2006 English , Cost utility
 
 
Self monitoring of blood glucose in patients with type 2 diabetes: cost utility analysis in a German government payer setting
Authors: Palmer AJ, Minshall ME, Valentine WJ, Foos V, Tunis SL
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Germany
Condition Year Language Analysis type
, Diabetes 2006 English , Cost utility
 
 
Self monitoring of blood glucose in patients with type 2 diabetes: cost utility analysis in a French government payer setting
Authors: Palmer AJ, Minshall ME, Valentine WJ, Foos V, Tunis SL
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , France
Condition Year Language Analysis type
, Diabetes 2006 English , Cost utility
 
 
Prevalence of metabolic síndrome in patients with Diabetes Mellitus 2 in Spain.
Authors: Rodr√≠guez A, Polavieja P, Garc√≠a R, Cobo A, Reviriego J, Carre√Īo A.
Affiliations: 
Publications: 
XXVI Congreso de la Sociedad Espa√Īola de Medicina Familiar y Comunitaria (SEMFYC), Valencia (Spain) 15-18 November
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2006 English , Epidemiological study
 
 
The efficacy of insulin glargine compared to other injectable therapies - A meta-analysis of clinical outcomes in insulin na√Įve type 2 diabetes patients
Authors: Pascoe K, McDonald-Everett CM, FitzGerland P, Yurgin NR,
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Australia
Condition Year Language Analysis type
, Diabetes 2006 English , Meta analysis
 
 
Overlapping cardiovascular risk factors in the United States adult diabetes population: Data from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes.
Authors: Stewart W, Clark N, Ansell B, Reed ML, Chapman R, Grandy S, for the SHIELD Study Group.
Affiliations: 
Publications: 
Circulation 2006; 113(21):44.
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
High prevalence of misdiagnosis of the metabolic syndrome in a self-reported survey: Possible confusion with having ‚Äúa metabolism problem‚ÄĚ.
Authors: Bays H, Chapman R, Klingman D, Fanning K, Grandy S.
Affiliations: 
Publications: 
2006 Annual Scientific Meeting of NAASO, the Obesity Society, Boston, MA, October 20-24, 2006.
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Diabetes symptoms reported in SHIELD by people with or at high risk for type 2 diabetes.
Authors: Clark N, Chapman R, Grandy S, for the SHIELD Study Group.
Affiliations: 
Publications: 
American Diabetes Association’s 66th Scientific Sessions, Washington, DC, June 9-13, 2006.
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Comparative health outcomes-based health economic evaluation of type 2 diabetes patients on basal insulin analogs
Authors: Cobden D, Valentine WJ, Koenen C, Palmer AJ, Roze S
Affiliations: 
Publications: 
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Continuous subcutaneous insulin infusions versus multiple daily injection of insulin in patients with type 1 diabetes: a long-term health economic analysis in the Norwegian and Swedish settings
Authors: Goodall G1, Nicklasson L2, Zakrzewska K3, Foos V1,Valentine WJ1,Roze S1, Palmer AJ1
Affiliations:  CORE‚ÄĒCenter for Outcomes Research, A Unit of IMS, Allschwil, Basel, Switzerland, 2 Medtronic AB, J√§rf√§lla, Sweden, 3 Medtronic AG, Tolochenaz, Switzerland
Publications: 

Value in Health, 2006:9 (6) A227
Document Types: , Poster
Countries: , Norway, Sweden
Condition Year Language Analysis type
, Diabetes 2006 English , Economic evaluation
 
 
Identifying high-risk populations in SHIELD with a 12-item screener questionnaire.
Authors: Grandy S, Reed M, Chapman R, for the SHIELD Study Group.
Affiliations: 
Publications: 
American Diabetes Association’s 66th Scientific Sessions, Washington, DC, June 9-13, 2006.
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Agreement between patient and physician assessment of health-related quality life of patients with type 2 diabetes treated by primary care physicians in Spain.
Authors: Lara N, Secnik K , Yurgin N, P√©rez P, Dilla T, Cordero LA, Badia X.
Affiliations: 
Publications: 
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
The CORE diabetes model - simulating long-term effect of implementing health policies for management of diabetes.
Authors: Palmer A, Valentine WJ, Ray JA, Lurati FM, Foos V, Minshall ME et al.
Affiliations: 
Publications: 
ISPOR 2nd Asia-Pacific Congress,Shanghai, China
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Economic evaluation of initiating insulin detemir among type 2 diabetes patients receiving oral medication
Authors: Palmer AJ, Cobden D, Valentine WJ, Wagner S, Roze S
Affiliations: 
Publications: 
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Management and treatment adherence in type 2 diabetic patients in Spain
Authors: Secnik K, Yurgin NR, Lara N, Badia X, Dilla T, Cordero LA
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Long-term clinical and economic outcomes for patients with type 1 diabetes treated with insulin aspart versus human soluble insulin in Sweden
Authors: Tucker D1, Brandt AS2, Foos V1, Munro V3, Goodall G1, Ray J1,Valentine WJ1, Roze S1, Palmer AJ1
Affiliations: 1 1 CORE‚ÄĒCenter for Outcomes Research, A Unit of IMS, Allschwil, Basel, Switzerland, 2 Novo Nordisk Scandinavia AB, Malmo, Sweden, 3 Novo Nordisk Ltd, Crawley, West Sussex, UK
Publications: 

Value in Health, Vol. 9, Issue 6, A226‚ÄďA227
Document Types: , Poster
Countries: , Sweden
Condition Year Language Analysis type
, Diabetes 2006 English , Economic evaluation
 
 
Therapy class conversion in patients with type 2 diabetes: economic evaluation of insulin detemir and NPH
Authors: Valentine WJ, Cobden D, Palmer AJ, Wagner S, Roze S
Affiliations: 
Publications: 
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Evaluating the long-term health outcomes and economics of initiating biphasic analog insulin compared to optimized oral therapy alone
Authors: Valentine WJ, Cobden D, Wagner S, Palmer AJ, Braceras R, Roze S
Affiliations: 
Publications: 
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Patient and physician drivers of health-related quality of life of patients with type 2 diabetes in primary care in Spain
Authors: Yurgin NR, Secnik K, Lara N, Badia X, Dilla T, Cordero LA
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
The CORE diabetes model - simulating long-term effects of implementing health policies for management of diabetes
Authors: Palmer A, Valentine WJ, Ray JA, Lurati FM, Foos V, Minshall ME, Roze S.
Affiliations: 
Publications: 
ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China
Document Types: , Poster
Countries: 
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Quantifying the impact of fear of hypoglycaemia on quality of life
Authors: Walters N, Gordois A, Brown A, Lindsay P, Gonzalo F, Comas S
Affiliations: 
Publications: 
ISPOR 9th Annual European Congress
Document Types: , Poster
Countries: , Australia
Condition Year Language Analysis type
, Diabetes, Health economics 2006 English , Burden of illness
 
 
Quality of life in people with and at risk for type 2 diabetes: Findings from the Study to Help Improve early Evaluation and management of risk factors Leading to Diabetes (SHIELD).
Authors: Chapman RH, Grandy S.
Affiliations: 
Publications: 
ISPOR 11th Annual International Meeting, Philadelphia, PA, May 20-24, 2006.
Document Types: , Oral presentation
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Modelling the effectiveness of oral agents in achieving HbAlc and lipid targets in patients with type 2 diabetes mellitus.
Authors: Lloyd AC1, Smith TW2, Bergenheim K3.
Affiliations: 1 Fourth Hurdle Consulting Ltd, London, UK 2ValueMedics Research LLC, Falls Church, VA, USA, 3AstraZeneca, M√∂lndal, Sweden
Publications: 
ISPOR 11th Annual International Meeting, Philadelphia, May 20th - 24th, 2006
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, Diabetes 2006 English , Cost effectiveness
 
 
The efficacy of insulin glargine compared to other injectable therapies‚ÄĒa meta-analysis of clinical outcomes in insulin na√Įve type 2 diabetes patients
Authors: Pascoe K, McDonald-Everett CM, FitzGerald P, Yurgin NR, Secnik K
Affiliations: 
Publications: 
ISPOR 9th Annual European Congress
Document Types: , Poster
Countries: , Australia
Condition Year Language Analysis type
, Diabetes 2006 English , Meta analysis
 
 
Increased incidence of carpal tunnel syndrome up to 10 years before diagnosis of diabetes
Authors: Gulliford MC, Latinovic R, Charlton J, & Hughes RAC
Affiliations: Division of Health and Social Care Research, King's College
Publications: 
Diabetes Care 29(8): 1929-1930
Document Types: , Article
Countries: , UK
Abstract: http://care.diabetesjournals.org/content/29/8/1929.full.pdf
Condition Year Language Analysis type
, Diabetes 2006 English , Retrospective database analysis
 
 
Population-based study of time to insulin after failure or oral antidiabetic (OA) therapy in type 2 diabetes (T2DM) in the UK
Authors: Rubino A, McQuay L, Kvasz M & Tennis P
Affiliations: RTI
Publications: 
Annual meeting of the American Diabetes Association Washington, USA
Document Types: , Abstract, Poster
Countries: , UK
Abstract: https://www.rtihs.org/publications/population-based-study-time-insulin-after-failure-or-oral-antidiabetic-oa-therapy-type
Condition Year Language Analysis type
, Diabetes 2006 English , Retrospective database analysis
 
 
Risk of Diabetes Associated With Prescribed Glucocorticoids in a Large Population
Authors: Gulliford MC, Charlton J & Latinovic R
Affiliations: Division of Health and Social Care Research, King's College London School of Medicine
Publications: 
Diabetes Care 29 (12): 2728-29
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://care.diabetesjournals.org/content/29/12/2728.full
Condition Year Language Analysis type
, Diabetes 2006 English , Retrospective database analysis
 
 
Time to insulin after failure of oral antidiabetic therapy in type 2 diabetes: A UK population-based analysis
Authors: Rubino A, McQuay L, Kvasz M & Tennis P
Affiliations: RTI
Publications: 
Pharmacoepidemiology and Drug Safety 15: (S1):S51
Document Types: , Abstract
Countries: , UK
Condition Year Language Analysis type
, Diabetes 2006 English , Retrospective database analysis
 
 
Copyright © 2019 IMS Health Incorporated. All rights reserved.